id	sid	tid	token	lemma	pos
ajlm-846	1	1	abstract	abstract	ADJ
ajlm-846	1	2	introduction	introduction	NOUN
ajlm-846	1	3	methods	method	NOUN
ajlm-846	1	4	results	result	VERB
ajlm-846	1	5	discussion	discussion	NOUN
ajlm-846	1	6	acknowledgements	acknowledgement	NOUN
ajlm-846	1	7	references	reference	NOUN
ajlm-846	1	8	about	about	ADP
ajlm-846	1	9	the	the	DET
ajlm-846	1	10	author(s	author(s	PROPN
ajlm-846	1	11	)	)	PUNCT
ajlm-846	1	12	brian	brian	PROPN
ajlm-846	1	13	r.	r.	PROPN
ajlm-846	1	14	kullin	kullin	PROPN
ajlm-846	1	15	department	department	PROPN
ajlm-846	1	16	of	of	ADP
ajlm-846	1	17	molecular	molecular	ADJ
ajlm-846	1	18	and	and	CCONJ
ajlm-846	1	19	cell	cell	NOUN
ajlm-846	1	20	biology	biology	NOUN
ajlm-846	1	21	,	,	PUNCT
ajlm-846	1	22	faculty	faculty	NOUN
ajlm-846	1	23	of	of	ADP
ajlm-846	1	24	science	science	NOUN
ajlm-846	1	25	,	,	PUNCT
ajlm-846	1	26	university	university	NOUN
ajlm-846	1	27	of	of	ADP
ajlm-846	1	28	cape	cape	PROPN
ajlm-846	1	29	town	town	NOUN
ajlm-846	1	30	,	,	PUNCT
ajlm-846	1	31	cape	cape	NOUN
ajlm-846	1	32	town	town	NOUN
ajlm-846	1	33	,	,	PUNCT
ajlm-846	1	34	south	south	PROPN
ajlm-846	1	35	africa	africa	PROPN
ajlm-846	1	36	sharon	sharon	PROPN
ajlm-846	1	37	reid	reid	PROPN
ajlm-846	1	38	department	department	PROPN
ajlm-846	1	39	of	of	ADP
ajlm-846	1	40	molecular	molecular	ADJ
ajlm-846	1	41	and	and	CCONJ
ajlm-846	1	42	cell	cell	NOUN
ajlm-846	1	43	biology	biology	NOUN
ajlm-846	1	44	,	,	PUNCT
ajlm-846	1	45	faculty	faculty	NOUN
ajlm-846	1	46	of	of	ADP
ajlm-846	1	47	science	science	NOUN
ajlm-846	1	48	,	,	PUNCT
ajlm-846	1	49	university	university	NOUN
ajlm-846	1	50	of	of	ADP
ajlm-846	1	51	cape	cape	PROPN
ajlm-846	1	52	town	town	NOUN
ajlm-846	1	53	,	,	PUNCT
ajlm-846	1	54	cape	cape	NOUN
ajlm-846	1	55	town	town	NOUN
ajlm-846	1	56	,	,	PUNCT
ajlm-846	1	57	south	south	PROPN
ajlm-846	1	58	africa	africa	PROPN
ajlm-846	1	59	valerie	valerie	PROPN
ajlm-846	1	60	abratt	abratt	PROPN
ajlm-846	1	61	department	department	PROPN
ajlm-846	1	62	of	of	ADP
ajlm-846	1	63	molecular	molecular	ADJ
ajlm-846	1	64	and	and	CCONJ
ajlm-846	1	65	cell	cell	NOUN
ajlm-846	1	66	biology	biology	NOUN
ajlm-846	1	67	,	,	PUNCT
ajlm-846	1	68	faculty	faculty	NOUN
ajlm-846	1	69	of	of	ADP
ajlm-846	1	70	science	science	NOUN
ajlm-846	1	71	,	,	PUNCT
ajlm-846	1	72	university	university	NOUN
ajlm-846	1	73	of	of	ADP
ajlm-846	1	74	cape	cape	PROPN
ajlm-846	1	75	town	town	NOUN
ajlm-846	1	76	,	,	PUNCT
ajlm-846	1	77	cape	cape	NOUN
ajlm-846	1	78	town	town	NOUN
ajlm-846	1	79	,	,	PUNCT
ajlm-846	1	80	south	south	PROPN
ajlm-846	1	81	africa	africa	PROPN
ajlm-846	1	82	citation	citation	PROPN
ajlm-846	1	83	kullin	kullin	PROPN
ajlm-846	1	84	br	br	PROPN
ajlm-846	1	85	,	,	PUNCT
ajlm-846	1	86	reid	reid	PROPN
ajlm-846	1	87	s	s	PROPN
ajlm-846	1	88	,	,	PUNCT
ajlm-846	1	89	abratt	abratt	PROPN
ajlm-846	1	90	v.	v.	ADP
ajlm-846	1	91	clostridium	clostridium	NOUN
ajlm-846	1	92	difficile	difficile	VERB
ajlm-846	1	93	in	in	ADP
ajlm-846	1	94	patients	patient	NOUN
ajlm-846	1	95	attending	attend	VERB
ajlm-846	1	96	tuberculosis	tuberculosis	NOUN
ajlm-846	1	97	hospitals	hospital	NOUN
ajlm-846	1	98	in	in	ADP
ajlm-846	1	99	cape	cape	NOUN
ajlm-846	1	100	town	town	NOUN
ajlm-846	1	101	,	,	PUNCT
ajlm-846	1	102	south	south	PROPN
ajlm-846	1	103	africa	africa	PROPN
ajlm-846	1	104	,	,	PUNCT
ajlm-846	1	105	2014–2015	2014–2015	NUM
ajlm-846	1	106	.	.	PUNCT
ajlm-846	2	1	afr	afr	PROPN
ajlm-846	2	2	j	j	PROPN
ajlm-846	2	3	lab	lab	PROPN
ajlm-846	2	4	med	med	PROPN
ajlm-846	2	5	.	.	PUNCT
ajlm-846	2	6	2018;7(2	2018;7(2	NUM
ajlm-846	2	7	)	)	PUNCT
ajlm-846	2	8	,	,	PUNCT
ajlm-846	2	9	a846	a846	PROPN
ajlm-846	2	10	.	.	PUNCT
ajlm-846	3	1	https://doi.org/10.4102/ajlm.v7i2.846	https://doi.org/10.4102/ajlm.v7i2.846	PROPN
ajlm-846	3	2	original	original	ADJ
ajlm-846	3	3	research	research	NOUN
ajlm-846	3	4	clostridium	clostridium	NOUN
ajlm-846	3	5	difficile	difficile	NOUN
ajlm-846	3	6	in	in	ADP
ajlm-846	3	7	patients	patient	NOUN
ajlm-846	3	8	attending	attend	VERB
ajlm-846	3	9	tuberculosis	tuberculosis	NOUN
ajlm-846	3	10	hospitals	hospital	NOUN
ajlm-846	3	11	in	in	ADP
ajlm-846	3	12	cape	cape	NOUN
ajlm-846	3	13	town	town	NOUN
ajlm-846	3	14	,	,	PUNCT
ajlm-846	3	15	south	south	PROPN
ajlm-846	3	16	africa	africa	PROPN
ajlm-846	3	17	,	,	PUNCT
ajlm-846	3	18	2014–2015	2014–2015	NUM
ajlm-846	3	19	brian	brian	PROPN
ajlm-846	3	20	r.	r.	PROPN
ajlm-846	3	21	kullin	kullin	PROPN
ajlm-846	3	22	,	,	PUNCT
ajlm-846	3	23	sharon	sharon	PROPN
ajlm-846	3	24	reid	reid	PROPN
ajlm-846	3	25	,	,	PUNCT
ajlm-846	3	26	valerie	valerie	PROPN
ajlm-846	3	27	abratt	abratt	PROPN
ajlm-846	3	28	received	receive	VERB
ajlm-846	3	29	:	:	PUNCT
ajlm-846	3	30	04	04	NUM
ajlm-846	3	31	june	june	PROPN
ajlm-846	3	32	2018	2018	NUM
ajlm-846	3	33	;	;	PUNCT
ajlm-846	3	34	accepted	accept	VERB
ajlm-846	3	35	:	:	PUNCT
ajlm-846	3	36	28	28	NUM
ajlm-846	3	37	sept	sept	PROPN
ajlm-846	3	38	.	.	PROPN
ajlm-846	3	39	2018	2018	NUM
ajlm-846	3	40	;	;	PUNCT
ajlm-846	3	41	published	publish	VERB
ajlm-846	3	42	:	:	PUNCT
ajlm-846	3	43	06	06	NUM
ajlm-846	3	44	dec	dec	PROPN
ajlm-846	3	45	.	.	PROPN
ajlm-846	4	1	2018	2018	NUM
ajlm-846	4	2	copyright	copyright	NOUN
ajlm-846	4	3	:	:	PUNCT
ajlm-846	4	4	©	©	PROPN
ajlm-846	4	5	2018	2018	NUM
ajlm-846	4	6	.	.	PUNCT
ajlm-846	5	1	the	the	DET
ajlm-846	5	2	author(s	author(s	PROPN
ajlm-846	5	3	)	)	PUNCT
ajlm-846	5	4	.	.	PUNCT
ajlm-846	6	1	licensee	licensee	NOUN
ajlm-846	6	2	:	:	PUNCT
ajlm-846	6	3	aosis	aosis	NOUN
ajlm-846	6	4	.	.	PUNCT
ajlm-846	7	1	this	this	PRON
ajlm-846	7	2	is	be	AUX
ajlm-846	7	3	an	an	DET
ajlm-846	7	4	open	open	ADJ
ajlm-846	7	5	access	access	NOUN
ajlm-846	7	6	article	article	NOUN
ajlm-846	7	7	distributed	distribute	VERB
ajlm-846	7	8	under	under	ADP
ajlm-846	7	9	the	the	DET
ajlm-846	7	10	terms	term	NOUN
ajlm-846	7	11	of	of	ADP
ajlm-846	7	12	the	the	DET
ajlm-846	7	13	creative	creative	ADJ
ajlm-846	7	14	commons	common	NOUN
ajlm-846	7	15	attribution	attribution	NOUN
ajlm-846	7	16	license	license	NOUN
ajlm-846	7	17	,	,	PUNCT
ajlm-846	7	18	which	which	PRON
ajlm-846	7	19	permits	permit	VERB
ajlm-846	7	20	unrestricted	unrestricted	ADJ
ajlm-846	7	21	use	use	NOUN
ajlm-846	7	22	,	,	PUNCT
ajlm-846	7	23	distribution	distribution	NOUN
ajlm-846	7	24	,	,	PUNCT
ajlm-846	7	25	and	and	CCONJ
ajlm-846	7	26	reproduction	reproduction	NOUN
ajlm-846	7	27	in	in	ADP
ajlm-846	7	28	any	any	DET
ajlm-846	7	29	medium	medium	NOUN
ajlm-846	7	30	,	,	PUNCT
ajlm-846	7	31	provided	provide	VERB
ajlm-846	7	32	the	the	DET
ajlm-846	7	33	original	original	ADJ
ajlm-846	7	34	work	work	NOUN
ajlm-846	7	35	is	be	AUX
ajlm-846	7	36	properly	properly	ADV
ajlm-846	7	37	cited	cite	VERB
ajlm-846	7	38	.	.	PUNCT
ajlm-846	8	1	abstract	abstract	ADJ
ajlm-846	8	2	background	background	NOUN
ajlm-846	8	3	:	:	PUNCT
ajlm-846	8	4	diarrhoea	diarrhoea	NOUN
ajlm-846	8	5	due	due	ADJ
ajlm-846	8	6	to	to	ADP
ajlm-846	8	7	clostridium	clostridium	NOUN
ajlm-846	8	8	difficile	difficile	ADJ
ajlm-846	8	9	infection	infection	NOUN
ajlm-846	8	10	(	(	PUNCT
ajlm-846	8	11	cdi	cdi	PROPN
ajlm-846	8	12	)	)	PUNCT
ajlm-846	8	13	poses	pose	VERB
ajlm-846	8	14	a	a	DET
ajlm-846	8	15	significant	significant	ADJ
ajlm-846	8	16	burden	burden	NOUN
ajlm-846	8	17	on	on	ADP
ajlm-846	8	18	healthcare	healthcare	NOUN
ajlm-846	8	19	systems	system	NOUN
ajlm-846	8	20	around	around	ADP
ajlm-846	8	21	the	the	DET
ajlm-846	8	22	world	world	NOUN
ajlm-846	8	23	.	.	PUNCT
ajlm-846	9	1	however	however	ADV
ajlm-846	9	2	,	,	PUNCT
ajlm-846	9	3	there	there	PRON
ajlm-846	9	4	are	be	VERB
ajlm-846	9	5	few	few	ADJ
ajlm-846	9	6	reports	report	NOUN
ajlm-846	9	7	on	on	ADP
ajlm-846	9	8	the	the	DET
ajlm-846	9	9	current	current	ADJ
ajlm-846	9	10	status	status	NOUN
ajlm-846	9	11	of	of	ADP
ajlm-846	9	12	the	the	DET
ajlm-846	9	13	disease	disease	NOUN
ajlm-846	9	14	in	in	ADP
ajlm-846	9	15	sub	sub	ADJ
ajlm-846	9	16	-	-	ADJ
ajlm-846	9	17	saharan	saharan	ADJ
ajlm-846	9	18	africa	africa	PROPN
ajlm-846	9	19	.	.	PUNCT
ajlm-846	10	1	objectives	objective	NOUN
ajlm-846	10	2	:	:	PUNCT
ajlm-846	10	3	this	this	DET
ajlm-846	10	4	study	study	NOUN
ajlm-846	10	5	examined	examine	VERB
ajlm-846	10	6	the	the	DET
ajlm-846	10	7	occurrence	occurrence	NOUN
ajlm-846	10	8	of	of	ADP
ajlm-846	10	9	cdi	cdi	PROPN
ajlm-846	10	10	in	in	ADP
ajlm-846	10	11	a	a	DET
ajlm-846	10	12	south	south	ADJ
ajlm-846	10	13	african	african	ADJ
ajlm-846	10	14	population	population	NOUN
ajlm-846	10	15	of	of	ADP
ajlm-846	10	16	tuberculosis	tuberculosis	NOUN
ajlm-846	10	17	patients	patient	NOUN
ajlm-846	10	18	,	,	PUNCT
ajlm-846	10	19	as	as	ADV
ajlm-846	10	20	well	well	ADV
ajlm-846	10	21	as	as	ADP
ajlm-846	10	22	the	the	DET
ajlm-846	10	23	molecular	molecular	ADJ
ajlm-846	10	24	epidemiology	epidemiology	NOUN
ajlm-846	10	25	and	and	CCONJ
ajlm-846	10	26	antibiotic	antibiotic	ADJ
ajlm-846	10	27	susceptibility	susceptibility	NOUN
ajlm-846	10	28	profiles	profile	NOUN
ajlm-846	10	29	of	of	ADP
ajlm-846	10	30	c.	c.	NOUN
ajlm-846	10	31	difficile	difficile	VERB
ajlm-846	10	32	strains	strain	VERB
ajlm-846	10	33	responsible	responsible	ADJ
ajlm-846	10	34	for	for	ADP
ajlm-846	10	35	disease	disease	NOUN
ajlm-846	10	36	.	.	PUNCT
ajlm-846	11	1	methods	method	NOUN
ajlm-846	11	2	:	:	PUNCT
ajlm-846	11	3	toxigenic	toxigenic	ADJ
ajlm-846	11	4	c.	c.	NOUN
ajlm-846	11	5	difficile	difficile	VERB
ajlm-846	11	6	in	in	ADP
ajlm-846	11	7	patients	patient	NOUN
ajlm-846	11	8	with	with	ADP
ajlm-846	11	9	suspected	suspect	VERB
ajlm-846	11	10	cdi	cdi	PROPN
ajlm-846	11	11	attending	attend	VERB
ajlm-846	11	12	two	two	NUM
ajlm-846	11	13	specialist	specialist	ADJ
ajlm-846	11	14	tuberculosis	tuberculosis	NOUN
ajlm-846	11	15	hospitals	hospital	NOUN
ajlm-846	11	16	in	in	ADP
ajlm-846	11	17	the	the	DET
ajlm-846	11	18	cape	cape	NOUN
ajlm-846	11	19	town	town	NOUN
ajlm-846	11	20	area	area	NOUN
ajlm-846	11	21	were	be	AUX
ajlm-846	11	22	detected	detect	VERB
ajlm-846	11	23	using	use	VERB
ajlm-846	11	24	a	a	DET
ajlm-846	11	25	pcr	pcr	NOUN
ajlm-846	11	26	-	-	PUNCT
ajlm-846	11	27	based	base	VERB
ajlm-846	11	28	diagnostic	diagnostic	ADJ
ajlm-846	11	29	assay	assay	NOUN
ajlm-846	11	30	(	(	PUNCT
ajlm-846	11	31	xpert	xpert	PROPN
ajlm-846	11	32	®	®	PROPN
ajlm-846	11	33	c.	c.	PROPN
ajlm-846	11	34	difficile	difficile	PROPN
ajlm-846	11	35	)	)	PUNCT
ajlm-846	11	36	.	.	PUNCT
ajlm-846	12	1	c.	c.	NOUN
ajlm-846	12	2	difficile	difficile	VERB
ajlm-846	12	3	strains	strain	NOUN
ajlm-846	12	4	isolated	isolate	VERB
ajlm-846	12	5	from	from	ADP
ajlm-846	12	6	pcr	pcr	ADJ
ajlm-846	12	7	-	-	ADJ
ajlm-846	12	8	positive	positive	ADJ
ajlm-846	12	9	specimens	specimen	NOUN
ajlm-846	12	10	were	be	AUX
ajlm-846	12	11	characterised	characterise	VERB
ajlm-846	12	12	by	by	ADP
ajlm-846	12	13	ribotyping	ribotype	VERB
ajlm-846	12	14	,	,	PUNCT
ajlm-846	12	15	multilocus	multilocus	NOUN
ajlm-846	12	16	variable	variable	ADJ
ajlm-846	12	17	-	-	PUNCT
ajlm-846	12	18	number	number	NOUN
ajlm-846	12	19	tandem	tandem	NOUN
ajlm-846	12	20	-	-	PUNCT
ajlm-846	12	21	repeat	repeat	NOUN
ajlm-846	12	22	analysis	analysis	NOUN
ajlm-846	12	23	and	and	CCONJ
ajlm-846	12	24	antibiotic	antibiotic	ADJ
ajlm-846	12	25	susceptibility	susceptibility	NOUN
ajlm-846	12	26	testing	testing	NOUN
ajlm-846	12	27	.	.	PUNCT
ajlm-846	13	1	results	result	NOUN
ajlm-846	13	2	:	:	PUNCT
ajlm-846	13	3	the	the	DET
ajlm-846	13	4	period	period	NOUN
ajlm-846	13	5	prevalence	prevalence	NOUN
ajlm-846	13	6	of	of	ADP
ajlm-846	13	7	cdi	cdi	PROPN
ajlm-846	13	8	was	be	AUX
ajlm-846	13	9	approximately	approximately	ADV
ajlm-846	13	10	70.07	70.07	NUM
ajlm-846	13	11	cases	case	NOUN
ajlm-846	13	12	per	per	ADP
ajlm-846	13	13	1000	1000	NUM
ajlm-846	13	14	patient	patient	NOUN
ajlm-846	13	15	admissions	admission	NOUN
ajlm-846	13	16	.	.	PUNCT
ajlm-846	14	1	strains	strain	NOUN
ajlm-846	14	2	belonging	belong	VERB
ajlm-846	14	3	to	to	PART
ajlm-846	14	4	ribotype	ribotype	VERB
ajlm-846	14	5	017	017	NUM
ajlm-846	14	6	(	(	PUNCT
ajlm-846	14	7	rt017	rt017	NOUN
ajlm-846	14	8	)	)	PUNCT
ajlm-846	14	9	made	make	VERB
ajlm-846	14	10	up	up	ADP
ajlm-846	14	11	over	over	ADP
ajlm-846	14	12	95	95	NUM
ajlm-846	14	13	%	%	NOUN
ajlm-846	14	14	of	of	ADP
ajlm-846	14	15	the	the	DET
ajlm-846	14	16	patient	patient	ADJ
ajlm-846	14	17	isolates	isolate	NOUN
ajlm-846	14	18	and	and	CCONJ
ajlm-846	14	19	all	all	PRON
ajlm-846	14	20	of	of	ADP
ajlm-846	14	21	them	they	PRON
ajlm-846	14	22	were	be	AUX
ajlm-846	14	23	multi	multi	ADJ
ajlm-846	14	24	-	-	ADJ
ajlm-846	14	25	drug	drug	ADJ
ajlm-846	14	26	resistant	resistant	ADJ
ajlm-846	14	27	.	.	PUNCT
ajlm-846	15	1	multilocus	multilocus	NOUN
ajlm-846	15	2	variable	variable	ADJ
ajlm-846	15	3	-	-	PUNCT
ajlm-846	15	4	number	number	NOUN
ajlm-846	15	5	tandem	tandem	NOUN
ajlm-846	15	6	-	-	PUNCT
ajlm-846	15	7	repeat	repeat	NOUN
ajlm-846	15	8	analysis	analysis	NOUN
ajlm-846	15	9	revealed	reveal	VERB
ajlm-846	15	10	several	several	ADJ
ajlm-846	15	11	clusters	cluster	NOUN
ajlm-846	15	12	of	of	ADP
ajlm-846	15	13	highly	highly	ADV
ajlm-846	15	14	related	related	ADJ
ajlm-846	15	15	c.	c.	NOUN
ajlm-846	15	16	difficile	difficile	NOUN
ajlm-846	15	17	rt017	rt017	X
ajlm-846	15	18	strains	strain	NOUN
ajlm-846	15	19	present	present	ADJ
ajlm-846	15	20	in	in	ADP
ajlm-846	15	21	tuberculosis	tuberculosis	NOUN
ajlm-846	15	22	patients	patient	NOUN
ajlm-846	15	23	in	in	ADP
ajlm-846	15	24	several	several	ADJ
ajlm-846	15	25	wards	ward	NOUN
ajlm-846	15	26	at	at	ADP
ajlm-846	15	27	each	each	DET
ajlm-846	15	28	hospital	hospital	NOUN
ajlm-846	15	29	.	.	PUNCT
ajlm-846	16	1	conclusion	conclusion	NOUN
ajlm-846	16	2	:	:	PUNCT
ajlm-846	16	3	tuberculosis	tuberculosis	NOUN
ajlm-846	16	4	patients	patient	NOUN
ajlm-846	16	5	represent	represent	VERB
ajlm-846	16	6	a	a	DET
ajlm-846	16	7	population	population	NOUN
ajlm-846	16	8	that	that	PRON
ajlm-846	16	9	may	may	AUX
ajlm-846	16	10	be	be	AUX
ajlm-846	16	11	at	at	ADP
ajlm-846	16	12	an	an	DET
ajlm-846	16	13	increased	increase	VERB
ajlm-846	16	14	risk	risk	NOUN
ajlm-846	16	15	of	of	ADP
ajlm-846	16	16	developing	develop	VERB
ajlm-846	16	17	cdi	cdi	PROPN
ajlm-846	16	18	and	and	CCONJ
ajlm-846	16	19	,	,	PUNCT
ajlm-846	16	20	in	in	ADP
ajlm-846	16	21	addition	addition	NOUN
ajlm-846	16	22	,	,	PUNCT
ajlm-846	16	23	may	may	AUX
ajlm-846	16	24	constitute	constitute	VERB
ajlm-846	16	25	a	a	DET
ajlm-846	16	26	multi	multi	ADJ
ajlm-846	16	27	-	-	ADJ
ajlm-846	16	28	drug	drug	ADJ
ajlm-846	16	29	resistant	resistant	ADJ
ajlm-846	16	30	reservoir	reservoir	NOUN
ajlm-846	16	31	of	of	ADP
ajlm-846	16	32	this	this	DET
ajlm-846	16	33	bacterium	bacterium	NOUN
ajlm-846	16	34	.	.	PUNCT
ajlm-846	17	1	this	this	DET
ajlm-846	17	2	warrants	warrant	NOUN
ajlm-846	17	3	further	further	ADJ
ajlm-846	17	4	investigation	investigation	NOUN
ajlm-846	17	5	and	and	CCONJ
ajlm-846	17	6	surveillance	surveillance	NOUN
ajlm-846	17	7	of	of	ADP
ajlm-846	17	8	the	the	DET
ajlm-846	17	9	disease	disease	NOUN
ajlm-846	17	10	in	in	ADP
ajlm-846	17	11	this	this	DET
ajlm-846	17	12	patient	patient	ADJ
ajlm-846	17	13	group	group	NOUN
ajlm-846	17	14	and	and	CCONJ
ajlm-846	17	15	other	other	ADJ
ajlm-846	17	16	high	high	ADJ
ajlm-846	17	17	-	-	PUNCT
ajlm-846	17	18	risk	risk	NOUN
ajlm-846	17	19	patient	patient	NOUN
ajlm-846	17	20	groups	group	NOUN
ajlm-846	17	21	in	in	ADP
ajlm-846	17	22	sub	sub	ADJ
ajlm-846	17	23	-	-	ADJ
ajlm-846	17	24	saharan	saharan	ADJ
ajlm-846	17	25	africa	africa	PROPN
ajlm-846	17	26	.	.	PUNCT
ajlm-846	18	1	introduction	introduction	NOUN
ajlm-846	18	2	clostridium	clostridium	NOUN
ajlm-846	18	3	difficile	difficile	ADJ
ajlm-846	18	4	infection	infection	NOUN
ajlm-846	18	5	(	(	PUNCT
ajlm-846	18	6	cdi	cdi	PROPN
ajlm-846	18	7	)	)	PUNCT
ajlm-846	18	8	is	be	AUX
ajlm-846	18	9	the	the	DET
ajlm-846	18	10	most	most	ADV
ajlm-846	18	11	common	common	ADJ
ajlm-846	18	12	cause	cause	NOUN
ajlm-846	18	13	of	of	ADP
ajlm-846	18	14	nosocomial	nosocomial	ADJ
ajlm-846	18	15	diarrhoea	diarrhoea	NOUN
ajlm-846	18	16	in	in	ADP
ajlm-846	18	17	the	the	DET
ajlm-846	18	18	developed	developed	ADJ
ajlm-846	18	19	world	world	NOUN
ajlm-846	18	20	,	,	PUNCT
ajlm-846	18	21	with	with	ADP
ajlm-846	18	22	complications	complication	NOUN
ajlm-846	18	23	of	of	ADP
ajlm-846	18	24	the	the	DET
ajlm-846	18	25	disease	disease	NOUN
ajlm-846	18	26	,	,	PUNCT
ajlm-846	18	27	including	include	VERB
ajlm-846	18	28	potentially	potentially	ADV
ajlm-846	18	29	life	life	NOUN
ajlm-846	18	30	-	-	PUNCT
ajlm-846	18	31	threatening	threaten	VERB
ajlm-846	18	32	pseudomembranous	pseudomembranous	ADJ
ajlm-846	18	33	colitis	colitis	NOUN
ajlm-846	18	34	and	and	CCONJ
ajlm-846	18	35	toxic	toxic	ADJ
ajlm-846	18	36	megacolon.1	megacolon.1	NOUN
ajlm-846	18	37	the	the	DET
ajlm-846	18	38	total	total	ADJ
ajlm-846	18	39	costs	cost	NOUN
ajlm-846	18	40	of	of	ADP
ajlm-846	18	41	cdi	cdi	PROPN
ajlm-846	18	42	treatment	treatment	NOUN
ajlm-846	18	43	are	be	AUX
ajlm-846	18	44	estimated	estimate	VERB
ajlm-846	18	45	to	to	PART
ajlm-846	18	46	be	be	AUX
ajlm-846	18	47	as	as	ADV
ajlm-846	18	48	high	high	ADJ
ajlm-846	18	49	as	as	ADP
ajlm-846	18	50	$	$	SYM
ajlm-846	18	51	2871.00	2871.00	NUM
ajlm-846	18	52	(	(	PUNCT
ajlm-846	18	53	united	united	PROPN
ajlm-846	18	54	states	states	PROPN
ajlm-846	18	55	dollars	dollar	NOUN
ajlm-846	18	56	)	)	PUNCT
ajlm-846	18	57	to	to	ADP
ajlm-846	18	58	$	$	SYM
ajlm-846	18	59	4846.00	4846.00	NUM
ajlm-846	18	60	per	per	ADP
ajlm-846	18	61	patient	patient	NOUN
ajlm-846	18	62	in	in	ADP
ajlm-846	18	63	the	the	DET
ajlm-846	18	64	united	united	PROPN
ajlm-846	18	65	states	states	PROPN
ajlm-846	18	66	and	and	CCONJ
ajlm-846	18	67	between	between	ADP
ajlm-846	18	68	$	$	SYM
ajlm-846	18	69	5243.00	5243.00	NUM
ajlm-846	18	70	and	and	CCONJ
ajlm-846	18	71	$	$	SYM
ajlm-846	18	72	8570.00	8570.00	NUM
ajlm-846	18	73	per	per	ADP
ajlm-846	18	74	patient	patient	NOUN
ajlm-846	18	75	in	in	ADP
ajlm-846	18	76	european	european	PROPN
ajlm-846	18	77	countries,2	countries,2	NOUN
ajlm-846	18	78	and	and	CCONJ
ajlm-846	18	79	there	there	PRON
ajlm-846	18	80	is	be	VERB
ajlm-846	18	81	evidence	evidence	NOUN
ajlm-846	18	82	to	to	PART
ajlm-846	18	83	suggest	suggest	VERB
ajlm-846	18	84	that	that	SCONJ
ajlm-846	18	85	treatment	treatment	NOUN
ajlm-846	18	86	failure	failure	NOUN
ajlm-846	18	87	and	and	CCONJ
ajlm-846	18	88	disease	disease	NOUN
ajlm-846	18	89	relapse	relapse	NOUN
ajlm-846	18	90	rates	rate	NOUN
ajlm-846	18	91	are	be	AUX
ajlm-846	18	92	increasing.3	increasing.3	PROPN
ajlm-846	18	93	since	since	SCONJ
ajlm-846	18	94	the	the	DET
ajlm-846	18	95	turn	turn	NOUN
ajlm-846	18	96	of	of	ADP
ajlm-846	18	97	the	the	DET
ajlm-846	18	98	century	century	NOUN
ajlm-846	18	99	,	,	PUNCT
ajlm-846	18	100	several	several	ADJ
ajlm-846	18	101	significant	significant	ADJ
ajlm-846	18	102	outbreaks	outbreak	NOUN
ajlm-846	18	103	of	of	ADP
ajlm-846	18	104	cdi	cdi	PROPN
ajlm-846	18	105	have	have	AUX
ajlm-846	18	106	occurred	occur	VERB
ajlm-846	18	107	and	and	CCONJ
ajlm-846	18	108	have	have	AUX
ajlm-846	18	109	been	be	AUX
ajlm-846	18	110	documented	document	VERB
ajlm-846	18	111	in	in	ADP
ajlm-846	18	112	north	north	PROPN
ajlm-846	18	113	america	america	PROPN
ajlm-846	18	114	and	and	CCONJ
ajlm-846	18	115	europe.4,5,6	europe.4,5,6	AUX
ajlm-846	18	116	toxigenic	toxigenic	ADJ
ajlm-846	18	117	c.	c.	NOUN
ajlm-846	18	118	difficile	difficile	VERB
ajlm-846	18	119	strains	strain	NOUN
ajlm-846	18	120	produce	produce	VERB
ajlm-846	18	121	two	two	NUM
ajlm-846	18	122	large	large	ADJ
ajlm-846	18	123	clostridial	clostridial	ADJ
ajlm-846	18	124	toxins	toxin	NOUN
ajlm-846	18	125	,	,	PUNCT
ajlm-846	18	126	tcda	tcda	NOUN
ajlm-846	18	127	and	and	CCONJ
ajlm-846	18	128	tcdb	tcdb	PROPN
ajlm-846	18	129	,	,	PUNCT
ajlm-846	18	130	both	both	PRON
ajlm-846	18	131	of	of	ADP
ajlm-846	18	132	which	which	PRON
ajlm-846	18	133	show	show	VERB
ajlm-846	18	134	cytotoxic	cytotoxic	ADJ
ajlm-846	18	135	activity	activity	NOUN
ajlm-846	18	136	and	and	CCONJ
ajlm-846	18	137	are	be	AUX
ajlm-846	18	138	responsible	responsible	ADJ
ajlm-846	18	139	for	for	ADP
ajlm-846	18	140	the	the	DET
ajlm-846	18	141	majority	majority	NOUN
ajlm-846	18	142	of	of	ADP
ajlm-846	18	143	disease	disease	NOUN
ajlm-846	18	144	symptoms.7	symptoms.7	VERB
ajlm-846	18	145	a	a	DET
ajlm-846	18	146	third	third	ADJ
ajlm-846	18	147	binary	binary	ADJ
ajlm-846	18	148	toxin	toxin	NOUN
ajlm-846	18	149	,	,	PUNCT
ajlm-846	18	150	cdtab	cdtab	NOUN
ajlm-846	18	151	is	be	AUX
ajlm-846	18	152	also	also	ADV
ajlm-846	18	153	produced	produce	VERB
ajlm-846	18	154	by	by	ADP
ajlm-846	18	155	some	some	DET
ajlm-846	18	156	strains	strain	NOUN
ajlm-846	18	157	,	,	PUNCT
ajlm-846	18	158	such	such	ADJ
ajlm-846	18	159	as	as	ADP
ajlm-846	18	160	those	those	PRON
ajlm-846	18	161	belonging	belong	VERB
ajlm-846	18	162	to	to	PART
ajlm-846	18	163	ribotype	ribotype	VERB
ajlm-846	18	164	027	027	NUM
ajlm-846	18	165	(	(	PUNCT
ajlm-846	18	166	rt027	rt027	NOUN
ajlm-846	18	167	)	)	PUNCT
ajlm-846	18	168	and	and	CCONJ
ajlm-846	18	169	rt078	rt078	NOUN
ajlm-846	18	170	,	,	PUNCT
ajlm-846	18	171	and	and	CCONJ
ajlm-846	18	172	may	may	AUX
ajlm-846	18	173	be	be	AUX
ajlm-846	18	174	associated	associate	VERB
ajlm-846	18	175	with	with	ADP
ajlm-846	18	176	increased	increase	VERB
ajlm-846	18	177	disease	disease	NOUN
ajlm-846	18	178	severity	severity	NOUN
ajlm-846	18	179	in	in	ADP
ajlm-846	18	180	some	some	DET
ajlm-846	18	181	settings.8	settings.8	PROPN
ajlm-846	18	182	several	several	ADJ
ajlm-846	18	183	toxin	toxin	NOUN
ajlm-846	18	184	variant	variant	NOUN
ajlm-846	18	185	strains	strain	NOUN
ajlm-846	18	186	have	have	AUX
ajlm-846	18	187	also	also	ADV
ajlm-846	18	188	been	be	AUX
ajlm-846	18	189	identified	identify	VERB
ajlm-846	18	190	.	.	PUNCT
ajlm-846	19	1	the	the	DET
ajlm-846	19	2	most	most	ADV
ajlm-846	19	3	common	common	ADJ
ajlm-846	19	4	of	of	ADP
ajlm-846	19	5	these	these	PRON
ajlm-846	19	6	is	be	AUX
ajlm-846	19	7	a	a	DET
ajlm-846	19	8	subset	subset	NOUN
ajlm-846	19	9	of	of	ADP
ajlm-846	19	10	strains	strain	NOUN
ajlm-846	19	11	that	that	PRON
ajlm-846	19	12	produce	produce	VERB
ajlm-846	19	13	only	only	ADV
ajlm-846	19	14	one	one	NUM
ajlm-846	19	15	functional	functional	ADJ
ajlm-846	19	16	toxin	toxin	NOUN
ajlm-846	19	17	(	(	PUNCT
ajlm-846	19	18	tcdb	tcdb	NOUN
ajlm-846	19	19	)	)	PUNCT
ajlm-846	19	20	and	and	CCONJ
ajlm-846	19	21	is	be	AUX
ajlm-846	19	22	mainly	mainly	ADV
ajlm-846	19	23	comprised	comprise	VERB
ajlm-846	19	24	of	of	ADP
ajlm-846	19	25	members	member	NOUN
ajlm-846	19	26	of	of	ADP
ajlm-846	19	27	the	the	DET
ajlm-846	19	28	rt017	rt017	PROPN
ajlm-846	19	29	group	group	NOUN
ajlm-846	19	30	.	.	PUNCT
ajlm-846	20	1	this	this	DET
ajlm-846	20	2	group	group	NOUN
ajlm-846	20	3	is	be	AUX
ajlm-846	20	4	widespread	widespread	ADJ
ajlm-846	20	5	in	in	ADP
ajlm-846	20	6	asia9	asia9	NOUN
ajlm-846	20	7	and	and	CCONJ
ajlm-846	20	8	is	be	AUX
ajlm-846	20	9	capable	capable	ADJ
ajlm-846	20	10	of	of	ADP
ajlm-846	20	11	causing	cause	VERB
ajlm-846	20	12	severe	severe	ADJ
ajlm-846	20	13	disease	disease	NOUN
ajlm-846	20	14	across	across	ADP
ajlm-846	20	15	diverse	diverse	ADJ
ajlm-846	20	16	populations.6	populations.6	PROPN
ajlm-846	20	17	the	the	DET
ajlm-846	20	18	most	most	ADV
ajlm-846	20	19	common	common	ADJ
ajlm-846	20	20	risk	risk	NOUN
ajlm-846	20	21	factor	factor	NOUN
ajlm-846	20	22	for	for	ADP
ajlm-846	20	23	the	the	DET
ajlm-846	20	24	development	development	NOUN
ajlm-846	20	25	of	of	ADP
ajlm-846	20	26	cdi	cdi	PROPN
ajlm-846	20	27	is	be	AUX
ajlm-846	20	28	previous	previous	ADJ
ajlm-846	20	29	exposure	exposure	NOUN
ajlm-846	20	30	to	to	ADP
ajlm-846	20	31	antibiotics	antibiotic	NOUN
ajlm-846	20	32	,	,	PUNCT
ajlm-846	20	33	particularly	particularly	ADV
ajlm-846	20	34	clindamycin	clindamycin	NOUN
ajlm-846	20	35	and	and	CCONJ
ajlm-846	20	36	cephalosporins	cephalosporin	NOUN
ajlm-846	20	37	and	and	CCONJ
ajlm-846	20	38	,	,	PUNCT
ajlm-846	20	39	less	less	ADV
ajlm-846	20	40	frequently	frequently	ADV
ajlm-846	20	41	,	,	PUNCT
ajlm-846	20	42	fluoroquinolones.10	fluoroquinolones.10	ADJ
ajlm-846	20	43	the	the	DET
ajlm-846	20	44	resulting	result	VERB
ajlm-846	20	45	dysbiosis	dysbiosis	NOUN
ajlm-846	20	46	allows	allow	VERB
ajlm-846	20	47	proliferation	proliferation	NOUN
ajlm-846	20	48	of	of	ADP
ajlm-846	20	49	c.	c.	NOUN
ajlm-846	20	50	difficile	difficile	NOUN
ajlm-846	20	51	and	and	CCONJ
ajlm-846	20	52	the	the	DET
ajlm-846	20	53	progression	progression	NOUN
ajlm-846	20	54	of	of	ADP
ajlm-846	20	55	disease	disease	NOUN
ajlm-846	20	56	symptoms	symptom	NOUN
ajlm-846	20	57	.	.	PUNCT
ajlm-846	21	1	additional	additional	ADJ
ajlm-846	21	2	risk	risk	NOUN
ajlm-846	21	3	factors	factor	NOUN
ajlm-846	21	4	include	include	VERB
ajlm-846	21	5	advanced	advanced	ADJ
ajlm-846	21	6	age,11	age,11	NOUN
ajlm-846	21	7	gastric	gastric	ADJ
ajlm-846	21	8	acid	acid	NOUN
ajlm-846	21	9	suppression	suppression	NOUN
ajlm-846	21	10	therapy12	therapy12	NOUN
ajlm-846	21	11	(	(	PUNCT
ajlm-846	21	12	although	although	SCONJ
ajlm-846	21	13	this	this	PRON
ajlm-846	21	14	is	be	AUX
ajlm-846	21	15	sometimes	sometimes	ADV
ajlm-846	21	16	debated13	debated13	NOUN
ajlm-846	21	17	)	)	PUNCT
ajlm-846	21	18	,	,	PUNCT
ajlm-846	21	19	co	co	NOUN
ajlm-846	21	20	-	-	NOUN
ajlm-846	21	21	morbidities	morbidity	NOUN
ajlm-846	21	22	such	such	ADJ
ajlm-846	21	23	as	as	ADP
ajlm-846	21	24	hiv14	hiv14	NOUN
ajlm-846	21	25	and	and	CCONJ
ajlm-846	21	26	exposure	exposure	NOUN
ajlm-846	21	27	to	to	ADP
ajlm-846	21	28	long	long	ADJ
ajlm-846	21	29	-	-	PUNCT
ajlm-846	21	30	term	term	NOUN
ajlm-846	21	31	healthcare	healthcare	NOUN
ajlm-846	21	32	facilities.15	facilities.15	NOUN
ajlm-846	21	33	there	there	ADV
ajlm-846	21	34	have	have	AUX
ajlm-846	21	35	also	also	ADV
ajlm-846	21	36	been	be	AUX
ajlm-846	21	37	several	several	ADJ
ajlm-846	21	38	case	case	NOUN
ajlm-846	21	39	reports	report	NOUN
ajlm-846	21	40	of	of	ADP
ajlm-846	21	41	cdi	cdi	PROPN
ajlm-846	21	42	occurring	occur	VERB
ajlm-846	21	43	in	in	ADP
ajlm-846	21	44	patients	patient	NOUN
ajlm-846	21	45	with	with	ADP
ajlm-846	21	46	tuberculosis,16,17,18,19	tuberculosis,16,17,18,19	NOUN
ajlm-846	21	47	possibly	possibly	ADV
ajlm-846	21	48	related	relate	VERB
ajlm-846	21	49	to	to	ADP
ajlm-846	21	50	the	the	DET
ajlm-846	21	51	long	long	ADJ
ajlm-846	21	52	-	-	PUNCT
ajlm-846	21	53	term	term	NOUN
ajlm-846	21	54	intensive	intensive	ADJ
ajlm-846	21	55	antibiotic	antibiotic	ADJ
ajlm-846	21	56	therapy	therapy	NOUN
ajlm-846	21	57	that	that	PRON
ajlm-846	21	58	they	they	PRON
ajlm-846	21	59	typically	typically	ADV
ajlm-846	21	60	receive	receive	VERB
ajlm-846	21	61	.	.	PUNCT
ajlm-846	22	1	however	however	ADV
ajlm-846	22	2	,	,	PUNCT
ajlm-846	22	3	there	there	PRON
ajlm-846	22	4	have	have	AUX
ajlm-846	22	5	been	be	AUX
ajlm-846	22	6	very	very	ADV
ajlm-846	22	7	few	few	ADJ
ajlm-846	22	8	studies	study	NOUN
ajlm-846	22	9	to	to	ADP
ajlm-846	22	10	date	date	NOUN
ajlm-846	22	11	specifically	specifically	ADV
ajlm-846	22	12	looking	look	VERB
ajlm-846	22	13	at	at	ADP
ajlm-846	22	14	cdi	cdi	PROPN
ajlm-846	22	15	in	in	ADP
ajlm-846	22	16	this	this	DET
ajlm-846	22	17	patient	patient	NOUN
ajlm-846	22	18	group	group	NOUN
ajlm-846	22	19	.	.	PUNCT
ajlm-846	23	1	chang	chang	PROPN
ajlm-846	23	2	et	et	PROPN
ajlm-846	23	3	al.20	al.20	PROPN
ajlm-846	23	4	examined	examine	VERB
ajlm-846	23	5	a	a	DET
ajlm-846	23	6	potential	potential	ADJ
ajlm-846	23	7	link	link	NOUN
ajlm-846	23	8	between	between	ADP
ajlm-846	23	9	fluoroquinolone	fluoroquinolone	NOUN
ajlm-846	23	10	use	use	NOUN
ajlm-846	23	11	and	and	CCONJ
ajlm-846	23	12	cdi	cdi	NOUN
ajlm-846	23	13	in	in	ADP
ajlm-846	23	14	tuberculosis	tuberculosis	NUM
ajlm-846	23	15	patients	patient	NOUN
ajlm-846	23	16	in	in	ADP
ajlm-846	23	17	hong	hong	PROPN
ajlm-846	23	18	kong	kong	PROPN
ajlm-846	23	19	and	and	CCONJ
ajlm-846	23	20	concluded	conclude	VERB
ajlm-846	23	21	that	that	SCONJ
ajlm-846	23	22	the	the	DET
ajlm-846	23	23	risk	risk	NOUN
ajlm-846	23	24	of	of	ADP
ajlm-846	23	25	cdi	cdi	PROPN
ajlm-846	23	26	was	be	AUX
ajlm-846	23	27	moderate	moderate	ADJ
ajlm-846	23	28	for	for	ADP
ajlm-846	23	29	these	these	DET
ajlm-846	23	30	patients	patient	NOUN
ajlm-846	23	31	,	,	PUNCT
ajlm-846	23	32	while	while	SCONJ
ajlm-846	23	33	lee	lee	PROPN
ajlm-846	23	34	et	et	PROPN
ajlm-846	23	35	al.21	al.21	PROPN
ajlm-846	23	36	detected	detect	VERB
ajlm-846	23	37	a	a	DET
ajlm-846	23	38	relatively	relatively	ADV
ajlm-846	23	39	low	low	ADJ
ajlm-846	23	40	incidence	incidence	NOUN
ajlm-846	23	41	of	of	ADP
ajlm-846	23	42	cdi	cdi	PROPN
ajlm-846	23	43	in	in	ADP
ajlm-846	23	44	korean	korean	ADJ
ajlm-846	23	45	tuberculosis	tuberculosis	NOUN
ajlm-846	23	46	patients	patient	NOUN
ajlm-846	23	47	(	(	PUNCT
ajlm-846	23	48	2.83	2.83	NUM
ajlm-846	23	49	cases	case	NOUN
ajlm-846	23	50	per	per	ADP
ajlm-846	23	51	1000	1000	NUM
ajlm-846	23	52	adults	adult	NOUN
ajlm-846	23	53	)	)	PUNCT
ajlm-846	23	54	.	.	PUNCT
ajlm-846	24	1	more	more	ADV
ajlm-846	24	2	recently	recently	ADV
ajlm-846	24	3	,	,	PUNCT
ajlm-846	24	4	however	however	ADV
ajlm-846	24	5	,	,	PUNCT
ajlm-846	24	6	legenza	legenza	PROPN
ajlm-846	24	7	et	et	PROPN
ajlm-846	24	8	al.22	al.22	PROPN
ajlm-846	24	9	identified	identify	VERB
ajlm-846	24	10	tuberculosis	tuberculosis	NOUN
ajlm-846	24	11	as	as	ADP
ajlm-846	24	12	an	an	DET
ajlm-846	24	13	independent	independent	ADJ
ajlm-846	24	14	risk	risk	NOUN
ajlm-846	24	15	factor	factor	NOUN
ajlm-846	24	16	for	for	ADP
ajlm-846	24	17	cdi	cdi	PROPN
ajlm-846	24	18	in	in	ADP
ajlm-846	24	19	patients	patient	NOUN
ajlm-846	24	20	in	in	ADP
ajlm-846	24	21	cape	cape	NOUN
ajlm-846	24	22	town	town	NOUN
ajlm-846	24	23	,	,	PUNCT
ajlm-846	24	24	south	south	PROPN
ajlm-846	24	25	africa	africa	PROPN
ajlm-846	24	26	,	,	PUNCT
ajlm-846	24	27	and	and	CCONJ
ajlm-846	24	28	there	there	PRON
ajlm-846	24	29	has	have	AUX
ajlm-846	24	30	been	be	AUX
ajlm-846	24	31	at	at	ADP
ajlm-846	24	32	least	least	ADV
ajlm-846	24	33	one	one	NUM
ajlm-846	24	34	report	report	NOUN
ajlm-846	24	35	of	of	ADP
ajlm-846	24	36	a	a	DET
ajlm-846	24	37	cdi	cdi	PROPN
ajlm-846	24	38	outbreak	outbreak	NOUN
ajlm-846	24	39	occurring	occur	VERB
ajlm-846	24	40	in	in	ADP
ajlm-846	24	41	a	a	DET
ajlm-846	24	42	tuberculosis	tuberculosis	NOUN
ajlm-846	24	43	hospital	hospital	NOUN
ajlm-846	24	44	in	in	ADP
ajlm-846	24	45	the	the	DET
ajlm-846	24	46	eastern	eastern	ADJ
ajlm-846	24	47	cape	cape	NOUN
ajlm-846	24	48	province,23	province,23	NOUN
ajlm-846	24	49	suggesting	suggest	VERB
ajlm-846	24	50	the	the	DET
ajlm-846	24	51	need	need	NOUN
ajlm-846	24	52	for	for	ADP
ajlm-846	24	53	further	further	ADJ
ajlm-846	24	54	research	research	NOUN
ajlm-846	24	55	in	in	ADP
ajlm-846	24	56	this	this	DET
ajlm-846	24	57	area	area	NOUN
ajlm-846	24	58	.	.	PUNCT
ajlm-846	25	1	while	while	SCONJ
ajlm-846	25	2	the	the	DET
ajlm-846	25	3	overall	overall	ADJ
ajlm-846	25	4	burden	burden	NOUN
ajlm-846	25	5	of	of	ADP
ajlm-846	25	6	cdi	cdi	PROPN
ajlm-846	25	7	in	in	ADP
ajlm-846	25	8	sub	sub	ADJ
ajlm-846	25	9	-	-	ADJ
ajlm-846	25	10	saharan	saharan	ADJ
ajlm-846	25	11	africa	africa	PROPN
ajlm-846	25	12	is	be	AUX
ajlm-846	25	13	largely	largely	ADV
ajlm-846	25	14	unknown	unknown	ADJ
ajlm-846	25	15	,	,	PUNCT
ajlm-846	25	16	data	datum	NOUN
ajlm-846	25	17	from	from	ADP
ajlm-846	25	18	the	the	DET
ajlm-846	25	19	limited	limited	ADJ
ajlm-846	25	20	number	number	NOUN
ajlm-846	25	21	of	of	ADP
ajlm-846	25	22	available	available	ADJ
ajlm-846	25	23	studies	study	NOUN
ajlm-846	25	24	suggest	suggest	VERB
ajlm-846	25	25	that	that	SCONJ
ajlm-846	25	26	the	the	DET
ajlm-846	25	27	prevalence	prevalence	NOUN
ajlm-846	25	28	of	of	ADP
ajlm-846	25	29	cdi	cdi	PROPN
ajlm-846	25	30	in	in	ADP
ajlm-846	25	31	the	the	DET
ajlm-846	25	32	region	region	NOUN
ajlm-846	25	33	is	be	AUX
ajlm-846	25	34	comparable	comparable	ADJ
ajlm-846	25	35	to	to	ADP
ajlm-846	25	36	that	that	PRON
ajlm-846	25	37	of	of	ADP
ajlm-846	25	38	high	high	ADJ
ajlm-846	25	39	income	income	NOUN
ajlm-846	25	40	countries	country	NOUN
ajlm-846	25	41	in	in	ADP
ajlm-846	25	42	europe	europe	PROPN
ajlm-846	25	43	and	and	CCONJ
ajlm-846	25	44	north	north	NOUN
ajlm-846	25	45	america.24,25	america.24,25	NOUN
ajlm-846	25	46	in	in	ADP
ajlm-846	25	47	south	south	PROPN
ajlm-846	25	48	africa	africa	PROPN
ajlm-846	25	49	,	,	PUNCT
ajlm-846	25	50	studies	study	NOUN
ajlm-846	25	51	carried	carry	VERB
ajlm-846	25	52	out	out	ADP
ajlm-846	25	53	in	in	ADP
ajlm-846	25	54	the	the	DET
ajlm-846	25	55	vhembe	vhembe	NOUN
ajlm-846	25	56	district	district	NOUN
ajlm-846	25	57	of	of	ADP
ajlm-846	25	58	limpopo	limpopo	PROPN
ajlm-846	25	59	province	province	PROPN
ajlm-846	25	60	and	and	CCONJ
ajlm-846	25	61	cape	cape	NOUN
ajlm-846	25	62	town	town	NOUN
ajlm-846	25	63	in	in	ADP
ajlm-846	25	64	the	the	DET
ajlm-846	25	65	western	western	ADJ
ajlm-846	25	66	cape	cape	NOUN
ajlm-846	25	67	report	report	VERB
ajlm-846	25	68	a	a	DET
ajlm-846	25	69	prevalence	prevalence	NOUN
ajlm-846	25	70	of	of	ADP
ajlm-846	25	71	toxigenic	toxigenic	ADJ
ajlm-846	25	72	c.	c.	NOUN
ajlm-846	25	73	difficile	difficile	NOUN
ajlm-846	25	74	of	of	ADP
ajlm-846	25	75	between	between	ADP
ajlm-846	25	76	10	10	NUM
ajlm-846	25	77	%	%	NOUN
ajlm-846	25	78	and	and	CCONJ
ajlm-846	25	79	20	20	NUM
ajlm-846	25	80	%	%	NOUN
ajlm-846	25	81	in	in	ADP
ajlm-846	25	82	patients	patient	NOUN
ajlm-846	25	83	with	with	ADP
ajlm-846	25	84	diarrhoea.26,27,28	diarrhoea.26,27,28	PROPN
ajlm-846	25	85	however	however	ADV
ajlm-846	25	86	,	,	PUNCT
ajlm-846	25	87	at	at	ADP
ajlm-846	25	88	least	least	ADJ
ajlm-846	25	89	two	two	NUM
ajlm-846	25	90	of	of	ADP
ajlm-846	25	91	the	the	DET
ajlm-846	25	92	previous	previous	ADJ
ajlm-846	25	93	studies	study	NOUN
ajlm-846	25	94	undertaken	undertake	VERB
ajlm-846	25	95	in	in	ADP
ajlm-846	25	96	the	the	DET
ajlm-846	25	97	country	country	NOUN
ajlm-846	25	98	relied	rely	VERB
ajlm-846	25	99	on	on	ADP
ajlm-846	25	100	diagnostic	diagnostic	ADJ
ajlm-846	25	101	testing	testing	NOUN
ajlm-846	25	102	that	that	PRON
ajlm-846	25	103	detected	detect	VERB
ajlm-846	25	104	toxin	toxin	NOUN
ajlm-846	25	105	a	a	PRON
ajlm-846	25	106	alone	alone	ADV
ajlm-846	25	107	,	,	PUNCT
ajlm-846	25	108	meaning	mean	VERB
ajlm-846	25	109	that	that	SCONJ
ajlm-846	25	110	the	the	DET
ajlm-846	25	111	rate	rate	NOUN
ajlm-846	25	112	of	of	ADP
ajlm-846	25	113	cdi	cdi	PROPN
ajlm-846	25	114	in	in	ADP
ajlm-846	25	115	the	the	DET
ajlm-846	25	116	country	country	NOUN
ajlm-846	25	117	may	may	AUX
ajlm-846	25	118	be	be	AUX
ajlm-846	25	119	underestimated.27,29	underestimated.27,29	NOUN
ajlm-846	25	120	additionally	additionally	ADV
ajlm-846	25	121	,	,	PUNCT
ajlm-846	25	122	epidemiological	epidemiological	ADJ
ajlm-846	25	123	information	information	NOUN
ajlm-846	25	124	regarding	regard	VERB
ajlm-846	25	125	cdi	cdi	PROPN
ajlm-846	25	126	and	and	CCONJ
ajlm-846	25	127	the	the	DET
ajlm-846	25	128	strains	strain	NOUN
ajlm-846	25	129	responsible	responsible	ADJ
ajlm-846	25	130	for	for	ADP
ajlm-846	25	131	disease	disease	NOUN
ajlm-846	25	132	is	be	AUX
ajlm-846	25	133	currently	currently	ADV
ajlm-846	25	134	lacking	lack	VERB
ajlm-846	25	135	,	,	PUNCT
ajlm-846	25	136	particularly	particularly	ADV
ajlm-846	25	137	for	for	ADP
ajlm-846	25	138	hiv	hiv	NOUN
ajlm-846	25	139	-	-	PUNCT
ajlm-846	25	140	positive	positive	ADJ
ajlm-846	25	141	/	/	SYM
ajlm-846	25	142	tuberculosis	tuberculosis	NOUN
ajlm-846	25	143	-	-	PUNCT
ajlm-846	25	144	positive	positive	ADJ
ajlm-846	25	145	patients	patient	NOUN
ajlm-846	25	146	,	,	PUNCT
ajlm-846	25	147	who	who	PRON
ajlm-846	25	148	may	may	AUX
ajlm-846	25	149	be	be	AUX
ajlm-846	25	150	at	at	ADP
ajlm-846	25	151	an	an	DET
ajlm-846	25	152	increased	increase	VERB
ajlm-846	25	153	risk	risk	NOUN
ajlm-846	25	154	of	of	ADP
ajlm-846	25	155	developing	develop	VERB
ajlm-846	25	156	cdi	cdi	PROPN
ajlm-846	25	157	.	.	PUNCT
ajlm-846	26	1	therefore	therefore	ADV
ajlm-846	26	2	,	,	PUNCT
ajlm-846	26	3	the	the	DET
ajlm-846	26	4	aim	aim	NOUN
ajlm-846	26	5	of	of	ADP
ajlm-846	26	6	the	the	DET
ajlm-846	26	7	current	current	ADJ
ajlm-846	26	8	study	study	NOUN
ajlm-846	26	9	was	be	AUX
ajlm-846	26	10	to	to	PART
ajlm-846	26	11	examine	examine	VERB
ajlm-846	26	12	cdi	cdi	PROPN
ajlm-846	26	13	in	in	ADP
ajlm-846	26	14	patients	patient	NOUN
ajlm-846	26	15	attending	attend	VERB
ajlm-846	26	16	two	two	NUM
ajlm-846	26	17	specialist	specialist	ADJ
ajlm-846	26	18	tuberculosis	tuberculosis	NOUN
ajlm-846	26	19	hospitals	hospital	NOUN
ajlm-846	26	20	in	in	ADP
ajlm-846	26	21	cape	cape	NOUN
ajlm-846	26	22	town	town	NOUN
ajlm-846	26	23	and	and	CCONJ
ajlm-846	26	24	to	to	PART
ajlm-846	26	25	determine	determine	VERB
ajlm-846	26	26	the	the	DET
ajlm-846	26	27	molecular	molecular	ADJ
ajlm-846	26	28	epidemiology	epidemiology	NOUN
ajlm-846	26	29	of	of	ADP
ajlm-846	26	30	strains	strain	NOUN
ajlm-846	26	31	isolated	isolate	VERB
ajlm-846	26	32	from	from	ADP
ajlm-846	26	33	these	these	DET
ajlm-846	26	34	patients	patient	NOUN
ajlm-846	26	35	.	.	PUNCT
ajlm-846	27	1	methods	method	NOUN
ajlm-846	27	2	ethical	ethical	ADJ
ajlm-846	27	3	considerations	consideration	NOUN
ajlm-846	27	4	all	all	DET
ajlm-846	27	5	procedures	procedure	NOUN
ajlm-846	27	6	performed	perform	VERB
ajlm-846	27	7	in	in	ADP
ajlm-846	27	8	studies	study	NOUN
ajlm-846	27	9	involving	involve	VERB
ajlm-846	27	10	human	human	ADJ
ajlm-846	27	11	participants	participant	NOUN
ajlm-846	27	12	were	be	AUX
ajlm-846	27	13	in	in	ADP
ajlm-846	27	14	accordance	accordance	NOUN
ajlm-846	27	15	with	with	ADP
ajlm-846	27	16	the	the	DET
ajlm-846	27	17	ethical	ethical	ADJ
ajlm-846	27	18	standards	standard	NOUN
ajlm-846	27	19	of	of	ADP
ajlm-846	27	20	the	the	DET
ajlm-846	27	21	institutional	institutional	ADJ
ajlm-846	27	22	and	and	CCONJ
ajlm-846	27	23	national	national	ADJ
ajlm-846	27	24	research	research	NOUN
ajlm-846	27	25	committees	committee	NOUN
ajlm-846	27	26	and	and	CCONJ
ajlm-846	27	27	with	with	ADP
ajlm-846	27	28	the	the	DET
ajlm-846	27	29	helsinki	helsinki	PROPN
ajlm-846	27	30	declaration	declaration	PROPN
ajlm-846	27	31	and	and	CCONJ
ajlm-846	27	32	its	its	PRON
ajlm-846	27	33	later	later	ADJ
ajlm-846	27	34	amendments	amendment	NOUN
ajlm-846	27	35	.	.	PUNCT
ajlm-846	28	1	this	this	DET
ajlm-846	28	2	study	study	NOUN
ajlm-846	28	3	was	be	AUX
ajlm-846	28	4	approved	approve	VERB
ajlm-846	28	5	by	by	ADP
ajlm-846	28	6	the	the	DET
ajlm-846	28	7	ethics	ethic	NOUN
ajlm-846	28	8	committee	committee	PROPN
ajlm-846	28	9	of	of	ADP
ajlm-846	28	10	the	the	DET
ajlm-846	28	11	university	university	PROPN
ajlm-846	28	12	of	of	ADP
ajlm-846	28	13	cape	cape	NOUN
ajlm-846	28	14	town	town	NOUN
ajlm-846	28	15	(	(	PUNCT
ajlm-846	28	16	hrec	hrec	NOUN
ajlm-846	28	17	number	number	NOUN
ajlm-846	28	18	:	:	PUNCT
ajlm-846	28	19	310/2008	310/2008	NUM
ajlm-846	28	20	)	)	PUNCT
ajlm-846	28	21	.	.	PUNCT
ajlm-846	29	1	for	for	ADP
ajlm-846	29	2	this	this	DET
ajlm-846	29	3	type	type	NOUN
ajlm-846	29	4	of	of	ADP
ajlm-846	29	5	observational	observational	ADJ
ajlm-846	29	6	and	and	CCONJ
ajlm-846	29	7	retrospective	retrospective	ADJ
ajlm-846	29	8	study	study	NOUN
ajlm-846	29	9	formal	formal	ADJ
ajlm-846	29	10	consent	consent	NOUN
ajlm-846	29	11	is	be	AUX
ajlm-846	29	12	not	not	PART
ajlm-846	29	13	required	require	VERB
ajlm-846	29	14	.	.	PUNCT
ajlm-846	30	1	study	study	NOUN
ajlm-846	30	2	setting	setting	NOUN
ajlm-846	30	3	and	and	CCONJ
ajlm-846	30	4	sample	sample	NOUN
ajlm-846	30	5	collection	collection	NOUN
ajlm-846	30	6	adult	adult	NOUN
ajlm-846	30	7	patients	patient	NOUN
ajlm-846	30	8	with	with	ADP
ajlm-846	30	9	tuberculosis	tuberculosis	NOUN
ajlm-846	30	10	attending	attend	VERB
ajlm-846	30	11	two	two	NUM
ajlm-846	30	12	specialist	specialist	ADJ
ajlm-846	30	13	tuberculosis	tuberculosis	NOUN
ajlm-846	30	14	hospitals	hospital	NOUN
ajlm-846	30	15	(	(	PUNCT
ajlm-846	30	16	designated	designate	VERB
ajlm-846	30	17	hospital	hospital	NOUN
ajlm-846	30	18	a	a	PRON
ajlm-846	30	19	and	and	CCONJ
ajlm-846	30	20	hospital	hospital	NOUN
ajlm-846	30	21	b	b	NOUN
ajlm-846	30	22	)	)	PUNCT
ajlm-846	30	23	in	in	ADP
ajlm-846	30	24	cape	cape	NOUN
ajlm-846	30	25	town	town	NOUN
ajlm-846	30	26	between	between	ADP
ajlm-846	30	27	september	september	PROPN
ajlm-846	30	28	2014	2014	NUM
ajlm-846	30	29	and	and	CCONJ
ajlm-846	30	30	september	september	PROPN
ajlm-846	30	31	2015	2015	NUM
ajlm-846	30	32	were	be	AUX
ajlm-846	30	33	included	include	VERB
ajlm-846	30	34	as	as	ADP
ajlm-846	30	35	part	part	NOUN
ajlm-846	30	36	of	of	ADP
ajlm-846	30	37	a	a	DET
ajlm-846	30	38	larger	large	ADJ
ajlm-846	30	39	surveillance	surveillance	NOUN
ajlm-846	30	40	study	study	NOUN
ajlm-846	30	41	for	for	ADP
ajlm-846	30	42	cdi	cdi	PROPN
ajlm-846	30	43	that	that	PRON
ajlm-846	30	44	has	have	AUX
ajlm-846	30	45	been	be	AUX
ajlm-846	30	46	published	publish	VERB
ajlm-846	30	47	more	more	ADV
ajlm-846	30	48	fully	fully	ADV
ajlm-846	30	49	elsewhere.30	elsewhere.30	NOUN
ajlm-846	30	50	both	both	PRON
ajlm-846	30	51	hospitals	hospital	NOUN
ajlm-846	30	52	house	house	NOUN
ajlm-846	30	53	patients	patient	NOUN
ajlm-846	30	54	undergoing	undergo	VERB
ajlm-846	30	55	tuberculosis	tuberculosis	NOUN
ajlm-846	30	56	therapy	therapy	NOUN
ajlm-846	30	57	with	with	ADP
ajlm-846	30	58	adult	adult	NOUN
ajlm-846	30	59	wards	ward	NOUN
ajlm-846	30	60	divided	divide	VERB
ajlm-846	30	61	into	into	ADP
ajlm-846	30	62	long	long	ADJ
ajlm-846	30	63	-	-	PUNCT
ajlm-846	30	64	stay	stay	VERB
ajlm-846	30	65	multi	multi	ADJ
ajlm-846	30	66	-	-	ADJ
ajlm-846	30	67	drug	drug	ADJ
ajlm-846	30	68	resistant	resistant	ADJ
ajlm-846	30	69	(	(	PUNCT
ajlm-846	30	70	mdr	mdr	NOUN
ajlm-846	30	71	)	)	PUNCT
ajlm-846	30	72	and	and	CCONJ
ajlm-846	30	73	extensively	extensively	ADV
ajlm-846	30	74	drug	drug	NOUN
ajlm-846	30	75	resistant	resistant	ADJ
ajlm-846	30	76	(	(	PUNCT
ajlm-846	30	77	xdr	xdr	PROPN
ajlm-846	30	78	)	)	PUNCT
ajlm-846	30	79	wards	ward	NOUN
ajlm-846	30	80	and	and	CCONJ
ajlm-846	30	81	short	short	ADJ
ajlm-846	30	82	-	-	PUNCT
ajlm-846	30	83	stay	stay	VERB
ajlm-846	30	84	separate	separate	ADJ
ajlm-846	30	85	male	male	ADJ
ajlm-846	30	86	and	and	CCONJ
ajlm-846	30	87	female	female	ADJ
ajlm-846	30	88	wards	ward	NOUN
ajlm-846	30	89	for	for	ADP
ajlm-846	30	90	drug	drug	NOUN
ajlm-846	30	91	sensitive	sensitive	ADJ
ajlm-846	30	92	patients	patient	NOUN
ajlm-846	30	93	.	.	PUNCT
ajlm-846	31	1	inclusion	inclusion	NOUN
ajlm-846	31	2	criteria	criterion	NOUN
ajlm-846	31	3	were	be	AUX
ajlm-846	31	4	clinical	clinical	ADJ
ajlm-846	31	5	suspicion	suspicion	NOUN
ajlm-846	31	6	of	of	ADP
ajlm-846	31	7	cdi	cdi	PROPN
ajlm-846	31	8	(	(	PUNCT
ajlm-846	31	9	based	base	VERB
ajlm-846	31	10	on	on	ADP
ajlm-846	31	11	a	a	DET
ajlm-846	31	12	c.	c.	NOUN
ajlm-846	31	13	difficile	difficile	VERB
ajlm-846	31	14	diagnostic	diagnostic	ADJ
ajlm-846	31	15	test	test	NOUN
ajlm-846	31	16	request	request	NOUN
ajlm-846	31	17	from	from	ADP
ajlm-846	31	18	the	the	DET
ajlm-846	31	19	attending	attend	VERB
ajlm-846	31	20	clinician	clinician	NOUN
ajlm-846	31	21	)	)	PUNCT
ajlm-846	31	22	and	and	CCONJ
ajlm-846	31	23	an	an	DET
ajlm-846	31	24	unformed	unformed	ADJ
ajlm-846	31	25	stool	stool	NOUN
ajlm-846	31	26	sample	sample	NOUN
ajlm-846	31	27	,	,	PUNCT
ajlm-846	31	28	collected	collect	VERB
ajlm-846	31	29	in	in	ADP
ajlm-846	31	30	sterile	sterile	ADJ
ajlm-846	31	31	specimen	speciman	NOUN
ajlm-846	31	32	containers	container	NOUN
ajlm-846	31	33	.	.	PUNCT
ajlm-846	32	1	during	during	ADP
ajlm-846	32	2	the	the	DET
ajlm-846	32	3	study	study	NOUN
ajlm-846	32	4	period	period	NOUN
ajlm-846	32	5	,	,	PUNCT
ajlm-846	32	6	stool	stool	NOUN
ajlm-846	32	7	samples	sample	NOUN
ajlm-846	32	8	submitted	submit	VERB
ajlm-846	32	9	to	to	ADP
ajlm-846	32	10	the	the	DET
ajlm-846	32	11	national	national	PROPN
ajlm-846	32	12	health	health	PROPN
ajlm-846	32	13	laboratory	laboratory	PROPN
ajlm-846	32	14	service	service	PROPN
ajlm-846	32	15	diagnostic	diagnostic	ADJ
ajlm-846	32	16	laboratory	laboratory	NOUN
ajlm-846	32	17	at	at	ADP
ajlm-846	32	18	groote	groote	PROPN
ajlm-846	32	19	schuur	schuur	PROPN
ajlm-846	32	20	hospital	hospital	NOUN
ajlm-846	32	21	that	that	PRON
ajlm-846	32	22	tested	test	VERB
ajlm-846	32	23	positive	positive	ADJ
ajlm-846	32	24	for	for	ADP
ajlm-846	32	25	c.	c.	NOUN
ajlm-846	32	26	difficile	difficile	NOUN
ajlm-846	32	27	using	use	VERB
ajlm-846	32	28	the	the	DET
ajlm-846	32	29	xpert	xpert	PROPN
ajlm-846	32	30	®	®	PROPN
ajlm-846	32	31	c.	c.	PROPN
ajlm-846	32	32	difficile	difficile	PROPN
ajlm-846	32	33	platform	platform	NOUN
ajlm-846	32	34	(	(	PUNCT
ajlm-846	32	35	cepheid	cepheid	NOUN
ajlm-846	32	36	,	,	PUNCT
ajlm-846	32	37	sunnyvale	sunnyvale	PROPN
ajlm-846	32	38	,	,	PUNCT
ajlm-846	32	39	california	california	PROPN
ajlm-846	32	40	,	,	PUNCT
ajlm-846	32	41	united	united	PROPN
ajlm-846	32	42	states	states	PROPN
ajlm-846	32	43	)	)	PUNCT
ajlm-846	32	44	were	be	AUX
ajlm-846	32	45	retained	retain	VERB
ajlm-846	32	46	at	at	ADP
ajlm-846	32	47	−70	−70	NOUN
ajlm-846	32	48	°	°	ADP
ajlm-846	32	49	c	c	NOUN
ajlm-846	32	50	for	for	ADP
ajlm-846	32	51	further	further	ADJ
ajlm-846	32	52	culture	culture	NOUN
ajlm-846	32	53	analysis	analysis	NOUN
ajlm-846	32	54	.	.	PUNCT
ajlm-846	33	1	recorded	record	VERB
ajlm-846	33	2	patient	patient	ADJ
ajlm-846	33	3	data	datum	NOUN
ajlm-846	33	4	were	be	AUX
ajlm-846	33	5	limited	limit	VERB
ajlm-846	33	6	to	to	ADP
ajlm-846	33	7	patient	patient	ADJ
ajlm-846	33	8	identification	identification	NOUN
ajlm-846	33	9	number	number	NOUN
ajlm-846	33	10	(	(	PUNCT
ajlm-846	33	11	necessary	necessary	ADJ
ajlm-846	33	12	to	to	PART
ajlm-846	33	13	identify	identify	VERB
ajlm-846	33	14	repeat	repeat	NOUN
ajlm-846	33	15	specimens	specimen	NOUN
ajlm-846	33	16	)	)	PUNCT
ajlm-846	33	17	,	,	PUNCT
ajlm-846	33	18	age	age	NOUN
ajlm-846	33	19	,	,	PUNCT
ajlm-846	33	20	gender	gender	NOUN
ajlm-846	33	21	as	as	ADV
ajlm-846	33	22	well	well	ADV
ajlm-846	33	23	as	as	ADP
ajlm-846	33	24	the	the	DET
ajlm-846	33	25	hospital	hospital	NOUN
ajlm-846	33	26	and	and	CCONJ
ajlm-846	33	27	ward	ward	VERB
ajlm-846	33	28	the	the	DET
ajlm-846	33	29	patient	patient	NOUN
ajlm-846	33	30	was	be	AUX
ajlm-846	33	31	in	in	ADV
ajlm-846	33	32	at	at	ADP
ajlm-846	33	33	the	the	DET
ajlm-846	33	34	time	time	NOUN
ajlm-846	33	35	of	of	ADP
ajlm-846	33	36	sample	sample	NOUN
ajlm-846	33	37	submission	submission	NOUN
ajlm-846	33	38	.	.	PUNCT
ajlm-846	34	1	c.	c.	NOUN
ajlm-846	34	2	difficile	difficile	VERB
ajlm-846	34	3	isolation	isolation	NOUN
ajlm-846	34	4	and	and	CCONJ
ajlm-846	34	5	characterisation	characterisation	NOUN
ajlm-846	34	6	c.	c.	NOUN
ajlm-846	34	7	difficile	difficile	PROPN
ajlm-846	34	8	was	be	AUX
ajlm-846	34	9	isolated	isolate	VERB
ajlm-846	34	10	from	from	ADP
ajlm-846	34	11	stool	stool	NOUN
ajlm-846	34	12	samples	sample	NOUN
ajlm-846	34	13	using	use	VERB
ajlm-846	34	14	cycloserine	cycloserine	ADJ
ajlm-846	34	15	cefoxitin	cefoxitin	NOUN
ajlm-846	34	16	egg	egg	NOUN
ajlm-846	34	17	yolk	yolk	NOUN
ajlm-846	34	18	agar.31	agar.31	NOUN
ajlm-846	34	19	briefly	briefly	ADV
ajlm-846	34	20	,	,	PUNCT
ajlm-846	34	21	stool	stool	NOUN
ajlm-846	34	22	was	be	AUX
ajlm-846	34	23	homogenised	homogenise	VERB
ajlm-846	34	24	in	in	ADP
ajlm-846	34	25	phosphate	phosphate	ADJ
ajlm-846	34	26	buffered	buffer	VERB
ajlm-846	34	27	saline	saline	NOUN
ajlm-846	34	28	and	and	CCONJ
ajlm-846	34	29	heat	heat	NOUN
ajlm-846	34	30	shocked	shock	VERB
ajlm-846	34	31	at	at	ADP
ajlm-846	34	32	60	60	NUM
ajlm-846	34	33	°	°	ADP
ajlm-846	34	34	c	c	NOUN
ajlm-846	34	35	for	for	ADP
ajlm-846	34	36	10	10	NUM
ajlm-846	34	37	minutes	minute	NOUN
ajlm-846	34	38	,	,	PUNCT
ajlm-846	34	39	before	before	ADP
ajlm-846	34	40	being	be	AUX
ajlm-846	34	41	inoculated	inoculate	VERB
ajlm-846	34	42	onto	onto	ADP
ajlm-846	34	43	cycloserine	cycloserine	ADJ
ajlm-846	34	44	cefoxitin	cefoxitin	NOUN
ajlm-846	34	45	egg	egg	NOUN
ajlm-846	34	46	yolk	yolk	NOUN
ajlm-846	34	47	agar	agar	NOUN
ajlm-846	34	48	.	.	PUNCT
ajlm-846	35	1	cultures	culture	NOUN
ajlm-846	35	2	were	be	AUX
ajlm-846	35	3	incubated	incubate	VERB
ajlm-846	35	4	for	for	ADP
ajlm-846	35	5	24–48	24–48	NUM
ajlm-846	35	6	hours	hour	NOUN
ajlm-846	35	7	at	at	ADP
ajlm-846	35	8	37	37	NUM
ajlm-846	35	9	°	°	SYM
ajlm-846	35	10	c	c	NOUN
ajlm-846	35	11	in	in	ADP
ajlm-846	35	12	an	an	DET
ajlm-846	35	13	anaerobic	anaerobic	NOUN
ajlm-846	35	14	chamber	chamber	NOUN
ajlm-846	35	15	under	under	ADP
ajlm-846	35	16	an	an	DET
ajlm-846	35	17	atmosphere	atmosphere	NOUN
ajlm-846	35	18	of	of	ADP
ajlm-846	35	19	5	5	NUM
ajlm-846	35	20	%	%	NOUN
ajlm-846	35	21	h2	h2	NOUN
ajlm-846	35	22	,	,	PUNCT
ajlm-846	35	23	10	10	NUM
ajlm-846	35	24	%	%	NOUN
ajlm-846	35	25	co2	co2	NOUN
ajlm-846	35	26	and	and	CCONJ
ajlm-846	35	27	85	85	NUM
ajlm-846	35	28	%	%	NOUN
ajlm-846	35	29	n2	n2	NOUN
ajlm-846	35	30	(	(	PUNCT
ajlm-846	35	31	forma	forma	NOUN
ajlm-846	35	32	scientific	scientific	ADJ
ajlm-846	35	33	,	,	PUNCT
ajlm-846	35	34	model	model	NOUN
ajlm-846	35	35	1024	1024	NUM
ajlm-846	35	36	,	,	PUNCT
ajlm-846	35	37	marietta	marietta	PROPN
ajlm-846	35	38	,	,	PUNCT
ajlm-846	35	39	ohio	ohio	PROPN
ajlm-846	35	40	,	,	PUNCT
ajlm-846	35	41	united	united	PROPN
ajlm-846	35	42	states	states	PROPN
ajlm-846	35	43	)	)	PUNCT
ajlm-846	35	44	.	.	PUNCT
ajlm-846	36	1	putative	putative	ADJ
ajlm-846	36	2	c.	c.	NOUN
ajlm-846	36	3	difficile	difficile	PROPN
ajlm-846	36	4	isolates	isolate	NOUN
ajlm-846	36	5	were	be	AUX
ajlm-846	36	6	confirmed	confirm	VERB
ajlm-846	36	7	by	by	ADP
ajlm-846	36	8	pcr	pcr	NOUN
ajlm-846	36	9	targeting	target	VERB
ajlm-846	36	10	the	the	DET
ajlm-846	36	11	c.	c.	NOUN
ajlm-846	36	12	difficile	difficile	PROPN
ajlm-846	36	13	tpi	tpi	PROPN
ajlm-846	36	14	gene	gene	NOUN
ajlm-846	36	15	,	,	PUNCT
ajlm-846	36	16	as	as	ADV
ajlm-846	36	17	well	well	ADV
ajlm-846	36	18	as	as	ADP
ajlm-846	36	19	the	the	DET
ajlm-846	36	20	various	various	ADJ
ajlm-846	36	21	toxin	toxin	NOUN
ajlm-846	36	22	-	-	PUNCT
ajlm-846	36	23	encoding	encoding	NOUN
ajlm-846	36	24	genes	gene	NOUN
ajlm-846	36	25	(	(	PUNCT
ajlm-846	36	26	tcda	tcda	NOUN
ajlm-846	36	27	,	,	PUNCT
ajlm-846	36	28	tcdb	tcdb	NOUN
ajlm-846	36	29	,	,	PUNCT
ajlm-846	36	30	cdta	cdta	PROPN
ajlm-846	36	31	,	,	PUNCT
ajlm-846	36	32	cdtb).32,33	cdtb).32,33	PROPN
ajlm-846	36	33	isolates	isolate	NOUN
ajlm-846	36	34	were	be	AUX
ajlm-846	36	35	typed	type	VERB
ajlm-846	36	36	by	by	ADP
ajlm-846	36	37	capillary	capillary	ADJ
ajlm-846	36	38	gel	gel	NOUN
ajlm-846	36	39	electrophoresis	electrophoresis	NOUN
ajlm-846	36	40	-	-	PUNCT
ajlm-846	36	41	based	base	VERB
ajlm-846	36	42	ribotyping34	ribotyping34	NOUN
ajlm-846	36	43	and	and	CCONJ
ajlm-846	36	44	matched	match	VERB
ajlm-846	36	45	against	against	ADP
ajlm-846	36	46	a	a	DET
ajlm-846	36	47	local	local	ADJ
ajlm-846	36	48	strain	strain	NOUN
ajlm-846	36	49	database	database	NOUN
ajlm-846	36	50	,	,	PUNCT
ajlm-846	36	51	which	which	PRON
ajlm-846	36	52	included	include	VERB
ajlm-846	36	53	a	a	DET
ajlm-846	36	54	selection	selection	NOUN
ajlm-846	36	55	of	of	ADP
ajlm-846	36	56	profiles	profile	NOUN
ajlm-846	36	57	from	from	ADP
ajlm-846	36	58	the	the	DET
ajlm-846	36	59	cardiff	cardiff	ADJ
ajlm-846	36	60	anaerobe	anaerobe	NOUN
ajlm-846	36	61	reference	reference	NOUN
ajlm-846	36	62	unit	unit	NOUN
ajlm-846	36	63	(	(	PUNCT
ajlm-846	36	64	named	name	VERB
ajlm-846	36	65	according	accord	VERB
ajlm-846	36	66	to	to	ADP
ajlm-846	36	67	the	the	DET
ajlm-846	36	68	standard	standard	ADJ
ajlm-846	36	69	nomenclature	nomenclature	NOUN
ajlm-846	36	70	)	)	PUNCT
ajlm-846	36	71	and	and	CCONJ
ajlm-846	36	72	the	the	DET
ajlm-846	36	73	swedish	swedish	PROPN
ajlm-846	36	74	institute	institute	PROPN
ajlm-846	36	75	for	for	ADP
ajlm-846	36	76	communicable	communicable	NOUN
ajlm-846	36	77	disease	disease	NOUN
ajlm-846	36	78	control	control	NOUN
ajlm-846	36	79	(	(	PUNCT
ajlm-846	36	80	names	name	NOUN
ajlm-846	36	81	preceded	precede	VERB
ajlm-846	36	82	by	by	ADP
ajlm-846	36	83	‘	'	PUNCT
ajlm-846	36	84	se	se	X
ajlm-846	36	85	’	'	PUNCT
ajlm-846	36	86	in	in	ADP
ajlm-846	36	87	the	the	DET
ajlm-846	36	88	designation).30	designation).30	NOUN
ajlm-846	36	89	further	further	ADJ
ajlm-846	36	90	characterisation	characterisation	NOUN
ajlm-846	36	91	by	by	ADP
ajlm-846	36	92	multilocus	multilocus	NOUN
ajlm-846	36	93	variable	variable	ADJ
ajlm-846	36	94	-	-	PUNCT
ajlm-846	36	95	number	number	NOUN
ajlm-846	36	96	tandem	tandem	NOUN
ajlm-846	36	97	-	-	PUNCT
ajlm-846	36	98	repeat	repeat	NOUN
ajlm-846	36	99	analysis	analysis	NOUN
ajlm-846	36	100	(	(	PUNCT
ajlm-846	36	101	mlva	mlva	NOUN
ajlm-846	36	102	)	)	PUNCT
ajlm-846	36	103	was	be	AUX
ajlm-846	36	104	carried	carry	VERB
ajlm-846	36	105	out	out	ADP
ajlm-846	36	106	as	as	SCONJ
ajlm-846	36	107	previously	previously	ADV
ajlm-846	36	108	described.35	described.35	NOUN
ajlm-846	36	109	briefly	briefly	NOUN
ajlm-846	36	110	,	,	PUNCT
ajlm-846	36	111	the	the	DET
ajlm-846	36	112	calculated	calculated	ADJ
ajlm-846	36	113	numbers	number	NOUN
ajlm-846	36	114	of	of	ADP
ajlm-846	36	115	repeats	repeat	NOUN
ajlm-846	36	116	at	at	ADP
ajlm-846	36	117	each	each	DET
ajlm-846	36	118	locus	locus	NOUN
ajlm-846	36	119	were	be	AUX
ajlm-846	36	120	used	use	VERB
ajlm-846	36	121	to	to	PART
ajlm-846	36	122	calculate	calculate	VERB
ajlm-846	36	123	a	a	DET
ajlm-846	36	124	dissimilarity	dissimilarity	NOUN
ajlm-846	36	125	matrix	matrix	NOUN
ajlm-846	36	126	based	base	VERB
ajlm-846	36	127	on	on	ADP
ajlm-846	36	128	the	the	DET
ajlm-846	36	129	manhattan	manhattan	PROPN
ajlm-846	36	130	distance	distance	NOUN
ajlm-846	36	131	between	between	ADP
ajlm-846	36	132	isolates	isolate	NOUN
ajlm-846	36	133	.	.	PUNCT
ajlm-846	37	1	this	this	DET
ajlm-846	37	2	dissimilarity	dissimilarity	NOUN
ajlm-846	37	3	matrix	matrix	NOUN
ajlm-846	37	4	was	be	AUX
ajlm-846	37	5	used	use	VERB
ajlm-846	37	6	to	to	PART
ajlm-846	37	7	construct	construct	VERB
ajlm-846	37	8	minimum	minimum	ADJ
ajlm-846	37	9	spanning	span	VERB
ajlm-846	37	10	trees	tree	NOUN
ajlm-846	37	11	using	use	VERB
ajlm-846	37	12	kruskal	kruskal	PROPN
ajlm-846	37	13	’s	’s	PART
ajlm-846	37	14	algorithm	algorithm	NOUN
ajlm-846	37	15	implemented	implement	VERB
ajlm-846	37	16	in	in	ADP
ajlm-846	37	17	the	the	DET
ajlm-846	37	18	mstgold	mstgold	NOUN
ajlm-846	37	19	program	program	NOUN
ajlm-846	37	20	(	(	PUNCT
ajlm-846	37	21	version	version	VERB
ajlm-846	37	22	2.4)36	2.4)36	NUM
ajlm-846	37	23	with	with	ADP
ajlm-846	37	24	a	a	DET
ajlm-846	37	25	final	final	ADJ
ajlm-846	37	26	consensus	consensus	NOUN
ajlm-846	37	27	tree	tree	NOUN
ajlm-846	37	28	generated	generate	VERB
ajlm-846	37	29	from	from	ADP
ajlm-846	37	30	2000	2000	NUM
ajlm-846	37	31	bootstrap	bootstrap	NOUN
ajlm-846	37	32	replicates	replicate	NOUN
ajlm-846	37	33	.	.	PUNCT
ajlm-846	38	1	final	final	ADJ
ajlm-846	38	2	tree	tree	NOUN
ajlm-846	38	3	editing	editing	NOUN
ajlm-846	38	4	was	be	AUX
ajlm-846	38	5	carried	carry	VERB
ajlm-846	38	6	out	out	ADP
ajlm-846	38	7	using	use	VERB
ajlm-846	38	8	the	the	DET
ajlm-846	38	9	gephi	gephi	ADJ
ajlm-846	38	10	graph	graph	NOUN
ajlm-846	38	11	visualiser	visualiser	PROPN
ajlm-846	38	12	(	(	PUNCT
ajlm-846	38	13	version	version	NOUN
ajlm-846	38	14	0.9.2).37	0.9.2).37	PRON
ajlm-846	38	15	strains	strain	VERB
ajlm-846	38	16	with	with	ADP
ajlm-846	38	17	a	a	DET
ajlm-846	38	18	total	total	ADJ
ajlm-846	38	19	summed	sum	VERB
ajlm-846	38	20	tandem	tandem	NOUN
ajlm-846	38	21	-	-	PUNCT
ajlm-846	38	22	repeat	repeat	NOUN
ajlm-846	38	23	difference	difference	NOUN
ajlm-846	38	24	of	of	ADP
ajlm-846	38	25	two	two	NUM
ajlm-846	38	26	or	or	CCONJ
ajlm-846	38	27	less	less	ADJ
ajlm-846	38	28	across	across	ADP
ajlm-846	38	29	all	all	DET
ajlm-846	38	30	loci	locus	NOUN
ajlm-846	38	31	were	be	AUX
ajlm-846	38	32	considered	consider	VERB
ajlm-846	38	33	clonally	clonally	ADV
ajlm-846	38	34	related	relate	VERB
ajlm-846	38	35	based	base	VERB
ajlm-846	38	36	on	on	ADP
ajlm-846	38	37	approaches	approach	NOUN
ajlm-846	38	38	used	use	VERB
ajlm-846	38	39	in	in	ADP
ajlm-846	38	40	previous	previous	ADJ
ajlm-846	38	41	studies.35,38,39	studies.35,38,39	NOUN
ajlm-846	38	42	antibiotic	antibiotic	ADJ
ajlm-846	38	43	susceptibility	susceptibility	NOUN
ajlm-846	38	44	testing	test	VERB
ajlm-846	38	45	minimum	minimum	ADJ
ajlm-846	38	46	inhibitory	inhibitory	ADJ
ajlm-846	38	47	concentrations	concentration	NOUN
ajlm-846	38	48	(	(	PUNCT
ajlm-846	38	49	mics	mic	NOUN
ajlm-846	38	50	)	)	PUNCT
ajlm-846	38	51	for	for	ADP
ajlm-846	38	52	various	various	ADJ
ajlm-846	38	53	antibiotics	antibiotic	NOUN
ajlm-846	38	54	were	be	AUX
ajlm-846	38	55	determined	determine	VERB
ajlm-846	38	56	using	use	VERB
ajlm-846	38	57	the	the	DET
ajlm-846	38	58	gradient	gradient	NOUN
ajlm-846	38	59	diffusion	diffusion	NOUN
ajlm-846	38	60	strip	strip	NOUN
ajlm-846	38	61	method	method	NOUN
ajlm-846	38	62	.	.	PUNCT
ajlm-846	39	1	testing	testing	NOUN
ajlm-846	39	2	was	be	AUX
ajlm-846	39	3	carried	carry	VERB
ajlm-846	39	4	out	out	ADP
ajlm-846	39	5	using	use	VERB
ajlm-846	39	6	either	either	CCONJ
ajlm-846	39	7	etest	et	ADJ
ajlm-846	39	8	®	®	NOUN
ajlm-846	39	9	strips	strip	NOUN
ajlm-846	39	10	(	(	PUNCT
ajlm-846	39	11	biomérieux	biomérieux	PROPN
ajlm-846	39	12	,	,	PUNCT
ajlm-846	39	13	johannesburg	johannesburg	PROPN
ajlm-846	39	14	,	,	PUNCT
ajlm-846	39	15	south	south	PROPN
ajlm-846	39	16	africa	africa	PROPN
ajlm-846	39	17	)	)	PUNCT
ajlm-846	39	18	(	(	PUNCT
ajlm-846	39	19	metronidazole	metronidazole	NOUN
ajlm-846	39	20	,	,	PUNCT
ajlm-846	39	21	vancomycin	vancomycin	PROPN
ajlm-846	39	22	,	,	PUNCT
ajlm-846	39	23	moxifloxacin	moxifloxacin	NOUN
ajlm-846	39	24	and	and	CCONJ
ajlm-846	39	25	erythromycin	erythromycin	NOUN
ajlm-846	39	26	)	)	PUNCT
ajlm-846	39	27	or	or	CCONJ
ajlm-846	39	28	mic	mic	ADJ
ajlm-846	39	29	test	test	NOUN
ajlm-846	39	30	strips	strip	NOUN
ajlm-846	39	31	(	(	PUNCT
ajlm-846	39	32	liofilchem	liofilchem	NOUN
ajlm-846	39	33	,	,	PUNCT
ajlm-846	39	34	roseto	roseto	NOUN
ajlm-846	39	35	degli	degli	NOUN
ajlm-846	39	36	abruzzi	abruzzi	NOUN
ajlm-846	39	37	,	,	PUNCT
ajlm-846	39	38	italy	italy	PROPN
ajlm-846	39	39	)	)	PUNCT
ajlm-846	39	40	(	(	PUNCT
ajlm-846	39	41	rifampicin	rifampicin	VERB
ajlm-846	39	42	)	)	PUNCT
ajlm-846	39	43	and	and	CCONJ
ajlm-846	39	44	isolates	isolate	NOUN
ajlm-846	39	45	were	be	AUX
ajlm-846	39	46	cultured	cultured	ADJ
ajlm-846	39	47	on	on	ADP
ajlm-846	39	48	brucella	brucella	NOUN
ajlm-846	39	49	agar	agar	NOUN
ajlm-846	39	50	(	(	PUNCT
ajlm-846	39	51	supplemented	supplement	VERB
ajlm-846	39	52	with	with	ADP
ajlm-846	39	53	5	5	NUM
ajlm-846	39	54	%	%	NOUN
ajlm-846	39	55	horse	horse	NOUN
ajlm-846	39	56	blood	blood	NOUN
ajlm-846	39	57	,	,	PUNCT
ajlm-846	39	58	5	5	NUM
ajlm-846	39	59	μg	μg	NOUN
ajlm-846	39	60	/	/	SYM
ajlm-846	39	61	ml	ml	ADP
ajlm-846	39	62	haemin	haemin	NOUN
ajlm-846	39	63	and	and	CCONJ
ajlm-846	39	64	10	10	NUM
ajlm-846	39	65	μg	μg	NOUN
ajlm-846	39	66	/	/	SYM
ajlm-846	39	67	ml	ml	NOUN
ajlm-846	39	68	vitamin	vitamin	NOUN
ajlm-846	39	69	k	k	NOUN
ajlm-846	39	70	)	)	PUNCT
ajlm-846	39	71	.	.	PUNCT
ajlm-846	40	1	clinical	clinical	ADJ
ajlm-846	40	2	breakpoints	breakpoint	NOUN
ajlm-846	40	3	were	be	AUX
ajlm-846	40	4	obtained	obtain	VERB
ajlm-846	40	5	from	from	ADP
ajlm-846	40	6	clinical	clinical	ADJ
ajlm-846	40	7	&	&	CCONJ
ajlm-846	40	8	laboratory	laboratory	PROPN
ajlm-846	40	9	standards	standards	PROPN
ajlm-846	40	10	institute	institute	PROPN
ajlm-846	40	11	tables40	tables40	PROPN
ajlm-846	40	12	(	(	PUNCT
ajlm-846	40	13	metronidazole	metronidazole	NOUN
ajlm-846	40	14	,	,	PUNCT
ajlm-846	40	15	moxifloxacin	moxifloxacin	NUM
ajlm-846	40	16	,	,	PUNCT
ajlm-846	40	17	erythromycin	erythromycin	NOUN
ajlm-846	40	18	)	)	PUNCT
ajlm-846	40	19	,	,	PUNCT
ajlm-846	40	20	from	from	ADP
ajlm-846	40	21	european	european	PROPN
ajlm-846	40	22	committee	committee	PROPN
ajlm-846	40	23	on	on	ADP
ajlm-846	40	24	antimicrobial	antimicrobial	ADJ
ajlm-846	40	25	susceptibility	susceptibility	NOUN
ajlm-846	40	26	testing	testing	NOUN
ajlm-846	40	27	tables41	tables41	NOUN
ajlm-846	40	28	(	(	PUNCT
ajlm-846	40	29	vancomycin	vancomycin	PROPN
ajlm-846	40	30	)	)	PUNCT
ajlm-846	40	31	,	,	PUNCT
ajlm-846	40	32	and	and	CCONJ
ajlm-846	40	33	published	publish	VERB
ajlm-846	40	34	data	datum	NOUN
ajlm-846	40	35	(	(	PUNCT
ajlm-846	40	36	rifampicin).42	rifampicin).42	NOUN
ajlm-846	40	37	c.	c.	NOUN
ajlm-846	40	38	difficile	difficile	VERB
ajlm-846	40	39	atcc	atcc	PROPN
ajlm-846	40	40	700057	700057	NUM
ajlm-846	40	41	and	and	CCONJ
ajlm-846	40	42	c.	c.	PROPN
ajlm-846	40	43	difficile	difficile	PROPN
ajlm-846	40	44	11/11	11/11	NUM
ajlm-846	40	45	were	be	AUX
ajlm-846	40	46	used	use	VERB
ajlm-846	40	47	as	as	ADP
ajlm-846	40	48	control	control	NOUN
ajlm-846	40	49	strains	strain	NOUN
ajlm-846	40	50	showing	show	VERB
ajlm-846	40	51	full	full	ADJ
ajlm-846	40	52	susceptibility	susceptibility	NOUN
ajlm-846	40	53	and	and	CCONJ
ajlm-846	40	54	reduced	reduce	VERB
ajlm-846	40	55	susceptibility	susceptibility	NOUN
ajlm-846	40	56	to	to	PART
ajlm-846	40	57	metronidazole	metronidazole	NOUN
ajlm-846	40	58	respectively.43	respectively.43	PROPN
ajlm-846	40	59	results	result	VERB
ajlm-846	40	60	xpert	xpert	PROPN
ajlm-846	40	61	data	data	PROPN
ajlm-846	40	62	between	between	ADP
ajlm-846	40	63	september	september	PROPN
ajlm-846	40	64	2014	2014	NUM
ajlm-846	40	65	and	and	CCONJ
ajlm-846	40	66	september	september	PROPN
ajlm-846	40	67	2015	2015	NUM
ajlm-846	40	68	,	,	PUNCT
ajlm-846	40	69	initially	initially	ADV
ajlm-846	40	70	,	,	PUNCT
ajlm-846	40	71	a	a	DET
ajlm-846	40	72	total	total	NOUN
ajlm-846	40	73	of	of	ADP
ajlm-846	40	74	212	212	NUM
ajlm-846	40	75	c.	c.	NOUN
ajlm-846	40	76	difficile	difficile	NOUN
ajlm-846	40	77	test	test	NOUN
ajlm-846	40	78	requests	request	NOUN
ajlm-846	40	79	were	be	AUX
ajlm-846	40	80	received	receive	VERB
ajlm-846	40	81	from	from	ADP
ajlm-846	40	82	the	the	DET
ajlm-846	40	83	two	two	NUM
ajlm-846	40	84	hospitals	hospital	NOUN
ajlm-846	40	85	.	.	PUNCT
ajlm-846	41	1	slightly	slightly	ADV
ajlm-846	41	2	more	more	ADJ
ajlm-846	41	3	than	than	ADP
ajlm-846	41	4	half	half	NOUN
ajlm-846	41	5	(	(	PUNCT
ajlm-846	41	6	120	120	NUM
ajlm-846	41	7	;	;	PUNCT
ajlm-846	41	8	56.6	56.6	NUM
ajlm-846	41	9	%	%	NOUN
ajlm-846	41	10	)	)	PUNCT
ajlm-846	41	11	of	of	ADP
ajlm-846	41	12	the	the	DET
ajlm-846	41	13	submitted	submit	VERB
ajlm-846	41	14	samples	sample	NOUN
ajlm-846	41	15	were	be	AUX
ajlm-846	41	16	from	from	ADP
ajlm-846	41	17	female	female	ADJ
ajlm-846	41	18	patients	patient	NOUN
ajlm-846	41	19	.	.	PUNCT
ajlm-846	42	1	repeat	repeat	NOUN
ajlm-846	42	2	specimens	specimen	NOUN
ajlm-846	42	3	were	be	AUX
ajlm-846	42	4	obtained	obtain	VERB
ajlm-846	42	5	from	from	ADP
ajlm-846	42	6	a	a	DET
ajlm-846	42	7	total	total	NOUN
ajlm-846	42	8	of	of	ADP
ajlm-846	42	9	seven	seven	NUM
ajlm-846	42	10	patients	patient	NOUN
ajlm-846	42	11	.	.	PUNCT
ajlm-846	43	1	two	two	NUM
ajlm-846	43	2	of	of	ADP
ajlm-846	43	3	these	these	PRON
ajlm-846	43	4	were	be	AUX
ajlm-846	43	5	classified	classify	VERB
ajlm-846	43	6	as	as	ADP
ajlm-846	43	7	duplicate	duplicate	ADJ
ajlm-846	43	8	specimens	specimen	NOUN
ajlm-846	43	9	(	(	PUNCT
ajlm-846	43	10	received	receive	VERB
ajlm-846	43	11	from	from	ADP
ajlm-846	43	12	the	the	DET
ajlm-846	43	13	same	same	ADJ
ajlm-846	43	14	patient	patient	NOUN
ajlm-846	43	15	within	within	ADP
ajlm-846	43	16	a	a	DET
ajlm-846	43	17	two	two	NUM
ajlm-846	43	18	-	-	PUNCT
ajlm-846	43	19	week	week	NOUN
ajlm-846	43	20	period	period	NOUN
ajlm-846	43	21	)	)	PUNCT
ajlm-846	43	22	and	and	CCONJ
ajlm-846	43	23	were	be	AUX
ajlm-846	43	24	removed	remove	VERB
ajlm-846	43	25	from	from	ADP
ajlm-846	43	26	subsequent	subsequent	ADJ
ajlm-846	43	27	analyses	analysis	NOUN
ajlm-846	43	28	,	,	PUNCT
ajlm-846	43	29	while	while	SCONJ
ajlm-846	43	30	the	the	DET
ajlm-846	43	31	remaining	remain	VERB
ajlm-846	43	32	five	five	NUM
ajlm-846	43	33	were	be	AUX
ajlm-846	43	34	classified	classify	VERB
ajlm-846	43	35	as	as	ADP
ajlm-846	43	36	recurrent	recurrent	ADJ
ajlm-846	43	37	disease	disease	NOUN
ajlm-846	43	38	,	,	PUNCT
ajlm-846	43	39	defined	define	VERB
ajlm-846	43	40	as	as	ADP
ajlm-846	43	41	including	include	VERB
ajlm-846	43	42	both	both	CCONJ
ajlm-846	43	43	relapse	relapse	NOUN
ajlm-846	43	44	and	and	CCONJ
ajlm-846	43	45	reinfection	reinfection	NOUN
ajlm-846	43	46	cases	case	NOUN
ajlm-846	43	47	.	.	PUNCT
ajlm-846	44	1	the	the	DET
ajlm-846	44	2	minimum	minimum	ADJ
ajlm-846	44	3	,	,	PUNCT
ajlm-846	44	4	maximum	maximum	ADJ
ajlm-846	44	5	and	and	CCONJ
ajlm-846	44	6	median	median	ADJ
ajlm-846	44	7	durations	duration	NOUN
ajlm-846	44	8	between	between	ADP
ajlm-846	44	9	tests	test	NOUN
ajlm-846	44	10	for	for	ADP
ajlm-846	44	11	patients	patient	NOUN
ajlm-846	44	12	with	with	ADP
ajlm-846	44	13	recurrent	recurrent	ADJ
ajlm-846	44	14	disease	disease	NOUN
ajlm-846	44	15	were	be	AUX
ajlm-846	44	16	60	60	NUM
ajlm-846	44	17	,	,	PUNCT
ajlm-846	44	18	161	161	NUM
ajlm-846	44	19	and	and	CCONJ
ajlm-846	44	20	90	90	NUM
ajlm-846	44	21	days	day	NOUN
ajlm-846	44	22	,	,	PUNCT
ajlm-846	44	23	respectively	respectively	ADV
ajlm-846	44	24	.	.	PUNCT
ajlm-846	45	1	samples	sample	NOUN
ajlm-846	45	2	were	be	AUX
ajlm-846	45	3	submitted	submit	VERB
ajlm-846	45	4	from	from	ADP
ajlm-846	45	5	patients	patient	NOUN
ajlm-846	45	6	housed	house	VERB
ajlm-846	45	7	in	in	ADP
ajlm-846	45	8	nine	nine	NUM
ajlm-846	45	9	different	different	ADJ
ajlm-846	45	10	wards	ward	NOUN
ajlm-846	45	11	across	across	ADP
ajlm-846	45	12	the	the	DET
ajlm-846	45	13	two	two	NUM
ajlm-846	45	14	hospitals	hospital	NOUN
ajlm-846	45	15	.	.	PUNCT
ajlm-846	46	1	a	a	DET
ajlm-846	46	2	total	total	NOUN
ajlm-846	46	3	of	of	ADP
ajlm-846	46	4	117	117	NUM
ajlm-846	46	5	test	test	NOUN
ajlm-846	46	6	requests	request	NOUN
ajlm-846	46	7	(	(	PUNCT
ajlm-846	46	8	55.7	55.7	NUM
ajlm-846	46	9	%	%	NOUN
ajlm-846	46	10	)	)	PUNCT
ajlm-846	46	11	were	be	AUX
ajlm-846	46	12	received	receive	VERB
ajlm-846	46	13	from	from	ADP
ajlm-846	46	14	patients	patient	NOUN
ajlm-846	46	15	in	in	ADP
ajlm-846	46	16	drug	drug	NOUN
ajlm-846	46	17	sensitive	sensitive	ADJ
ajlm-846	46	18	(	(	PUNCT
ajlm-846	46	19	ds	ds	ADJ
ajlm-846	46	20	)	)	PUNCT
ajlm-846	46	21	tuberculosis	tuberculosis	NOUN
ajlm-846	46	22	wards	ward	NOUN
ajlm-846	46	23	,	,	PUNCT
ajlm-846	46	24	77	77	NUM
ajlm-846	46	25	(	(	PUNCT
ajlm-846	46	26	36.7	36.7	NUM
ajlm-846	46	27	%	%	NOUN
ajlm-846	46	28	)	)	PUNCT
ajlm-846	46	29	from	from	ADP
ajlm-846	46	30	patients	patient	NOUN
ajlm-846	46	31	in	in	ADP
ajlm-846	46	32	mdr	mdr	PROPN
ajlm-846	46	33	tuberculosis	tuberculosis	NOUN
ajlm-846	46	34	wards	ward	NOUN
ajlm-846	46	35	and	and	CCONJ
ajlm-846	46	36	four	four	NUM
ajlm-846	46	37	(	(	PUNCT
ajlm-846	46	38	1.9	1.9	NUM
ajlm-846	46	39	%	%	NOUN
ajlm-846	46	40	)	)	PUNCT
ajlm-846	46	41	from	from	ADP
ajlm-846	46	42	patients	patient	NOUN
ajlm-846	46	43	in	in	ADP
ajlm-846	46	44	pre	pre	ADJ
ajlm-846	46	45	-	-	ADJ
ajlm-846	46	46	xdr	xdr	ADJ
ajlm-846	46	47	tuberculosis	tuberculosis	NOUN
ajlm-846	46	48	and	and	CCONJ
ajlm-846	46	49	xdr	xdr	NOUN
ajlm-846	46	50	tuberculosis	tuberculosis	NOUN
ajlm-846	46	51	wards	ward	NOUN
ajlm-846	46	52	.	.	PUNCT
ajlm-846	47	1	a	a	DET
ajlm-846	47	2	further	further	ADJ
ajlm-846	47	3	12	12	NUM
ajlm-846	47	4	samples	sample	NOUN
ajlm-846	47	5	(	(	PUNCT
ajlm-846	47	6	5.7	5.7	NUM
ajlm-846	47	7	%	%	NOUN
ajlm-846	47	8	)	)	PUNCT
ajlm-846	47	9	did	do	AUX
ajlm-846	47	10	not	not	PART
ajlm-846	47	11	have	have	VERB
ajlm-846	47	12	ward	ward	NOUN
ajlm-846	47	13	information	information	NOUN
ajlm-846	47	14	.	.	PUNCT
ajlm-846	48	1	overall	overall	ADV
ajlm-846	48	2	,	,	PUNCT
ajlm-846	48	3	xpert	xpert	PROPN
ajlm-846	48	4	c.	c.	PROPN
ajlm-846	48	5	difficile	difficile	ADJ
ajlm-846	48	6	-	-	ADJ
ajlm-846	48	7	positive	positive	ADJ
ajlm-846	48	8	results	result	NOUN
ajlm-846	48	9	were	be	AUX
ajlm-846	48	10	obtained	obtain	VERB
ajlm-846	48	11	for	for	ADP
ajlm-846	48	12	152	152	NUM
ajlm-846	48	13	samples	sample	NOUN
ajlm-846	48	14	(	(	PUNCT
ajlm-846	48	15	72.4	72.4	NUM
ajlm-846	48	16	%	%	NOUN
ajlm-846	48	17	)	)	PUNCT
ajlm-846	48	18	in	in	ADP
ajlm-846	48	19	the	the	DET
ajlm-846	48	20	non	non	ADJ
ajlm-846	48	21	-	-	ADJ
ajlm-846	48	22	repeat	repeat	ADJ
ajlm-846	48	23	dataset	dataset	NOUN
ajlm-846	48	24	(	(	PUNCT
ajlm-846	48	25	figure	figure	NOUN
ajlm-846	48	26	1	1	NUM
ajlm-846	48	27	)	)	PUNCT
ajlm-846	48	28	.	.	PUNCT
ajlm-846	49	1	a	a	DET
ajlm-846	49	2	total	total	NOUN
ajlm-846	49	3	of	of	ADP
ajlm-846	49	4	three	three	NUM
ajlm-846	49	5	samples	sample	NOUN
ajlm-846	49	6	(	(	PUNCT
ajlm-846	49	7	1.4	1.4	NUM
ajlm-846	49	8	%	%	NOUN
ajlm-846	49	9	)	)	PUNCT
ajlm-846	49	10	yielded	yield	VERB
ajlm-846	49	11	indeterminate	indeterminate	ADJ
ajlm-846	49	12	results	result	NOUN
ajlm-846	49	13	and	and	CCONJ
ajlm-846	49	14	were	be	AUX
ajlm-846	49	15	not	not	PART
ajlm-846	49	16	repeated	repeat	VERB
ajlm-846	49	17	.	.	PUNCT
ajlm-846	50	1	the	the	DET
ajlm-846	50	2	period	period	NOUN
ajlm-846	50	3	prevalence	prevalence	NOUN
ajlm-846	50	4	for	for	ADP
ajlm-846	50	5	hospital	hospital	NOUN
ajlm-846	50	6	a	a	PRON
ajlm-846	50	7	was	be	AUX
ajlm-846	50	8	approximately	approximately	ADV
ajlm-846	50	9	84.05	84.05	NUM
ajlm-846	50	10	cases	case	NOUN
ajlm-846	50	11	per	per	ADP
ajlm-846	50	12	1000	1000	NUM
ajlm-846	50	13	patient	patient	ADJ
ajlm-846	50	14	admissions	admission	NOUN
ajlm-846	50	15	and	and	CCONJ
ajlm-846	50	16	for	for	ADP
ajlm-846	50	17	hospital	hospital	NOUN
ajlm-846	50	18	b	b	PROPN
ajlm-846	50	19	was	be	AUX
ajlm-846	50	20	approximately	approximately	ADV
ajlm-846	50	21	60.03	60.03	NUM
ajlm-846	50	22	cases	case	NOUN
ajlm-846	50	23	per	per	ADP
ajlm-846	50	24	1000	1000	NUM
ajlm-846	50	25	admissions	admission	NOUN
ajlm-846	50	26	(	(	PUNCT
ajlm-846	50	27	70.07	70.07	NUM
ajlm-846	50	28	cases	case	NOUN
ajlm-846	50	29	per	per	ADP
ajlm-846	50	30	1000	1000	NUM
ajlm-846	50	31	admissions	admission	NOUN
ajlm-846	50	32	overall	overall	ADJ
ajlm-846	50	33	)	)	PUNCT
ajlm-846	50	34	.	.	PUNCT
ajlm-846	51	1	most	most	ADJ
ajlm-846	51	2	samples	sample	NOUN
ajlm-846	51	3	(	(	PUNCT
ajlm-846	51	4	145	145	NUM
ajlm-846	51	5	;	;	PUNCT
ajlm-846	51	6	69	69	NUM
ajlm-846	51	7	%	%	NOUN
ajlm-846	51	8	)	)	PUNCT
ajlm-846	51	9	were	be	AUX
ajlm-846	51	10	submitted	submit	VERB
ajlm-846	51	11	by	by	ADP
ajlm-846	51	12	patients	patient	NOUN
ajlm-846	51	13	between	between	ADP
ajlm-846	51	14	the	the	DET
ajlm-846	51	15	ages	age	NOUN
ajlm-846	51	16	of	of	ADP
ajlm-846	51	17	24	24	NUM
ajlm-846	51	18	and	and	CCONJ
ajlm-846	51	19	45	45	NUM
ajlm-846	51	20	and	and	CCONJ
ajlm-846	51	21	the	the	DET
ajlm-846	51	22	median	median	ADJ
ajlm-846	51	23	age	age	NOUN
ajlm-846	51	24	for	for	ADP
ajlm-846	51	25	xpert	xpert	PROPN
ajlm-846	51	26	c.	c.	PROPN
ajlm-846	51	27	difficile	difficile	VERB
ajlm-846	51	28	positive	positive	ADJ
ajlm-846	51	29	patients	patient	NOUN
ajlm-846	51	30	(	(	PUNCT
ajlm-846	51	31	median	median	PROPN
ajlm-846	51	32	38	38	NUM
ajlm-846	51	33	,	,	PUNCT
ajlm-846	51	34	interquartile	interquartile	NOUN
ajlm-846	51	35	range	range	NOUN
ajlm-846	51	36	31–45.25	31–45.25	NUM
ajlm-846	51	37	)	)	PUNCT
ajlm-846	51	38	was	be	AUX
ajlm-846	51	39	slightly	slightly	ADV
ajlm-846	51	40	higher	high	ADJ
ajlm-846	51	41	than	than	ADP
ajlm-846	51	42	for	for	ADP
ajlm-846	51	43	xpert	xpert	PROPN
ajlm-846	51	44	c.	c.	PROPN
ajlm-846	51	45	difficile	difficile	VERB
ajlm-846	51	46	negative	negative	ADJ
ajlm-846	51	47	patients	patient	NOUN
ajlm-846	51	48	(	(	PUNCT
ajlm-846	51	49	median	median	NOUN
ajlm-846	51	50	34	34	NUM
ajlm-846	51	51	,	,	PUNCT
ajlm-846	51	52	interquartile	interquartile	NOUN
ajlm-846	51	53	range	range	NOUN
ajlm-846	51	54	30–40	30–40	NUM
ajlm-846	51	55	)	)	PUNCT
ajlm-846	51	56	.	.	PUNCT
ajlm-846	52	1	figure	figure	VERB
ajlm-846	52	2	1	1	NUM
ajlm-846	52	3	:	:	PUNCT
ajlm-846	52	4	detection	detection	NOUN
ajlm-846	52	5	of	of	ADP
ajlm-846	52	6	c.	c.	PROPN
ajlm-846	52	7	difficile	difficile	VERB
ajlm-846	52	8	in	in	ADP
ajlm-846	52	9	samples	sample	NOUN
ajlm-846	52	10	provided	provide	VERB
ajlm-846	52	11	by	by	ADP
ajlm-846	52	12	patients	patient	NOUN
ajlm-846	52	13	attending	attend	VERB
ajlm-846	52	14	hospital	hospital	NOUN
ajlm-846	52	15	a	a	PRON
ajlm-846	52	16	and	and	CCONJ
ajlm-846	52	17	hospital	hospital	NOUN
ajlm-846	52	18	b	b	NOUN
ajlm-846	52	19	stratified	stratify	VERB
ajlm-846	52	20	by	by	ADP
ajlm-846	52	21	patient	patient	ADJ
ajlm-846	52	22	age	age	NOUN
ajlm-846	52	23	.	.	PUNCT
ajlm-846	53	1	the	the	DET
ajlm-846	53	2	relative	relative	ADJ
ajlm-846	53	3	proportions	proportion	NOUN
ajlm-846	53	4	of	of	ADP
ajlm-846	53	5	samples	sample	NOUN
ajlm-846	53	6	provided	provide	VERB
ajlm-846	53	7	by	by	ADP
ajlm-846	53	8	patients	patient	NOUN
ajlm-846	53	9	in	in	ADP
ajlm-846	53	10	hospital	hospital	NOUN
ajlm-846	53	11	a	a	PRON
ajlm-846	53	12	and	and	CCONJ
ajlm-846	53	13	hospital	hospital	NOUN
ajlm-846	53	14	b	b	PROPN
ajlm-846	53	15	testing	testing	NOUN
ajlm-846	53	16	positive	positive	ADJ
ajlm-846	53	17	(	(	PUNCT
ajlm-846	53	18	+	+	NOUN
ajlm-846	53	19	ve	ve	NOUN
ajlm-846	53	20	)	)	PUNCT
ajlm-846	53	21	and	and	CCONJ
ajlm-846	53	22	negative	negative	ADJ
ajlm-846	53	23	(	(	PUNCT
ajlm-846	53	24	-ve	-ve	NOUN
ajlm-846	53	25	)	)	PUNCT
ajlm-846	53	26	by	by	ADP
ajlm-846	53	27	the	the	DET
ajlm-846	53	28	xpert	xpert	PROPN
ajlm-846	53	29	®	®	PROPN
ajlm-846	53	30	c.	c.	PROPN
ajlm-846	53	31	difficile	difficile	PROPN
ajlm-846	53	32	test	test	NOUN
ajlm-846	53	33	(	(	PUNCT
ajlm-846	53	34	xpert	xpert	PROPN
ajlm-846	53	35	)	)	PUNCT
ajlm-846	53	36	,	,	PUNCT
ajlm-846	53	37	along	along	ADP
ajlm-846	53	38	with	with	ADP
ajlm-846	53	39	those	those	PRON
ajlm-846	53	40	that	that	PRON
ajlm-846	53	41	yielded	yield	VERB
ajlm-846	53	42	an	an	DET
ajlm-846	53	43	indeterminate	indeterminate	ADJ
ajlm-846	53	44	or	or	CCONJ
ajlm-846	53	45	invalid	invalid	ADJ
ajlm-846	53	46	result	result	NOUN
ajlm-846	53	47	(	(	PUNCT
ajlm-846	53	48	ind	ind	NOUN
ajlm-846	53	49	)	)	PUNCT
ajlm-846	53	50	.	.	PUNCT
ajlm-846	54	1	numbers	number	NOUN
ajlm-846	54	2	above	above	ADP
ajlm-846	54	3	the	the	DET
ajlm-846	54	4	columns	column	NOUN
ajlm-846	54	5	represent	represent	VERB
ajlm-846	54	6	total	total	ADJ
ajlm-846	54	7	number	number	NOUN
ajlm-846	54	8	of	of	ADP
ajlm-846	54	9	tests	test	NOUN
ajlm-846	54	10	performed	perform	VERB
ajlm-846	54	11	for	for	ADP
ajlm-846	54	12	each	each	DET
ajlm-846	54	13	category	category	NOUN
ajlm-846	54	14	.	.	PUNCT
ajlm-846	55	1	frequency	frequency	NOUN
ajlm-846	55	2	of	of	ADP
ajlm-846	55	3	clostridium	clostridium	NOUN
ajlm-846	55	4	difficile	difficile	ADJ
ajlm-846	55	5	infection	infection	NOUN
ajlm-846	55	6	cases	case	NOUN
ajlm-846	55	7	stratified	stratify	VERB
ajlm-846	55	8	by	by	ADP
ajlm-846	55	9	ward	ward	NOUN
ajlm-846	55	10	the	the	DET
ajlm-846	55	11	cumulative	cumulative	ADJ
ajlm-846	55	12	frequency	frequency	NOUN
ajlm-846	55	13	of	of	ADP
ajlm-846	55	14	xpert	xpert	PROPN
ajlm-846	55	15	c.	c.	PROPN
ajlm-846	55	16	difficile	difficile	ADJ
ajlm-846	55	17	-	-	ADJ
ajlm-846	55	18	positive	positive	ADJ
ajlm-846	55	19	samples	sample	NOUN
ajlm-846	55	20	received	receive	VERB
ajlm-846	55	21	from	from	ADP
ajlm-846	55	22	each	each	DET
ajlm-846	55	23	ward	ward	NOUN
ajlm-846	55	24	in	in	ADP
ajlm-846	55	25	the	the	DET
ajlm-846	55	26	two	two	NUM
ajlm-846	55	27	hospitals	hospital	NOUN
ajlm-846	55	28	was	be	AUX
ajlm-846	55	29	analysed	analyse	VERB
ajlm-846	55	30	in	in	ADP
ajlm-846	55	31	28	28	NUM
ajlm-846	55	32	-	-	PUNCT
ajlm-846	55	33	day	day	NOUN
ajlm-846	55	34	windows	window	NOUN
ajlm-846	55	35	for	for	ADP
ajlm-846	55	36	the	the	DET
ajlm-846	55	37	entire	entire	ADJ
ajlm-846	55	38	study	study	NOUN
ajlm-846	55	39	period	period	NOUN
ajlm-846	55	40	,	,	PUNCT
ajlm-846	55	41	to	to	PART
ajlm-846	55	42	allow	allow	VERB
ajlm-846	55	43	the	the	DET
ajlm-846	55	44	identification	identification	NOUN
ajlm-846	55	45	of	of	ADP
ajlm-846	55	46	periods	period	NOUN
ajlm-846	55	47	of	of	ADP
ajlm-846	55	48	increased	increase	VERB
ajlm-846	55	49	cdi	cdi	PROPN
ajlm-846	55	50	prevalence	prevalence	NOUN
ajlm-846	55	51	(	(	PUNCT
ajlm-846	55	52	figure	figure	NOUN
ajlm-846	55	53	2	2	NUM
ajlm-846	55	54	)	)	PUNCT
ajlm-846	55	55	.	.	PUNCT
ajlm-846	56	1	hospital	hospital	NOUN
ajlm-846	56	2	a	a	DET
ajlm-846	56	3	experienced	experienced	ADJ
ajlm-846	56	4	several	several	ADJ
ajlm-846	56	5	periods	period	NOUN
ajlm-846	56	6	of	of	ADP
ajlm-846	56	7	increased	increase	VERB
ajlm-846	56	8	incidence	incidence	NOUN
ajlm-846	56	9	(	(	PUNCT
ajlm-846	56	10	five	five	NUM
ajlm-846	56	11	or	or	CCONJ
ajlm-846	56	12	more	more	ADJ
ajlm-846	56	13	samples	sample	NOUN
ajlm-846	56	14	per	per	ADP
ajlm-846	56	15	28	28	NUM
ajlm-846	56	16	-	-	PUNCT
ajlm-846	56	17	day	day	NOUN
ajlm-846	56	18	window	window	NOUN
ajlm-846	56	19	)	)	PUNCT
ajlm-846	56	20	.	.	PUNCT
ajlm-846	57	1	ward	ward	NOUN
ajlm-846	57	2	2	2	NUM
ajlm-846	57	3	(	(	PUNCT
ajlm-846	57	4	mdr	mdr	NOUN
ajlm-846	57	5	tuberculosis	tuberculosis	NOUN
ajlm-846	57	6	)	)	PUNCT
ajlm-846	57	7	showed	show	VERB
ajlm-846	57	8	four	four	NUM
ajlm-846	57	9	peaks	peak	NOUN
ajlm-846	57	10	,	,	PUNCT
ajlm-846	57	11	occurring	occur	VERB
ajlm-846	57	12	throughout	throughout	ADP
ajlm-846	57	13	the	the	DET
ajlm-846	57	14	study	study	NOUN
ajlm-846	57	15	period	period	NOUN
ajlm-846	57	16	.	.	PUNCT
ajlm-846	58	1	ward	ward	NOUN
ajlm-846	58	2	3	3	NUM
ajlm-846	58	3	(	(	PUNCT
ajlm-846	58	4	ds	ds	ADJ
ajlm-846	58	5	tuberculosis	tuberculosis	NOUN
ajlm-846	58	6	)	)	PUNCT
ajlm-846	58	7	showed	show	VERB
ajlm-846	58	8	two	two	NUM
ajlm-846	58	9	peaks	peak	NOUN
ajlm-846	58	10	,	,	PUNCT
ajlm-846	58	11	the	the	DET
ajlm-846	58	12	first	first	ADJ
ajlm-846	58	13	of	of	ADP
ajlm-846	58	14	which	which	PRON
ajlm-846	58	15	occurred	occur	VERB
ajlm-846	58	16	during	during	ADP
ajlm-846	58	17	the	the	DET
ajlm-846	58	18	november	november	PROPN
ajlm-846	58	19	–	–	PUNCT
ajlm-846	58	20	december	december	PROPN
ajlm-846	58	21	2014	2014	NUM
ajlm-846	58	22	period	period	NOUN
ajlm-846	58	23	with	with	ADP
ajlm-846	58	24	the	the	DET
ajlm-846	58	25	second	second	ADJ
ajlm-846	58	26	occurring	occurring	NOUN
ajlm-846	58	27	near	near	ADP
ajlm-846	58	28	the	the	DET
ajlm-846	58	29	end	end	NOUN
ajlm-846	58	30	of	of	ADP
ajlm-846	58	31	the	the	DET
ajlm-846	58	32	study	study	NOUN
ajlm-846	58	33	.	.	PUNCT
ajlm-846	59	1	hospital	hospital	PROPN
ajlm-846	59	2	b	b	PROPN
ajlm-846	59	3	experienced	experience	VERB
ajlm-846	59	4	three	three	NUM
ajlm-846	59	5	periods	period	NOUN
ajlm-846	59	6	of	of	ADP
ajlm-846	59	7	increased	increase	VERB
ajlm-846	59	8	incidence	incidence	NOUN
ajlm-846	59	9	across	across	ADP
ajlm-846	59	10	two	two	NUM
ajlm-846	59	11	wards	ward	NOUN
ajlm-846	59	12	.	.	PUNCT
ajlm-846	60	1	both	both	PRON
ajlm-846	60	2	ward	ward	VERB
ajlm-846	60	3	1	1	NUM
ajlm-846	60	4	(	(	PUNCT
ajlm-846	60	5	ds	ds	ADJ
ajlm-846	60	6	tuberculosis	tuberculosis	NOUN
ajlm-846	60	7	)	)	PUNCT
ajlm-846	60	8	and	and	CCONJ
ajlm-846	60	9	ward	ward	VERB
ajlm-846	60	10	3	3	NUM
ajlm-846	60	11	(	(	PUNCT
ajlm-846	60	12	ds	ds	ADJ
ajlm-846	60	13	tuberculosis	tuberculosis	NOUN
ajlm-846	60	14	)	)	PUNCT
ajlm-846	60	15	showed	show	VERB
ajlm-846	60	16	peaks	peak	NOUN
ajlm-846	60	17	during	during	ADP
ajlm-846	60	18	the	the	DET
ajlm-846	60	19	november	november	PROPN
ajlm-846	60	20	–	–	PUNCT
ajlm-846	60	21	december	december	PROPN
ajlm-846	60	22	2014	2014	NUM
ajlm-846	60	23	period	period	NOUN
ajlm-846	60	24	,	,	PUNCT
ajlm-846	60	25	with	with	ADP
ajlm-846	60	26	an	an	DET
ajlm-846	60	27	additional	additional	ADJ
ajlm-846	60	28	peak	peak	NOUN
ajlm-846	60	29	during	during	ADP
ajlm-846	60	30	january	january	PROPN
ajlm-846	60	31	2015	2015	NUM
ajlm-846	60	32	observed	observe	VERB
ajlm-846	60	33	for	for	ADP
ajlm-846	60	34	ward	ward	NOUN
ajlm-846	60	35	1	1	NUM
ajlm-846	60	36	.	.	PUNCT
ajlm-846	60	37	figure	figure	VERB
ajlm-846	60	38	2	2	NUM
ajlm-846	60	39	:	:	PUNCT
ajlm-846	60	40	frequency	frequency	NOUN
ajlm-846	60	41	of	of	ADP
ajlm-846	60	42	cdi	cdi	PROPN
ajlm-846	60	43	cases	case	NOUN
ajlm-846	60	44	per	per	ADP
ajlm-846	60	45	ward	ward	NOUN
ajlm-846	60	46	.	.	PUNCT
ajlm-846	61	1	the	the	DET
ajlm-846	61	2	number	number	NOUN
ajlm-846	61	3	of	of	ADP
ajlm-846	61	4	cdi	cdi	PROPN
ajlm-846	61	5	cases	case	NOUN
ajlm-846	61	6	in	in	ADP
ajlm-846	61	7	28	28	NUM
ajlm-846	61	8	-	-	PUNCT
ajlm-846	61	9	day	day	NOUN
ajlm-846	61	10	windows	window	NOUN
ajlm-846	61	11	for	for	ADP
ajlm-846	61	12	each	each	DET
ajlm-846	61	13	ward	ward	NOUN
ajlm-846	61	14	in	in	ADP
ajlm-846	61	15	hospital	hospital	NOUN
ajlm-846	61	16	a	a	DET
ajlm-846	61	17	(	(	PUNCT
ajlm-846	61	18	a	a	NOUN
ajlm-846	61	19	)	)	PUNCT
ajlm-846	61	20	and	and	CCONJ
ajlm-846	61	21	hospital	hospital	NOUN
ajlm-846	61	22	b	b	PROPN
ajlm-846	61	23	(	(	PUNCT
ajlm-846	61	24	b	b	NOUN
ajlm-846	61	25	)	)	PUNCT
ajlm-846	61	26	over	over	ADP
ajlm-846	61	27	the	the	DET
ajlm-846	61	28	study	study	NOUN
ajlm-846	61	29	period	period	NOUN
ajlm-846	61	30	.	.	PUNCT
ajlm-846	62	1	windows	window	NOUN
ajlm-846	62	2	move	move	VERB
ajlm-846	62	3	along	along	ADP
ajlm-846	62	4	the	the	DET
ajlm-846	62	5	x	x	NOUN
ajlm-846	62	6	-	-	NOUN
ajlm-846	62	7	axis	axis	NOUN
ajlm-846	62	8	in	in	ADP
ajlm-846	62	9	one	one	NUM
ajlm-846	62	10	-	-	PUNCT
ajlm-846	62	11	day	day	NOUN
ajlm-846	62	12	steps	step	NOUN
ajlm-846	62	13	.	.	PUNCT
ajlm-846	63	1	wards	ward	NOUN
ajlm-846	63	2	are	be	AUX
ajlm-846	63	3	designated	designate	VERB
ajlm-846	63	4	as	as	ADP
ajlm-846	63	5	housing	housing	NOUN
ajlm-846	63	6	patients	patient	NOUN
ajlm-846	63	7	undergoing	undergo	VERB
ajlm-846	63	8	standard	standard	ADJ
ajlm-846	63	9	tuberculosis	tuberculosis	NOUN
ajlm-846	63	10	treatment	treatment	NOUN
ajlm-846	63	11	(	(	PUNCT
ajlm-846	63	12	ds	ds	NOUN
ajlm-846	63	13	)	)	PUNCT
ajlm-846	63	14	or	or	CCONJ
ajlm-846	63	15	mdr	mdr	PROPN
ajlm-846	63	16	/	/	SYM
ajlm-846	63	17	xdr	xdr	PROPN
ajlm-846	63	18	treatment	treatment	NOUN
ajlm-846	63	19	regimens	regimen	NOUN
ajlm-846	63	20	(	(	PUNCT
ajlm-846	63	21	mdr	mdr	PROPN
ajlm-846	63	22	/	/	SYM
ajlm-846	63	23	xdr	xdr	PROPN
ajlm-846	63	24	)	)	PUNCT
ajlm-846	63	25	.	.	PUNCT
ajlm-846	64	1	isolation	isolation	NOUN
ajlm-846	64	2	and	and	CCONJ
ajlm-846	64	3	molecular	molecular	ADJ
ajlm-846	64	4	epidemiology	epidemiology	NOUN
ajlm-846	64	5	of	of	ADP
ajlm-846	64	6	c.	c.	NOUN
ajlm-846	64	7	difficile	difficile	VERB
ajlm-846	64	8	strains	strain	NOUN
ajlm-846	64	9	of	of	ADP
ajlm-846	64	10	the	the	DET
ajlm-846	64	11	152	152	NUM
ajlm-846	64	12	xpert	xpert	PROPN
ajlm-846	64	13	c.	c.	PROPN
ajlm-846	64	14	difficile	difficile	VERB
ajlm-846	64	15	positive	positive	ADJ
ajlm-846	64	16	samples	sample	NOUN
ajlm-846	64	17	,	,	PUNCT
ajlm-846	64	18	only	only	ADV
ajlm-846	64	19	119	119	NUM
ajlm-846	64	20	(	(	PUNCT
ajlm-846	64	21	78.3	78.3	NUM
ajlm-846	64	22	%	%	NOUN
ajlm-846	64	23	)	)	PUNCT
ajlm-846	64	24	were	be	AUX
ajlm-846	64	25	retained	retain	VERB
ajlm-846	64	26	for	for	ADP
ajlm-846	64	27	culture	culture	NOUN
ajlm-846	64	28	analysis	analysis	NOUN
ajlm-846	64	29	mostly	mostly	ADV
ajlm-846	64	30	due	due	ADJ
ajlm-846	64	31	to	to	ADP
ajlm-846	64	32	insufficient	insufficient	ADJ
ajlm-846	64	33	left	leave	VERB
ajlm-846	64	34	over	over	ADP
ajlm-846	64	35	sample	sample	NOUN
ajlm-846	64	36	.	.	PUNCT
ajlm-846	65	1	toxigenic	toxigenic	ADJ
ajlm-846	65	2	c.	c.	PROPN
ajlm-846	65	3	difficile	difficile	NOUN
ajlm-846	65	4	(	(	PUNCT
ajlm-846	65	5	n	n	NOUN
ajlm-846	65	6	=	=	SYM
ajlm-846	65	7	110	110	NUM
ajlm-846	65	8	)	)	PUNCT
ajlm-846	65	9	were	be	AUX
ajlm-846	65	10	isolated	isolate	VERB
ajlm-846	65	11	from	from	ADP
ajlm-846	65	12	110	110	NUM
ajlm-846	65	13	of	of	ADP
ajlm-846	65	14	these	these	DET
ajlm-846	65	15	samples	sample	NOUN
ajlm-846	65	16	(	(	PUNCT
ajlm-846	65	17	92.4	92.4	NUM
ajlm-846	65	18	%	%	NOUN
ajlm-846	65	19	)	)	PUNCT
ajlm-846	65	20	.	.	PUNCT
ajlm-846	66	1	rt017	rt017	NOUN
ajlm-846	66	2	,	,	PUNCT
ajlm-846	66	3	toxin	toxin	NOUN
ajlm-846	66	4	a	a	PRON
ajlm-846	66	5	-	-	PUNCT
ajlm-846	66	6	b+	b+	NOUN
ajlm-846	66	7	isolates	isolate	NOUN
ajlm-846	66	8	accounted	account	VERB
ajlm-846	66	9	for	for	ADP
ajlm-846	66	10	105	105	NUM
ajlm-846	66	11	(	(	PUNCT
ajlm-846	66	12	95.5	95.5	NUM
ajlm-846	66	13	%	%	NOUN
ajlm-846	66	14	)	)	PUNCT
ajlm-846	66	15	of	of	ADP
ajlm-846	66	16	the	the	DET
ajlm-846	66	17	total	total	ADJ
ajlm-846	66	18	number	number	NOUN
ajlm-846	66	19	of	of	ADP
ajlm-846	66	20	strains	strain	NOUN
ajlm-846	66	21	isolated	isolate	VERB
ajlm-846	66	22	from	from	ADP
ajlm-846	66	23	patients	patient	NOUN
ajlm-846	66	24	in	in	ADP
ajlm-846	66	25	both	both	PRON
ajlm-846	66	26	ds	ds	ADJ
ajlm-846	66	27	tuberculosis	tuberculosis	NOUN
ajlm-846	66	28	and	and	CCONJ
ajlm-846	66	29	mdr	mdr	NOUN
ajlm-846	66	30	tuberculosis	tuberculosis	NOUN
ajlm-846	66	31	wards	ward	NOUN
ajlm-846	66	32	.	.	PUNCT
ajlm-846	67	1	the	the	DET
ajlm-846	67	2	remaining	remain	VERB
ajlm-846	67	3	five	five	NUM
ajlm-846	67	4	toxin	toxin	NOUN
ajlm-846	67	5	a+b+	a+b+	NOUN
ajlm-846	67	6	isolates	isolate	NOUN
ajlm-846	67	7	were	be	AUX
ajlm-846	67	8	typed	type	VERB
ajlm-846	67	9	as	as	ADP
ajlm-846	67	10	rt002	rt002	PROPN
ajlm-846	67	11	(	(	PUNCT
ajlm-846	67	12	one	one	NUM
ajlm-846	67	13	isolate	isolate	NOUN
ajlm-846	67	14	)	)	PUNCT
ajlm-846	67	15	,	,	PUNCT
ajlm-846	67	16	rt046	rt046	PROPN
ajlm-846	67	17	(	(	PUNCT
ajlm-846	67	18	one	one	NUM
ajlm-846	67	19	isolate	isolate	NOUN
ajlm-846	67	20	)	)	PUNCT
ajlm-846	67	21	and	and	CCONJ
ajlm-846	67	22	rt(se)108	rt(se)108	PROPN
ajlm-846	67	23	(	(	PUNCT
ajlm-846	67	24	three	three	NUM
ajlm-846	67	25	isolates	isolate	NOUN
ajlm-846	67	26	)	)	PUNCT
ajlm-846	67	27	and	and	CCONJ
ajlm-846	67	28	were	be	AUX
ajlm-846	67	29	all	all	PRON
ajlm-846	67	30	isolated	isolate	VERB
ajlm-846	67	31	from	from	ADP
ajlm-846	67	32	samples	sample	NOUN
ajlm-846	67	33	submitted	submit	VERB
ajlm-846	67	34	by	by	ADP
ajlm-846	67	35	patients	patient	NOUN
ajlm-846	67	36	in	in	ADP
ajlm-846	67	37	ds	ds	ADJ
ajlm-846	67	38	tuberculosis	tuberculosis	NOUN
ajlm-846	67	39	wards	ward	NOUN
ajlm-846	67	40	from	from	ADP
ajlm-846	67	41	hospital	hospital	PROPN
ajlm-846	67	42	b.	b.	PROPN
ajlm-846	67	43	mlva	mlva	PROPN
ajlm-846	67	44	revealed	reveal	VERB
ajlm-846	67	45	close	close	ADJ
ajlm-846	67	46	relationships	relationship	NOUN
ajlm-846	67	47	between	between	ADP
ajlm-846	67	48	many	many	ADJ
ajlm-846	67	49	of	of	ADP
ajlm-846	67	50	the	the	DET
ajlm-846	67	51	rt017	rt017	PROPN
ajlm-846	67	52	strains	strain	VERB
ajlm-846	67	53	from	from	ADP
ajlm-846	67	54	the	the	DET
ajlm-846	67	55	two	two	NUM
ajlm-846	67	56	hospitals	hospital	NOUN
ajlm-846	67	57	.	.	PUNCT
ajlm-846	68	1	just	just	ADV
ajlm-846	68	2	over	over	ADP
ajlm-846	68	3	half	half	NOUN
ajlm-846	68	4	(	(	PUNCT
ajlm-846	68	5	53.4	53.4	NUM
ajlm-846	68	6	%	%	NOUN
ajlm-846	68	7	)	)	PUNCT
ajlm-846	68	8	of	of	ADP
ajlm-846	68	9	all	all	DET
ajlm-846	68	10	isolates	isolate	NOUN
ajlm-846	68	11	from	from	ADP
ajlm-846	68	12	hospital	hospital	NOUN
ajlm-846	68	13	a	a	DET
ajlm-846	68	14	clustered	clustered	ADJ
ajlm-846	68	15	in	in	ADP
ajlm-846	68	16	one	one	NUM
ajlm-846	68	17	large	large	ADJ
ajlm-846	68	18	group	group	NOUN
ajlm-846	68	19	of	of	ADP
ajlm-846	68	20	clonally	clonally	ADV
ajlm-846	68	21	related	relate	VERB
ajlm-846	68	22	strains	strain	NOUN
ajlm-846	68	23	(	(	PUNCT
ajlm-846	68	24	summed	sum	VERB
ajlm-846	68	25	tandem	tandem	NOUN
ajlm-846	68	26	-	-	PUNCT
ajlm-846	68	27	repeat	repeat	NOUN
ajlm-846	68	28	difference	difference	NOUN
ajlm-846	68	29	≤	≤	NUM
ajlm-846	68	30	2	2	NUM
ajlm-846	68	31	)	)	PUNCT
ajlm-846	68	32	in	in	ADP
ajlm-846	68	33	a	a	DET
ajlm-846	68	34	minimum	minimum	ADJ
ajlm-846	68	35	spanning	span	VERB
ajlm-846	68	36	tree	tree	NOUN
ajlm-846	68	37	(	(	PUNCT
ajlm-846	68	38	figure	figure	NOUN
ajlm-846	68	39	3a	3a	NUM
ajlm-846	68	40	)	)	PUNCT
ajlm-846	68	41	.	.	PUNCT
ajlm-846	69	1	strains	strain	NOUN
ajlm-846	69	2	in	in	ADP
ajlm-846	69	3	this	this	DET
ajlm-846	69	4	group	group	NOUN
ajlm-846	69	5	were	be	AUX
ajlm-846	69	6	isolated	isolate	VERB
ajlm-846	69	7	throughout	throughout	ADP
ajlm-846	69	8	the	the	DET
ajlm-846	69	9	course	course	NOUN
ajlm-846	69	10	of	of	ADP
ajlm-846	69	11	the	the	DET
ajlm-846	69	12	study	study	NOUN
ajlm-846	69	13	from	from	ADP
ajlm-846	69	14	patients	patient	NOUN
ajlm-846	69	15	in	in	ADP
ajlm-846	69	16	all	all	DET
ajlm-846	69	17	four	four	NUM
ajlm-846	69	18	wards	ward	NOUN
ajlm-846	69	19	that	that	PRON
ajlm-846	69	20	experienced	experience	VERB
ajlm-846	69	21	cases	case	NOUN
ajlm-846	69	22	of	of	ADP
ajlm-846	69	23	cdi	cdi	PROPN
ajlm-846	69	24	.	.	PUNCT
ajlm-846	70	1	a	a	DET
ajlm-846	70	2	second	second	ADV
ajlm-846	70	3	smaller	small	ADJ
ajlm-846	70	4	group	group	NOUN
ajlm-846	70	5	of	of	ADP
ajlm-846	70	6	eight	eight	NUM
ajlm-846	70	7	strains	strain	NOUN
ajlm-846	70	8	was	be	AUX
ajlm-846	70	9	also	also	ADV
ajlm-846	70	10	evident	evident	ADJ
ajlm-846	70	11	and	and	CCONJ
ajlm-846	70	12	comprised	comprise	VERB
ajlm-846	70	13	of	of	ADP
ajlm-846	70	14	strains	strain	NOUN
ajlm-846	70	15	isolated	isolate	VERB
ajlm-846	70	16	from	from	ADP
ajlm-846	70	17	three	three	NUM
ajlm-846	70	18	of	of	ADP
ajlm-846	70	19	the	the	DET
ajlm-846	70	20	four	four	NUM
ajlm-846	70	21	wards	ward	NOUN
ajlm-846	70	22	between	between	ADP
ajlm-846	70	23	january	january	PROPN
ajlm-846	70	24	2015	2015	NUM
ajlm-846	70	25	and	and	CCONJ
ajlm-846	70	26	november	november	PROPN
ajlm-846	70	27	2015	2015	NUM
ajlm-846	70	28	.	.	PUNCT
ajlm-846	71	1	hospital	hospital	NOUN
ajlm-846	71	2	b	b	PROPN
ajlm-846	71	3	showed	show	VERB
ajlm-846	71	4	several	several	ADJ
ajlm-846	71	5	groups	group	NOUN
ajlm-846	71	6	of	of	ADP
ajlm-846	71	7	three	three	NUM
ajlm-846	71	8	or	or	CCONJ
ajlm-846	71	9	more	more	ADV
ajlm-846	71	10	clonally	clonally	ADV
ajlm-846	71	11	related	relate	VERB
ajlm-846	71	12	strains	strain	NOUN
ajlm-846	71	13	(	(	PUNCT
ajlm-846	71	14	figure	figure	NOUN
ajlm-846	71	15	3b	3b	NUM
ajlm-846	71	16	)	)	PUNCT
ajlm-846	71	17	,	,	PUNCT
ajlm-846	71	18	which	which	PRON
ajlm-846	71	19	together	together	ADV
ajlm-846	71	20	accounted	account	VERB
ajlm-846	71	21	for	for	ADP
ajlm-846	71	22	76.9	76.9	NUM
ajlm-846	71	23	%	%	NOUN
ajlm-846	71	24	of	of	ADP
ajlm-846	71	25	all	all	DET
ajlm-846	71	26	isolates	isolate	NOUN
ajlm-846	71	27	.	.	PUNCT
ajlm-846	72	1	as	as	ADP
ajlm-846	72	2	for	for	ADP
ajlm-846	72	3	hospital	hospital	NOUN
ajlm-846	72	4	a	a	PRON
ajlm-846	72	5	,	,	PUNCT
ajlm-846	72	6	the	the	DET
ajlm-846	72	7	clusters	cluster	NOUN
ajlm-846	72	8	contained	contain	VERB
ajlm-846	72	9	strains	strain	NOUN
ajlm-846	72	10	that	that	PRON
ajlm-846	72	11	were	be	AUX
ajlm-846	72	12	isolated	isolate	VERB
ajlm-846	72	13	from	from	ADP
ajlm-846	72	14	patients	patient	NOUN
ajlm-846	72	15	in	in	ADP
ajlm-846	72	16	different	different	ADJ
ajlm-846	72	17	wards	ward	NOUN
ajlm-846	72	18	throughout	throughout	ADP
ajlm-846	72	19	the	the	DET
ajlm-846	72	20	study	study	NOUN
ajlm-846	72	21	period	period	NOUN
ajlm-846	72	22	.	.	PUNCT
ajlm-846	73	1	it	it	PRON
ajlm-846	73	2	was	be	AUX
ajlm-846	73	3	noted	note	VERB
ajlm-846	73	4	that	that	SCONJ
ajlm-846	73	5	,	,	PUNCT
ajlm-846	73	6	in	in	ADP
ajlm-846	73	7	both	both	DET
ajlm-846	73	8	hospitals	hospital	NOUN
ajlm-846	73	9	,	,	PUNCT
ajlm-846	73	10	sets	set	NOUN
ajlm-846	73	11	of	of	ADP
ajlm-846	73	12	three	three	NUM
ajlm-846	73	13	or	or	CCONJ
ajlm-846	73	14	four	four	NUM
ajlm-846	73	15	clonally	clonally	ADV
ajlm-846	73	16	identical	identical	ADJ
ajlm-846	73	17	strains	strain	NOUN
ajlm-846	73	18	were	be	AUX
ajlm-846	73	19	isolated	isolate	VERB
ajlm-846	73	20	from	from	ADP
ajlm-846	73	21	different	different	ADJ
ajlm-846	73	22	patients	patient	NOUN
ajlm-846	73	23	in	in	ADP
ajlm-846	73	24	a	a	DET
ajlm-846	73	25	single	single	ADJ
ajlm-846	73	26	ward	ward	NOUN
ajlm-846	73	27	at	at	ADP
ajlm-846	73	28	different	different	ADJ
ajlm-846	73	29	time	time	NOUN
ajlm-846	73	30	points	point	NOUN
ajlm-846	73	31	,	,	PUNCT
ajlm-846	73	32	suggesting	suggest	VERB
ajlm-846	73	33	possible	possible	ADJ
ajlm-846	73	34	patient	patient	NOUN
ajlm-846	73	35	-	-	PUNCT
ajlm-846	73	36	to	to	ADP
ajlm-846	73	37	-	-	PUNCT
ajlm-846	73	38	patient	patient	NOUN
ajlm-846	73	39	transfer	transfer	NOUN
ajlm-846	73	40	events	event	NOUN
ajlm-846	73	41	.	.	PUNCT
ajlm-846	74	1	figure	figure	VERB
ajlm-846	74	2	3	3	NUM
ajlm-846	74	3	:	:	PUNCT
ajlm-846	74	4	minimum	minimum	ADJ
ajlm-846	74	5	spanning	span	VERB
ajlm-846	74	6	tree	tree	NOUN
ajlm-846	74	7	of	of	ADP
ajlm-846	74	8	mlva	mlva	PROPN
ajlm-846	74	9	data	datum	NOUN
ajlm-846	74	10	for	for	ADP
ajlm-846	74	11	c.	c.	PROPN
ajlm-846	74	12	difficile	difficile	PROPN
ajlm-846	74	13	rt017	rt017	PROPN
ajlm-846	74	14	isolates	isolate	NOUN
ajlm-846	74	15	showing	show	VERB
ajlm-846	74	16	their	their	PRON
ajlm-846	74	17	clonal	clonal	ADJ
ajlm-846	74	18	relationships	relationship	NOUN
ajlm-846	74	19	and	and	CCONJ
ajlm-846	74	20	isolation	isolation	NOUN
ajlm-846	74	21	sites	site	NOUN
ajlm-846	74	22	.	.	PUNCT
ajlm-846	75	1	strains	strain	NOUN
ajlm-846	75	2	isolated	isolate	VERB
ajlm-846	75	3	from	from	ADP
ajlm-846	75	4	hospital	hospital	NOUN
ajlm-846	75	5	a	a	DET
ajlm-846	75	6	(	(	PUNCT
ajlm-846	75	7	a	a	NOUN
ajlm-846	75	8	)	)	PUNCT
ajlm-846	75	9	and	and	CCONJ
ajlm-846	75	10	hospital	hospital	NOUN
ajlm-846	75	11	b	b	PROPN
ajlm-846	75	12	(	(	PUNCT
ajlm-846	75	13	b	b	NOUN
ajlm-846	75	14	)	)	PUNCT
ajlm-846	75	15	are	be	AUX
ajlm-846	75	16	represented	represent	VERB
ajlm-846	75	17	by	by	ADP
ajlm-846	75	18	circles	circle	NOUN
ajlm-846	75	19	with	with	ADP
ajlm-846	75	20	the	the	DET
ajlm-846	75	21	date	date	NOUN
ajlm-846	75	22	of	of	ADP
ajlm-846	75	23	isolation	isolation	NOUN
ajlm-846	75	24	included	include	VERB
ajlm-846	75	25	in	in	ADP
ajlm-846	75	26	the	the	DET
ajlm-846	75	27	circle	circle	NOUN
ajlm-846	75	28	and	and	CCONJ
ajlm-846	75	29	the	the	DET
ajlm-846	75	30	circle	circle	NOUN
ajlm-846	75	31	colour	colour	NOUN
ajlm-846	75	32	representing	represent	VERB
ajlm-846	75	33	the	the	DET
ajlm-846	75	34	ward	ward	NOUN
ajlm-846	75	35	that	that	SCONJ
ajlm-846	75	36	the	the	DET
ajlm-846	75	37	patient	patient	NOUN
ajlm-846	75	38	was	be	AUX
ajlm-846	75	39	in	in	ADV
ajlm-846	75	40	at	at	ADP
ajlm-846	75	41	the	the	DET
ajlm-846	75	42	time	time	NOUN
ajlm-846	75	43	of	of	ADP
ajlm-846	75	44	sample	sample	NOUN
ajlm-846	75	45	submission	submission	NOUN
ajlm-846	75	46	.	.	PUNCT
ajlm-846	76	1	larger	large	ADJ
ajlm-846	76	2	circles	circle	NOUN
ajlm-846	76	3	represent	represent	VERB
ajlm-846	76	4	multiple	multiple	ADJ
ajlm-846	76	5	identical	identical	ADJ
ajlm-846	76	6	isolates	isolate	NOUN
ajlm-846	76	7	,	,	PUNCT
ajlm-846	76	8	with	with	ADP
ajlm-846	76	9	the	the	DET
ajlm-846	76	10	size	size	NOUN
ajlm-846	76	11	of	of	ADP
ajlm-846	76	12	the	the	DET
ajlm-846	76	13	circle	circle	NOUN
ajlm-846	76	14	proportional	proportional	NOUN
ajlm-846	76	15	to	to	ADP
ajlm-846	76	16	the	the	DET
ajlm-846	76	17	number	number	NOUN
ajlm-846	76	18	of	of	ADP
ajlm-846	76	19	isolates	isolate	NOUN
ajlm-846	76	20	.	.	PUNCT
ajlm-846	77	1	the	the	DET
ajlm-846	77	2	total	total	ADJ
ajlm-846	77	3	summed	sum	VERB
ajlm-846	77	4	tandem	tandem	NOUN
ajlm-846	77	5	-	-	PUNCT
ajlm-846	77	6	repeat	repeat	NOUN
ajlm-846	77	7	difference	difference	NOUN
ajlm-846	77	8	between	between	ADP
ajlm-846	77	9	strains	strain	NOUN
ajlm-846	77	10	is	be	AUX
ajlm-846	77	11	given	give	VERB
ajlm-846	77	12	by	by	ADP
ajlm-846	77	13	the	the	DET
ajlm-846	77	14	numbers	number	NOUN
ajlm-846	77	15	between	between	ADP
ajlm-846	77	16	each	each	DET
ajlm-846	77	17	circle	circle	NOUN
ajlm-846	77	18	.	.	PUNCT
ajlm-846	78	1	clonally	clonally	ADV
ajlm-846	78	2	related	relate	VERB
ajlm-846	78	3	isolates	isolate	NOUN
ajlm-846	78	4	(	(	PUNCT
ajlm-846	78	5	summed	sum	VERB
ajlm-846	78	6	tandem	tandem	NOUN
ajlm-846	78	7	-	-	PUNCT
ajlm-846	78	8	repeat	repeat	NOUN
ajlm-846	78	9	difference	difference	NOUN
ajlm-846	78	10	≤	≤	NUM
ajlm-846	78	11	2	2	NUM
ajlm-846	78	12	)	)	PUNCT
ajlm-846	78	13	are	be	AUX
ajlm-846	78	14	grouped	group	VERB
ajlm-846	78	15	within	within	ADP
ajlm-846	78	16	the	the	DET
ajlm-846	78	17	shaded	shade	VERB
ajlm-846	78	18	areas	area	NOUN
ajlm-846	78	19	–	–	PUNCT
ajlm-846	78	20	(	(	PUNCT
ajlm-846	78	21	)	)	PUNCT
ajlm-846	78	22	pairs	pair	NOUN
ajlm-846	78	23	,	,	PUNCT
ajlm-846	78	24	(	(	PUNCT
ajlm-846	78	25	)	)	PUNCT
ajlm-846	78	26	clusters	cluster	NOUN
ajlm-846	78	27	.	.	PUNCT
ajlm-846	79	1	the	the	DET
ajlm-846	79	2	trees	tree	NOUN
ajlm-846	79	3	have	have	AUX
ajlm-846	79	4	been	be	AUX
ajlm-846	79	5	redrawn	redrawn	VERB
ajlm-846	79	6	for	for	ADP
ajlm-846	79	7	ease	ease	NOUN
ajlm-846	79	8	of	of	ADP
ajlm-846	79	9	viewing	view	VERB
ajlm-846	79	10	and	and	CCONJ
ajlm-846	79	11	are	be	AUX
ajlm-846	79	12	not	not	PART
ajlm-846	79	13	to	to	PART
ajlm-846	79	14	scale	scale	VERB
ajlm-846	79	15	.	.	PUNCT
ajlm-846	80	1	figure	figure	NOUN
ajlm-846	80	2	3	3	NUM
ajlm-846	80	3	(	(	PUNCT
ajlm-846	80	4	continues	continue	VERB
ajlm-846	80	5	...	...	PUNCT
ajlm-846	80	6	):	):	PUNCT
ajlm-846	80	7	minimum	minimum	ADJ
ajlm-846	80	8	spanning	span	VERB
ajlm-846	80	9	tree	tree	NOUN
ajlm-846	80	10	of	of	ADP
ajlm-846	80	11	mlva	mlva	PROPN
ajlm-846	80	12	data	datum	NOUN
ajlm-846	80	13	for	for	ADP
ajlm-846	80	14	c.	c.	PROPN
ajlm-846	80	15	difficile	difficile	PROPN
ajlm-846	80	16	rt017	rt017	PROPN
ajlm-846	80	17	isolates	isolate	NOUN
ajlm-846	80	18	showing	show	VERB
ajlm-846	80	19	their	their	PRON
ajlm-846	80	20	clonal	clonal	ADJ
ajlm-846	80	21	relationships	relationship	NOUN
ajlm-846	80	22	and	and	CCONJ
ajlm-846	80	23	isolation	isolation	NOUN
ajlm-846	80	24	sites	site	NOUN
ajlm-846	80	25	.	.	PUNCT
ajlm-846	81	1	strains	strain	NOUN
ajlm-846	81	2	isolated	isolate	VERB
ajlm-846	81	3	from	from	ADP
ajlm-846	81	4	hospital	hospital	NOUN
ajlm-846	81	5	a	a	DET
ajlm-846	81	6	(	(	PUNCT
ajlm-846	81	7	a	a	NOUN
ajlm-846	81	8	)	)	PUNCT
ajlm-846	81	9	and	and	CCONJ
ajlm-846	81	10	hospital	hospital	NOUN
ajlm-846	81	11	b	b	PROPN
ajlm-846	81	12	(	(	PUNCT
ajlm-846	81	13	b	b	NOUN
ajlm-846	81	14	)	)	PUNCT
ajlm-846	81	15	are	be	AUX
ajlm-846	81	16	represented	represent	VERB
ajlm-846	81	17	by	by	ADP
ajlm-846	81	18	circles	circle	NOUN
ajlm-846	81	19	with	with	ADP
ajlm-846	81	20	the	the	DET
ajlm-846	81	21	date	date	NOUN
ajlm-846	81	22	of	of	ADP
ajlm-846	81	23	isolation	isolation	NOUN
ajlm-846	81	24	included	include	VERB
ajlm-846	81	25	in	in	ADP
ajlm-846	81	26	the	the	DET
ajlm-846	81	27	circle	circle	NOUN
ajlm-846	81	28	and	and	CCONJ
ajlm-846	81	29	the	the	DET
ajlm-846	81	30	circle	circle	NOUN
ajlm-846	81	31	colour	colour	NOUN
ajlm-846	81	32	representing	represent	VERB
ajlm-846	81	33	the	the	DET
ajlm-846	81	34	ward	ward	NOUN
ajlm-846	81	35	that	that	SCONJ
ajlm-846	81	36	the	the	DET
ajlm-846	81	37	patient	patient	NOUN
ajlm-846	81	38	was	be	AUX
ajlm-846	81	39	in	in	ADV
ajlm-846	81	40	at	at	ADP
ajlm-846	81	41	the	the	DET
ajlm-846	81	42	time	time	NOUN
ajlm-846	81	43	of	of	ADP
ajlm-846	81	44	sample	sample	NOUN
ajlm-846	81	45	submission	submission	NOUN
ajlm-846	81	46	.	.	PUNCT
ajlm-846	82	1	larger	large	ADJ
ajlm-846	82	2	circles	circle	NOUN
ajlm-846	82	3	represent	represent	VERB
ajlm-846	82	4	multiple	multiple	ADJ
ajlm-846	82	5	identical	identical	ADJ
ajlm-846	82	6	isolates	isolate	NOUN
ajlm-846	82	7	,	,	PUNCT
ajlm-846	82	8	with	with	ADP
ajlm-846	82	9	the	the	DET
ajlm-846	82	10	size	size	NOUN
ajlm-846	82	11	of	of	ADP
ajlm-846	82	12	the	the	DET
ajlm-846	82	13	circle	circle	NOUN
ajlm-846	82	14	proportional	proportional	NOUN
ajlm-846	82	15	to	to	ADP
ajlm-846	82	16	the	the	DET
ajlm-846	82	17	number	number	NOUN
ajlm-846	82	18	of	of	ADP
ajlm-846	82	19	isolates	isolate	NOUN
ajlm-846	82	20	.	.	PUNCT
ajlm-846	83	1	the	the	DET
ajlm-846	83	2	total	total	ADJ
ajlm-846	83	3	summed	sum	VERB
ajlm-846	83	4	tandem	tandem	NOUN
ajlm-846	83	5	-	-	PUNCT
ajlm-846	83	6	repeat	repeat	NOUN
ajlm-846	83	7	difference	difference	NOUN
ajlm-846	83	8	between	between	ADP
ajlm-846	83	9	strains	strain	NOUN
ajlm-846	83	10	is	be	AUX
ajlm-846	83	11	given	give	VERB
ajlm-846	83	12	by	by	ADP
ajlm-846	83	13	the	the	DET
ajlm-846	83	14	numbers	number	NOUN
ajlm-846	83	15	between	between	ADP
ajlm-846	83	16	each	each	DET
ajlm-846	83	17	circle	circle	NOUN
ajlm-846	83	18	.	.	PUNCT
ajlm-846	84	1	clonally	clonally	ADV
ajlm-846	84	2	related	relate	VERB
ajlm-846	84	3	isolates	isolate	NOUN
ajlm-846	84	4	(	(	PUNCT
ajlm-846	84	5	summed	sum	VERB
ajlm-846	84	6	tandem	tandem	NOUN
ajlm-846	84	7	-	-	PUNCT
ajlm-846	84	8	repeat	repeat	NOUN
ajlm-846	84	9	difference	difference	NOUN
ajlm-846	84	10	≤	≤	NUM
ajlm-846	84	11	2	2	NUM
ajlm-846	84	12	)	)	PUNCT
ajlm-846	84	13	are	be	AUX
ajlm-846	84	14	grouped	group	VERB
ajlm-846	84	15	within	within	ADP
ajlm-846	84	16	the	the	DET
ajlm-846	84	17	shaded	shade	VERB
ajlm-846	84	18	areas	area	NOUN
ajlm-846	84	19	–	–	PUNCT
ajlm-846	84	20	(	(	PUNCT
ajlm-846	84	21	)	)	PUNCT
ajlm-846	84	22	pairs	pair	NOUN
ajlm-846	84	23	,	,	PUNCT
ajlm-846	84	24	(	(	PUNCT
ajlm-846	84	25	)	)	PUNCT
ajlm-846	84	26	clusters	cluster	NOUN
ajlm-846	84	27	.	.	PUNCT
ajlm-846	85	1	the	the	DET
ajlm-846	85	2	trees	tree	NOUN
ajlm-846	85	3	have	have	AUX
ajlm-846	85	4	been	be	AUX
ajlm-846	85	5	redrawn	redrawn	VERB
ajlm-846	85	6	for	for	ADP
ajlm-846	85	7	ease	ease	NOUN
ajlm-846	85	8	of	of	ADP
ajlm-846	85	9	viewing	view	VERB
ajlm-846	85	10	and	and	CCONJ
ajlm-846	85	11	are	be	AUX
ajlm-846	85	12	not	not	PART
ajlm-846	85	13	to	to	PART
ajlm-846	85	14	scale	scale	VERB
ajlm-846	85	15	.	.	PUNCT
ajlm-846	86	1	antibiotic	antibiotic	ADJ
ajlm-846	86	2	susceptibility	susceptibility	NOUN
ajlm-846	86	3	of	of	ADP
ajlm-846	86	4	isolates	isolate	NOUN
ajlm-846	86	5	complete	complete	ADJ
ajlm-846	86	6	antibiotic	antibiotic	ADJ
ajlm-846	86	7	susceptibility	susceptibility	NOUN
ajlm-846	86	8	testing	testing	NOUN
ajlm-846	86	9	data	datum	NOUN
ajlm-846	86	10	(	(	PUNCT
ajlm-846	86	11	metronidazole	metronidazole	NOUN
ajlm-846	86	12	,	,	PUNCT
ajlm-846	86	13	vancomycin	vancomycin	PROPN
ajlm-846	86	14	,	,	PUNCT
ajlm-846	86	15	erythromycin	erythromycin	NOUN
ajlm-846	86	16	and	and	CCONJ
ajlm-846	86	17	moxifloxacin	moxifloxacin	ADJ
ajlm-846	86	18	)	)	PUNCT
ajlm-846	86	19	were	be	AUX
ajlm-846	86	20	available	available	ADJ
ajlm-846	86	21	for	for	ADP
ajlm-846	86	22	a	a	DET
ajlm-846	86	23	total	total	NOUN
ajlm-846	86	24	of	of	ADP
ajlm-846	86	25	77	77	NUM
ajlm-846	86	26	isolates	isolate	NOUN
ajlm-846	86	27	,	,	PUNCT
ajlm-846	86	28	43	43	NUM
ajlm-846	86	29	from	from	ADP
ajlm-846	86	30	patients	patient	NOUN
ajlm-846	86	31	attending	attend	VERB
ajlm-846	86	32	hospital	hospital	NOUN
ajlm-846	86	33	a	a	PRON
ajlm-846	86	34	and	and	CCONJ
ajlm-846	86	35	34	34	NUM
ajlm-846	86	36	from	from	ADP
ajlm-846	86	37	patients	patient	NOUN
ajlm-846	86	38	attending	attend	VERB
ajlm-846	86	39	hospital	hospital	NOUN
ajlm-846	86	40	b.	b.	PROPN
ajlm-846	86	41	additional	additional	ADJ
ajlm-846	86	42	antibiotic	antibiotic	ADJ
ajlm-846	86	43	susceptibility	susceptibility	NOUN
ajlm-846	86	44	testing	testing	NOUN
ajlm-846	86	45	data	datum	NOUN
ajlm-846	86	46	were	be	AUX
ajlm-846	86	47	available	available	ADJ
ajlm-846	86	48	for	for	ADP
ajlm-846	86	49	some	some	DET
ajlm-846	86	50	strains	strain	NOUN
ajlm-846	86	51	and	and	CCONJ
ajlm-846	86	52	these	these	PRON
ajlm-846	86	53	were	be	AUX
ajlm-846	86	54	included	include	VERB
ajlm-846	86	55	in	in	ADP
ajlm-846	86	56	the	the	DET
ajlm-846	86	57	analysis	analysis	NOUN
ajlm-846	86	58	.	.	PUNCT
ajlm-846	87	1	all	all	DET
ajlm-846	87	2	isolates	isolate	NOUN
ajlm-846	87	3	from	from	ADP
ajlm-846	87	4	both	both	DET
ajlm-846	87	5	hospitals	hospital	NOUN
ajlm-846	87	6	were	be	AUX
ajlm-846	87	7	susceptible	susceptible	ADJ
ajlm-846	87	8	to	to	ADP
ajlm-846	87	9	vancomycin	vancomycin	PROPN
ajlm-846	87	10	in	in	ADP
ajlm-846	87	11	vitro	vitro	X
ajlm-846	87	12	(	(	PUNCT
ajlm-846	87	13	table	table	NOUN
ajlm-846	87	14	1	1	NUM
ajlm-846	87	15	)	)	PUNCT
ajlm-846	87	16	.	.	PUNCT
ajlm-846	88	1	similarly	similarly	ADV
ajlm-846	88	2	,	,	PUNCT
ajlm-846	88	3	none	none	NOUN
ajlm-846	88	4	of	of	ADP
ajlm-846	88	5	the	the	DET
ajlm-846	88	6	isolates	isolate	NOUN
ajlm-846	88	7	was	be	AUX
ajlm-846	88	8	resistant	resistant	ADJ
ajlm-846	88	9	to	to	ADP
ajlm-846	88	10	metronidazole	metronidazole	NOUN
ajlm-846	88	11	,	,	PUNCT
ajlm-846	88	12	although	although	SCONJ
ajlm-846	88	13	four	four	NUM
ajlm-846	88	14	isolates	isolate	NOUN
ajlm-846	88	15	from	from	ADP
ajlm-846	88	16	hospital	hospital	NOUN
ajlm-846	88	17	a	a	DET
ajlm-846	88	18	showed	show	VERB
ajlm-846	88	19	reduced	reduce	VERB
ajlm-846	88	20	susceptibility	susceptibility	NOUN
ajlm-846	88	21	to	to	ADP
ajlm-846	88	22	the	the	DET
ajlm-846	88	23	antibiotic	antibiotic	ADJ
ajlm-846	88	24	(	(	PUNCT
ajlm-846	88	25	mic	mic	ADJ
ajlm-846	88	26	>	>	X
ajlm-846	88	27	2	2	NUM
ajlm-846	88	28	mg	mg	PROPN
ajlm-846	88	29	/	/	SYM
ajlm-846	88	30	l	l	NOUN
ajlm-846	88	31	)	)	PUNCT
ajlm-846	88	32	.	.	PUNCT
ajlm-846	89	1	all	all	PRON
ajlm-846	89	2	but	but	SCONJ
ajlm-846	89	3	one	one	NUM
ajlm-846	89	4	of	of	ADP
ajlm-846	89	5	the	the	DET
ajlm-846	89	6	tested	test	VERB
ajlm-846	89	7	isolates	isolate	NOUN
ajlm-846	89	8	(	(	PUNCT
ajlm-846	89	9	a	a	DET
ajlm-846	89	10	rt002	rt002	NOUN
ajlm-846	89	11	isolate	isolate	NOUN
ajlm-846	89	12	)	)	PUNCT
ajlm-846	89	13	were	be	AUX
ajlm-846	89	14	resistant	resistant	ADJ
ajlm-846	89	15	to	to	ADP
ajlm-846	89	16	rifampicin	rifampicin	VERB
ajlm-846	89	17	.	.	PUNCT
ajlm-846	90	1	all	all	PRON
ajlm-846	90	2	tested	test	VERB
ajlm-846	90	3	rt017	rt017	PROPN
ajlm-846	90	4	isolates	isolate	NOUN
ajlm-846	90	5	(	(	PUNCT
ajlm-846	90	6	n=72	n=72	NOUN
ajlm-846	90	7	)	)	PUNCT
ajlm-846	90	8	were	be	AUX
ajlm-846	90	9	resistant	resistant	ADJ
ajlm-846	90	10	to	to	ADP
ajlm-846	90	11	moxifloxacin	moxifloxacin	NUM
ajlm-846	90	12	,	,	PUNCT
ajlm-846	90	13	while	while	SCONJ
ajlm-846	90	14	the	the	DET
ajlm-846	90	15	remaining	remain	VERB
ajlm-846	90	16	non	non	ADJ
ajlm-846	90	17	-	-	ADJ
ajlm-846	90	18	rt017	rt017	ADJ
ajlm-846	90	19	isolates	isolate	NOUN
ajlm-846	90	20	were	be	AUX
ajlm-846	90	21	susceptible	susceptible	ADJ
ajlm-846	90	22	to	to	ADP
ajlm-846	90	23	the	the	DET
ajlm-846	90	24	antibiotic	antibiotic	NOUN
ajlm-846	90	25	.	.	PUNCT
ajlm-846	91	1	erythromycin	erythromycin	PROPN
ajlm-846	91	2	resistance	resistance	NOUN
ajlm-846	91	3	was	be	AUX
ajlm-846	91	4	observed	observe	VERB
ajlm-846	91	5	in	in	ADP
ajlm-846	91	6	over	over	ADP
ajlm-846	91	7	two	two	NUM
ajlm-846	91	8	-	-	PUNCT
ajlm-846	91	9	thirds	third	NOUN
ajlm-846	91	10	of	of	ADP
ajlm-846	91	11	the	the	DET
ajlm-846	91	12	isolates	isolate	NOUN
ajlm-846	91	13	(	(	PUNCT
ajlm-846	91	14	72.6	72.6	NUM
ajlm-846	91	15	%	%	NOUN
ajlm-846	91	16	)	)	PUNCT
ajlm-846	91	17	.	.	PUNCT
ajlm-846	92	1	multi	multi	ADJ
ajlm-846	92	2	-	-	ADJ
ajlm-846	92	3	drug	drug	ADJ
ajlm-846	92	4	resistance	resistance	NOUN
ajlm-846	92	5	was	be	AUX
ajlm-846	92	6	observed	observe	VERB
ajlm-846	92	7	for	for	ADP
ajlm-846	92	8	all	all	DET
ajlm-846	92	9	tested	test	VERB
ajlm-846	92	10	rt017	rt017	PROPN
ajlm-846	92	11	strains	strain	NOUN
ajlm-846	92	12	(	(	PUNCT
ajlm-846	92	13	table	table	NOUN
ajlm-846	92	14	2	2	NUM
ajlm-846	92	15	)	)	PUNCT
ajlm-846	92	16	,	,	PUNCT
ajlm-846	92	17	with	with	ADP
ajlm-846	92	18	73.6	73.6	NUM
ajlm-846	92	19	%	%	NOUN
ajlm-846	92	20	of	of	ADP
ajlm-846	92	21	isolates	isolate	NOUN
ajlm-846	92	22	resistant	resistant	ADJ
ajlm-846	92	23	to	to	ADP
ajlm-846	92	24	erythromycin	erythromycin	PROPN
ajlm-846	92	25	,	,	PUNCT
ajlm-846	92	26	moxifloxacin	moxifloxacin	PRON
ajlm-846	92	27	and	and	CCONJ
ajlm-846	92	28	rifampicin	rifampicin	VERB
ajlm-846	92	29	and	and	CCONJ
ajlm-846	92	30	a	a	DET
ajlm-846	92	31	further	further	ADJ
ajlm-846	92	32	26.4	26.4	NUM
ajlm-846	92	33	%	%	NOUN
ajlm-846	92	34	of	of	ADP
ajlm-846	92	35	isolates	isolate	NOUN
ajlm-846	92	36	co	co	ADJ
ajlm-846	92	37	-	-	ADJ
ajlm-846	92	38	resistant	resistant	ADJ
ajlm-846	92	39	to	to	ADP
ajlm-846	92	40	moxifloxacin	moxifloxacin	PRON
ajlm-846	92	41	and	and	CCONJ
ajlm-846	92	42	rifampicin	rifampicin	VERB
ajlm-846	92	43	.	.	PUNCT
ajlm-846	93	1	co	co	NOUN
ajlm-846	93	2	-	-	NOUN
ajlm-846	93	3	resistance	resistance	NOUN
ajlm-846	93	4	was	be	AUX
ajlm-846	93	5	also	also	ADV
ajlm-846	93	6	observed	observe	VERB
ajlm-846	93	7	for	for	ADP
ajlm-846	93	8	rt(se)108	rt(se)108	PROPN
ajlm-846	93	9	strains	strain	VERB
ajlm-846	93	10	,	,	PUNCT
ajlm-846	93	11	with	with	ADP
ajlm-846	93	12	two	two	NUM
ajlm-846	93	13	isolates	isolate	NOUN
ajlm-846	93	14	resistant	resistant	ADJ
ajlm-846	93	15	to	to	ADP
ajlm-846	93	16	erythromycin	erythromycin	NOUN
ajlm-846	93	17	and	and	CCONJ
ajlm-846	93	18	rifampicin	rifampicin	VERB
ajlm-846	93	19	.	.	PUNCT
ajlm-846	94	1	there	there	PRON
ajlm-846	94	2	were	be	VERB
ajlm-846	94	3	no	no	DET
ajlm-846	94	4	significant	significant	ADJ
ajlm-846	94	5	differences	difference	NOUN
ajlm-846	94	6	in	in	ADP
ajlm-846	94	7	antibiotic	antibiotic	ADJ
ajlm-846	94	8	resistance	resistance	NOUN
ajlm-846	94	9	patterns	pattern	NOUN
ajlm-846	94	10	between	between	ADP
ajlm-846	94	11	wards	ward	NOUN
ajlm-846	94	12	and	and	CCONJ
ajlm-846	94	13	between	between	ADP
ajlm-846	94	14	hospitals	hospital	NOUN
ajlm-846	94	15	.	.	PUNCT
ajlm-846	95	1	table	table	NOUN
ajlm-846	95	2	1	1	NUM
ajlm-846	95	3	:	:	PUNCT
ajlm-846	95	4	 	 	SPACE
ajlm-846	95	5	antibiotic	antibiotic	ADJ
ajlm-846	95	6	susceptibility	susceptibility	NOUN
ajlm-846	95	7	data	datum	NOUN
ajlm-846	95	8	for	for	ADP
ajlm-846	95	9	isolates	isolate	NOUN
ajlm-846	95	10	.	.	PUNCT
ajlm-846	96	1	table	table	NOUN
ajlm-846	96	2	2	2	NUM
ajlm-846	96	3	:	:	PUNCT
ajlm-846	96	4	 	 	SPACE
ajlm-846	96	5	multi	multi	ADJ
ajlm-846	96	6	-	-	ADJ
ajlm-846	96	7	drug	drug	ADJ
ajlm-846	96	8	resistance	resistance	NOUN
ajlm-846	96	9	by	by	ADP
ajlm-846	96	10	ribotype	ribotype	NOUN
ajlm-846	96	11	.	.	PUNCT
ajlm-846	97	1	discussion	discussion	NOUN
ajlm-846	97	2	there	there	PRON
ajlm-846	97	3	is	be	VERB
ajlm-846	97	4	a	a	DET
ajlm-846	97	5	clear	clear	ADJ
ajlm-846	97	6	need	need	NOUN
ajlm-846	97	7	for	for	ADP
ajlm-846	97	8	further	further	ADJ
ajlm-846	97	9	study	study	NOUN
ajlm-846	97	10	and	and	CCONJ
ajlm-846	97	11	increased	increase	VERB
ajlm-846	97	12	surveillance	surveillance	NOUN
ajlm-846	97	13	of	of	ADP
ajlm-846	97	14	cdi	cdi	PROPN
ajlm-846	97	15	in	in	ADP
ajlm-846	97	16	sub	sub	ADJ
ajlm-846	97	17	-	-	ADJ
ajlm-846	97	18	saharan	saharan	ADJ
ajlm-846	97	19	africa	africa	PROPN
ajlm-846	97	20	.	.	PUNCT
ajlm-846	98	1	both	both	PRON
ajlm-846	98	2	hospital	hospital	NOUN
ajlm-846	98	3	and	and	CCONJ
ajlm-846	98	4	community	community	NOUN
ajlm-846	98	5	-	-	PUNCT
ajlm-846	98	6	acquired	acquire	VERB
ajlm-846	98	7	cdi	cdi	NOUN
ajlm-846	98	8	cases	case	NOUN
ajlm-846	98	9	have	have	VERB
ajlm-846	98	10	the	the	DET
ajlm-846	98	11	potential	potential	NOUN
ajlm-846	98	12	to	to	PART
ajlm-846	98	13	pose	pose	VERB
ajlm-846	98	14	significant	significant	ADJ
ajlm-846	98	15	challenges	challenge	NOUN
ajlm-846	98	16	to	to	ADP
ajlm-846	98	17	healthcare	healthcare	NOUN
ajlm-846	98	18	systems	system	NOUN
ajlm-846	98	19	and	and	CCONJ
ajlm-846	98	20	there	there	PRON
ajlm-846	98	21	are	be	VERB
ajlm-846	98	22	currently	currently	ADV
ajlm-846	98	23	no	no	DET
ajlm-846	98	24	data	datum	NOUN
ajlm-846	98	25	on	on	ADP
ajlm-846	98	26	the	the	DET
ajlm-846	98	27	economic	economic	ADJ
ajlm-846	98	28	burden	burden	NOUN
ajlm-846	98	29	of	of	ADP
ajlm-846	98	30	cdi	cdi	PROPN
ajlm-846	98	31	outbreaks	outbreak	NOUN
ajlm-846	98	32	in	in	ADP
ajlm-846	98	33	the	the	DET
ajlm-846	98	34	region	region	NOUN
ajlm-846	98	35	.	.	PUNCT
ajlm-846	99	1	an	an	DET
ajlm-846	99	2	inclusive	inclusive	ADJ
ajlm-846	99	3	‘	'	PUNCT
ajlm-846	99	4	one	one	NUM
ajlm-846	99	5	-	-	PUNCT
ajlm-846	99	6	health	health	NOUN
ajlm-846	99	7	’	'	PUNCT
ajlm-846	99	8	approach	approach	NOUN
ajlm-846	99	9	involving	involve	VERB
ajlm-846	99	10	researchers	researcher	NOUN
ajlm-846	99	11	at	at	ADP
ajlm-846	99	12	multiple	multiple	ADJ
ajlm-846	99	13	levels	level	NOUN
ajlm-846	99	14	in	in	ADP
ajlm-846	99	15	the	the	DET
ajlm-846	99	16	community	community	NOUN
ajlm-846	99	17	and	and	CCONJ
ajlm-846	99	18	hospital	hospital	NOUN
ajlm-846	99	19	environment	environment	NOUN
ajlm-846	99	20	is	be	AUX
ajlm-846	99	21	important	important	ADJ
ajlm-846	99	22	.	.	PUNCT
ajlm-846	100	1	a	a	DET
ajlm-846	100	2	first	first	ADJ
ajlm-846	100	3	step	step	NOUN
ajlm-846	100	4	in	in	ADP
ajlm-846	100	5	this	this	DET
ajlm-846	100	6	direction	direction	NOUN
ajlm-846	100	7	is	be	AUX
ajlm-846	100	8	the	the	DET
ajlm-846	100	9	establishment	establishment	NOUN
ajlm-846	100	10	of	of	ADP
ajlm-846	100	11	systematic	systematic	ADJ
ajlm-846	100	12	sentinel	sentinel	ADJ
ajlm-846	100	13	surveillance	surveillance	NOUN
ajlm-846	100	14	of	of	ADP
ajlm-846	100	15	cdi	cdi	PROPN
ajlm-846	100	16	in	in	ADP
ajlm-846	100	17	high	high	ADJ
ajlm-846	100	18	-	-	PUNCT
ajlm-846	100	19	risk	risk	NOUN
ajlm-846	100	20	populations	population	NOUN
ajlm-846	100	21	to	to	PART
ajlm-846	100	22	monitor	monitor	VERB
ajlm-846	100	23	the	the	DET
ajlm-846	100	24	incidence	incidence	NOUN
ajlm-846	100	25	of	of	ADP
ajlm-846	100	26	cdi	cdi	PROPN
ajlm-846	100	27	,	,	PUNCT
ajlm-846	100	28	as	as	ADV
ajlm-846	100	29	well	well	ADV
ajlm-846	100	30	as	as	ADP
ajlm-846	100	31	the	the	DET
ajlm-846	100	32	predominant	predominant	ADJ
ajlm-846	100	33	strain	strain	NOUN
ajlm-846	100	34	types	type	NOUN
ajlm-846	100	35	and	and	CCONJ
ajlm-846	100	36	circulating	circulate	VERB
ajlm-846	100	37	antibiotic	antibiotic	ADJ
ajlm-846	100	38	resistance	resistance	NOUN
ajlm-846	100	39	phenotypes	phenotype	NOUN
ajlm-846	100	40	.	.	PUNCT
ajlm-846	101	1	similar	similar	ADJ
ajlm-846	101	2	programmes	programme	NOUN
ajlm-846	101	3	in	in	ADP
ajlm-846	101	4	high	high	ADJ
ajlm-846	101	5	income	income	NOUN
ajlm-846	101	6	nations	nation	NOUN
ajlm-846	101	7	have	have	AUX
ajlm-846	101	8	been	be	AUX
ajlm-846	101	9	successful	successful	ADJ
ajlm-846	101	10	in	in	ADP
ajlm-846	101	11	reducing	reduce	VERB
ajlm-846	101	12	both	both	CCONJ
ajlm-846	101	13	the	the	DET
ajlm-846	101	14	incidence	incidence	NOUN
ajlm-846	101	15	of	of	ADP
ajlm-846	101	16	infection	infection	NOUN
ajlm-846	101	17	and	and	CCONJ
ajlm-846	101	18	mortality	mortality	NOUN
ajlm-846	101	19	due	due	ADP
ajlm-846	101	20	to	to	ADP
ajlm-846	101	21	cdi44	cdi44	PROPN
ajlm-846	101	22	and	and	CCONJ
ajlm-846	101	23	would	would	AUX
ajlm-846	101	24	be	be	AUX
ajlm-846	101	25	of	of	ADP
ajlm-846	101	26	benefit	benefit	NOUN
ajlm-846	101	27	to	to	ADP
ajlm-846	101	28	countries	country	NOUN
ajlm-846	101	29	in	in	ADP
ajlm-846	101	30	sub	sub	ADJ
ajlm-846	101	31	-	-	ADJ
ajlm-846	101	32	saharan	saharan	ADJ
ajlm-846	101	33	africa	africa	PROPN
ajlm-846	101	34	.	.	PUNCT
ajlm-846	102	1	in	in	ADP
ajlm-846	102	2	the	the	DET
ajlm-846	102	3	current	current	ADJ
ajlm-846	102	4	study	study	NOUN
ajlm-846	102	5	,	,	PUNCT
ajlm-846	102	6	cdi	cdi	PROPN
ajlm-846	102	7	cases	case	NOUN
ajlm-846	102	8	were	be	AUX
ajlm-846	102	9	examined	examine	VERB
ajlm-846	102	10	in	in	ADP
ajlm-846	102	11	at	at	ADP
ajlm-846	102	12	-	-	PUNCT
ajlm-846	102	13	risk	risk	NOUN
ajlm-846	102	14	populations	population	NOUN
ajlm-846	102	15	of	of	ADP
ajlm-846	102	16	patients	patient	NOUN
ajlm-846	102	17	undergoing	undergo	VERB
ajlm-846	102	18	long	long	ADJ
ajlm-846	102	19	-	-	PUNCT
ajlm-846	102	20	term	term	NOUN
ajlm-846	102	21	anti	anti	ADJ
ajlm-846	102	22	-	-	ADJ
ajlm-846	102	23	tuberculosis	tuberculosis	ADJ
ajlm-846	102	24	therapy	therapy	NOUN
ajlm-846	102	25	.	.	PUNCT
ajlm-846	103	1	cdi	cdi	PROPN
ajlm-846	103	2	was	be	AUX
ajlm-846	103	3	common	common	ADJ
ajlm-846	103	4	at	at	ADP
ajlm-846	103	5	both	both	PRON
ajlm-846	103	6	tuberculosis	tuberculosis	NOUN
ajlm-846	103	7	institutions	institution	NOUN
ajlm-846	103	8	with	with	ADP
ajlm-846	103	9	at	at	ADV
ajlm-846	103	10	least	least	ADV
ajlm-846	103	11	four	four	NUM
ajlm-846	103	12	wards	ward	NOUN
ajlm-846	103	13	experiencing	experience	VERB
ajlm-846	103	14	spikes	spike	NOUN
ajlm-846	103	15	in	in	ADP
ajlm-846	103	16	the	the	DET
ajlm-846	103	17	infection	infection	NOUN
ajlm-846	103	18	rates	rate	NOUN
ajlm-846	103	19	during	during	ADP
ajlm-846	103	20	the	the	DET
ajlm-846	103	21	study	study	NOUN
ajlm-846	103	22	period	period	NOUN
ajlm-846	103	23	.	.	PUNCT
ajlm-846	104	1	three	three	NUM
ajlm-846	104	2	of	of	ADP
ajlm-846	104	3	these	these	DET
ajlm-846	104	4	wards	ward	NOUN
ajlm-846	104	5	housed	house	VERB
ajlm-846	104	6	patients	patient	NOUN
ajlm-846	104	7	undergoing	undergo	VERB
ajlm-846	104	8	ds	ds	ADJ
ajlm-846	104	9	tuberculosis	tuberculosis	NOUN
ajlm-846	104	10	treatment	treatment	NOUN
ajlm-846	104	11	regimens	regimen	NOUN
ajlm-846	104	12	,	,	PUNCT
ajlm-846	104	13	while	while	SCONJ
ajlm-846	104	14	one	one	NUM
ajlm-846	104	15	housed	house	VERB
ajlm-846	104	16	patients	patient	NOUN
ajlm-846	104	17	receiving	receive	VERB
ajlm-846	104	18	mdr	mdr	NOUN
ajlm-846	104	19	tuberculosis	tuberculosis	NOUN
ajlm-846	104	20	therapy	therapy	NOUN
ajlm-846	104	21	.	.	PUNCT
ajlm-846	105	1	although	although	SCONJ
ajlm-846	105	2	c.	c.	PROPN
ajlm-846	105	3	difficile	difficile	VERB
ajlm-846	105	4	outbreak	outbreak	NOUN
ajlm-846	105	5	definitions	definition	NOUN
ajlm-846	105	6	vary	vary	VERB
ajlm-846	105	7	across	across	ADP
ajlm-846	105	8	countries	country	NOUN
ajlm-846	105	9	,	,	PUNCT
ajlm-846	105	10	a	a	DET
ajlm-846	105	11	rate	rate	NOUN
ajlm-846	105	12	of	of	ADP
ajlm-846	105	13	five	five	NUM
ajlm-846	105	14	or	or	CCONJ
ajlm-846	105	15	more	more	ADJ
ajlm-846	105	16	cases	case	NOUN
ajlm-846	105	17	in	in	ADP
ajlm-846	105	18	a	a	DET
ajlm-846	105	19	single	single	ADJ
ajlm-846	105	20	ward	ward	NOUN
ajlm-846	105	21	with	with	ADP
ajlm-846	105	22	at	at	ADV
ajlm-846	105	23	least	least	ADV
ajlm-846	105	24	20	20	NUM
ajlm-846	105	25	beds	bed	NOUN
ajlm-846	105	26	over	over	ADP
ajlm-846	105	27	a	a	DET
ajlm-846	105	28	four	four	NUM
ajlm-846	105	29	-	-	PUNCT
ajlm-846	105	30	week	week	NOUN
ajlm-846	105	31	period	period	NOUN
ajlm-846	105	32	is	be	AUX
ajlm-846	105	33	generally	generally	ADV
ajlm-846	105	34	used	use	VERB
ajlm-846	105	35	as	as	ADP
ajlm-846	105	36	a	a	DET
ajlm-846	105	37	threshold	threshold	NOUN
ajlm-846	105	38	to	to	PART
ajlm-846	105	39	initiate	initiate	VERB
ajlm-846	105	40	outbreak	outbreak	NOUN
ajlm-846	105	41	investigations	investigation	NOUN
ajlm-846	105	42	.	.	PUNCT
ajlm-846	106	1	that	that	SCONJ
ajlm-846	106	2	this	this	PRON
ajlm-846	106	3	occurred	occur	VERB
ajlm-846	106	4	in	in	ADP
ajlm-846	106	5	four	four	NUM
ajlm-846	106	6	different	different	ADJ
ajlm-846	106	7	wards	ward	NOUN
ajlm-846	106	8	during	during	ADP
ajlm-846	106	9	the	the	DET
ajlm-846	106	10	study	study	NOUN
ajlm-846	106	11	is	be	AUX
ajlm-846	106	12	concerning	concern	VERB
ajlm-846	106	13	and	and	CCONJ
ajlm-846	106	14	suggests	suggest	VERB
ajlm-846	106	15	the	the	DET
ajlm-846	106	16	need	need	NOUN
ajlm-846	106	17	for	for	ADP
ajlm-846	106	18	enhanced	enhanced	ADJ
ajlm-846	106	19	surveillance	surveillance	NOUN
ajlm-846	106	20	of	of	ADP
ajlm-846	106	21	c.	c.	NOUN
ajlm-846	106	22	difficile	difficile	VERB
ajlm-846	106	23	in	in	ADP
ajlm-846	106	24	these	these	DET
ajlm-846	106	25	hospitals	hospital	NOUN
ajlm-846	106	26	to	to	PART
ajlm-846	106	27	help	help	VERB
ajlm-846	106	28	to	to	PART
ajlm-846	106	29	prevent	prevent	VERB
ajlm-846	106	30	further	further	ADJ
ajlm-846	106	31	infections	infection	NOUN
ajlm-846	106	32	.	.	PUNCT
ajlm-846	107	1	toxin	toxin	NOUN
ajlm-846	107	2	a	a	DET
ajlm-846	107	3	-	-	PUNCT
ajlm-846	107	4	negative	negative	ADJ
ajlm-846	107	5	,	,	PUNCT
ajlm-846	107	6	toxin	toxin	NOUN
ajlm-846	107	7	b	b	NOUN
ajlm-846	107	8	-	-	PUNCT
ajlm-846	107	9	positive	positive	ADJ
ajlm-846	107	10	rt017	rt017	PROPN
ajlm-846	107	11	strains	strain	NOUN
ajlm-846	107	12	made	make	VERB
ajlm-846	107	13	up	up	ADP
ajlm-846	107	14	the	the	DET
ajlm-846	107	15	majority	majority	NOUN
ajlm-846	107	16	of	of	ADP
ajlm-846	107	17	tuberculosis	tuberculosis	NOUN
ajlm-846	107	18	patient	patient	ADJ
ajlm-846	107	19	isolates	isolate	NOUN
ajlm-846	107	20	.	.	PUNCT
ajlm-846	108	1	strains	strain	NOUN
ajlm-846	108	2	belonging	belong	VERB
ajlm-846	108	3	to	to	ADP
ajlm-846	108	4	this	this	DET
ajlm-846	108	5	ribotype	ribotype	NOUN
ajlm-846	108	6	have	have	AUX
ajlm-846	108	7	been	be	AUX
ajlm-846	108	8	implicated	implicate	VERB
ajlm-846	108	9	in	in	ADP
ajlm-846	108	10	outbreaks	outbreak	NOUN
ajlm-846	108	11	in	in	ADP
ajlm-846	108	12	canada,45	canada,45	PROPN
ajlm-846	108	13	china,46	china,46	PROPN
ajlm-846	108	14	korea,47	korea,47	PROPN
ajlm-846	108	15	argentina,48	argentina,48	DET
ajlm-846	108	16	israel,49	israel,49	NOUN
ajlm-846	108	17	japan50	japan50	NOUN
ajlm-846	108	18	and	and	CCONJ
ajlm-846	108	19	europe6,51	europe6,51	PROPN
ajlm-846	108	20	and	and	CCONJ
ajlm-846	108	21	they	they	PRON
ajlm-846	108	22	are	be	AUX
ajlm-846	108	23	often	often	ADV
ajlm-846	108	24	resistant	resistant	ADJ
ajlm-846	108	25	to	to	ADP
ajlm-846	108	26	multiple	multiple	ADJ
ajlm-846	108	27	drugs.42,52	drugs.42,52	NOUN
ajlm-846	108	28	moreover	moreover	ADV
ajlm-846	108	29	,	,	PUNCT
ajlm-846	108	30	in	in	ADP
ajlm-846	108	31	previous	previous	ADJ
ajlm-846	108	32	studies	study	NOUN
ajlm-846	108	33	rt017	rt017	X
ajlm-846	108	34	strains	strain	NOUN
ajlm-846	108	35	have	have	AUX
ajlm-846	108	36	been	be	AUX
ajlm-846	108	37	shown	show	VERB
ajlm-846	108	38	to	to	PART
ajlm-846	108	39	have	have	VERB
ajlm-846	108	40	a	a	DET
ajlm-846	108	41	similar	similar	ADJ
ajlm-846	108	42	30	30	NUM
ajlm-846	108	43	-	-	PUNCT
ajlm-846	108	44	day	day	NOUN
ajlm-846	108	45	mortality	mortality	NOUN
ajlm-846	108	46	rate	rate	NOUN
ajlm-846	108	47	of	of	ADP
ajlm-846	108	48	the	the	DET
ajlm-846	108	49	so	so	ADV
ajlm-846	108	50	-	-	PUNCT
ajlm-846	108	51	called	call	VERB
ajlm-846	108	52	‘	'	PUNCT
ajlm-846	108	53	hypervirulent	hypervirulent	ADJ
ajlm-846	108	54	’	'	PUNCT
ajlm-846	109	1	rt027	rt027	PROPN
ajlm-846	109	2	strains.5,53	strains.5,53	PROPN
ajlm-846	109	3	rt017	rt017	PROPN
ajlm-846	109	4	strains	strain	NOUN
ajlm-846	109	5	were	be	AUX
ajlm-846	109	6	also	also	ADV
ajlm-846	109	7	commonly	commonly	ADV
ajlm-846	109	8	isolated	isolate	VERB
ajlm-846	109	9	from	from	ADP
ajlm-846	109	10	other	other	ADJ
ajlm-846	109	11	hospitals	hospital	NOUN
ajlm-846	109	12	in	in	ADP
ajlm-846	109	13	cape	cape	NOUN
ajlm-846	109	14	town	town	NOUN
ajlm-846	109	15	during	during	ADP
ajlm-846	109	16	the	the	DET
ajlm-846	109	17	same	same	ADJ
ajlm-846	109	18	time	time	NOUN
ajlm-846	109	19	period	period	NOUN
ajlm-846	109	20	,	,	PUNCT
ajlm-846	109	21	suggesting	suggest	VERB
ajlm-846	109	22	that	that	SCONJ
ajlm-846	109	23	these	these	DET
ajlm-846	109	24	strains	strain	NOUN
ajlm-846	109	25	are	be	AUX
ajlm-846	109	26	circulating	circulate	VERB
ajlm-846	109	27	more	more	ADV
ajlm-846	109	28	broadly	broadly	ADV
ajlm-846	109	29	in	in	ADP
ajlm-846	109	30	the	the	DET
ajlm-846	109	31	cape	cape	NOUN
ajlm-846	109	32	town	town	NOUN
ajlm-846	109	33	patient	patient	NOUN
ajlm-846	109	34	population.30,54	population.30,54	VERB
ajlm-846	109	35	it	it	PRON
ajlm-846	109	36	is	be	AUX
ajlm-846	109	37	possible	possible	ADJ
ajlm-846	109	38	that	that	SCONJ
ajlm-846	109	39	the	the	DET
ajlm-846	109	40	previous	previous	ADJ
ajlm-846	109	41	use	use	NOUN
ajlm-846	109	42	of	of	ADP
ajlm-846	109	43	standalone	standalone	ADJ
ajlm-846	109	44	enzyme	enzyme	NOUN
ajlm-846	109	45	immunoassay	immunoassay	ADJ
ajlm-846	109	46	diagnostic	diagnostic	ADJ
ajlm-846	109	47	tests	test	NOUN
ajlm-846	109	48	that	that	PRON
ajlm-846	109	49	target	target	VERB
ajlm-846	109	50	toxin	toxin	NOUN
ajlm-846	109	51	a	a	PRON
ajlm-846	109	52	alone	alone	ADV
ajlm-846	109	53	allowed	allow	VERB
ajlm-846	109	54	rt017	rt017	PROPN
ajlm-846	109	55	strains	strain	NOUN
ajlm-846	109	56	to	to	PART
ajlm-846	109	57	proliferate	proliferate	VERB
ajlm-846	109	58	undetected	undetected	ADJ
ajlm-846	109	59	in	in	ADP
ajlm-846	109	60	the	the	DET
ajlm-846	109	61	region	region	NOUN
ajlm-846	109	62	,	,	PUNCT
ajlm-846	109	63	providing	provide	VERB
ajlm-846	109	64	a	a	DET
ajlm-846	109	65	reservoir	reservoir	NOUN
ajlm-846	109	66	of	of	ADP
ajlm-846	109	67	strains	strain	NOUN
ajlm-846	109	68	in	in	ADP
ajlm-846	109	69	the	the	DET
ajlm-846	109	70	healthcare	healthcare	NOUN
ajlm-846	109	71	environment	environment	NOUN
ajlm-846	109	72	with	with	ADP
ajlm-846	109	73	the	the	DET
ajlm-846	109	74	potential	potential	NOUN
ajlm-846	109	75	to	to	PART
ajlm-846	109	76	cause	cause	VERB
ajlm-846	109	77	outbreaks	outbreak	NOUN
ajlm-846	109	78	in	in	ADP
ajlm-846	109	79	susceptible	susceptible	ADJ
ajlm-846	109	80	patient	patient	ADJ
ajlm-846	109	81	populations	population	NOUN
ajlm-846	109	82	.	.	PUNCT
ajlm-846	110	1	several	several	ADJ
ajlm-846	110	2	rt017	rt017	PROPN
ajlm-846	110	3	strains	strain	NOUN
ajlm-846	110	4	isolated	isolate	VERB
ajlm-846	110	5	from	from	ADP
ajlm-846	110	6	both	both	DET
ajlm-846	110	7	hospitals	hospital	NOUN
ajlm-846	110	8	were	be	AUX
ajlm-846	110	9	highly	highly	ADV
ajlm-846	110	10	related	relate	VERB
ajlm-846	110	11	by	by	ADP
ajlm-846	110	12	mlva	mlva	PROPN
ajlm-846	110	13	,	,	PUNCT
ajlm-846	110	14	suggesting	suggest	VERB
ajlm-846	110	15	possible	possible	ADJ
ajlm-846	110	16	patient	patient	NOUN
ajlm-846	110	17	-	-	PUNCT
ajlm-846	110	18	to	to	ADP
ajlm-846	110	19	-	-	PUNCT
ajlm-846	110	20	patient	patient	ADJ
ajlm-846	110	21	strain	strain	NOUN
ajlm-846	110	22	transfer	transfer	NOUN
ajlm-846	110	23	.	.	PUNCT
ajlm-846	111	1	in	in	ADP
ajlm-846	111	2	a	a	DET
ajlm-846	111	3	large	large	ADJ
ajlm-846	111	4	scale	scale	NOUN
ajlm-846	111	5	epidemiological	epidemiological	ADJ
ajlm-846	111	6	analysis	analysis	NOUN
ajlm-846	111	7	of	of	ADP
ajlm-846	111	8	c.	c.	NOUN
ajlm-846	111	9	difficile	difficile	VERB
ajlm-846	111	10	strains	strain	NOUN
ajlm-846	111	11	infecting	infect	VERB
ajlm-846	111	12	patients	patient	NOUN
ajlm-846	111	13	in	in	ADP
ajlm-846	111	14	england	england	PROPN
ajlm-846	111	15	,	,	PUNCT
ajlm-846	111	16	eyre	eyre	PROPN
ajlm-846	111	17	et	et	NOUN
ajlm-846	111	18	al.55	al.55	NOUN
ajlm-846	111	19	defined	define	VERB
ajlm-846	111	20	several	several	ADJ
ajlm-846	111	21	possible	possible	ADJ
ajlm-846	111	22	transmission	transmission	NOUN
ajlm-846	111	23	relationships	relationship	NOUN
ajlm-846	111	24	for	for	ADP
ajlm-846	111	25	patients	patient	NOUN
ajlm-846	111	26	with	with	ADP
ajlm-846	111	27	clonally	clonally	ADV
ajlm-846	111	28	related	relate	VERB
ajlm-846	111	29	c.	c.	NOUN
ajlm-846	111	30	difficile	difficile	NOUN
ajlm-846	111	31	strains	strain	NOUN
ajlm-846	111	32	.	.	PUNCT
ajlm-846	112	1	for	for	ADP
ajlm-846	112	2	hospital	hospital	NOUN
ajlm-846	112	3	-	-	PUNCT
ajlm-846	112	4	acquired	acquire	VERB
ajlm-846	112	5	cases	case	NOUN
ajlm-846	112	6	,	,	PUNCT
ajlm-846	112	7	these	these	PRON
ajlm-846	112	8	included	include	VERB
ajlm-846	112	9	‘	'	PUNCT
ajlm-846	112	10	ward	ward	NOUN
ajlm-846	112	11	contacts	contact	NOUN
ajlm-846	112	12	’	'	PUNCT
ajlm-846	112	13	(	(	PUNCT
ajlm-846	112	14	two	two	NUM
ajlm-846	112	15	or	or	CCONJ
ajlm-846	112	16	more	more	ADJ
ajlm-846	112	17	patients	patient	NOUN
ajlm-846	112	18	occupying	occupy	VERB
ajlm-846	112	19	the	the	DET
ajlm-846	112	20	same	same	ADJ
ajlm-846	112	21	ward	ward	NOUN
ajlm-846	112	22	over	over	ADP
ajlm-846	112	23	a	a	DET
ajlm-846	112	24	concurrent	concurrent	ADJ
ajlm-846	112	25	time	time	NOUN
ajlm-846	112	26	interval	interval	NOUN
ajlm-846	112	27	that	that	PRON
ajlm-846	112	28	allowed	allow	VERB
ajlm-846	112	29	for	for	ADP
ajlm-846	112	30	direct	direct	ADJ
ajlm-846	112	31	patient	patient	NOUN
ajlm-846	112	32	-	-	PUNCT
ajlm-846	112	33	to	to	ADP
ajlm-846	112	34	-	-	PUNCT
ajlm-846	112	35	patient	patient	NOUN
ajlm-846	112	36	transmission	transmission	NOUN
ajlm-846	112	37	)	)	PUNCT
ajlm-846	112	38	,	,	PUNCT
ajlm-846	112	39	‘	'	PUNCT
ajlm-846	112	40	ward	ward	NOUN
ajlm-846	112	41	contamination	contamination	NOUN
ajlm-846	112	42	’	'	PUNCT
ajlm-846	112	43	(	(	PUNCT
ajlm-846	112	44	patients	patient	NOUN
ajlm-846	112	45	occupying	occupy	VERB
ajlm-846	112	46	the	the	DET
ajlm-846	112	47	same	same	ADJ
ajlm-846	112	48	ward	ward	NOUN
ajlm-846	112	49	but	but	CCONJ
ajlm-846	112	50	with	with	ADP
ajlm-846	112	51	an	an	DET
ajlm-846	112	52	interval	interval	NOUN
ajlm-846	112	53	of	of	ADP
ajlm-846	112	54	1–28	1–28	NOUN
ajlm-846	112	55	days	day	NOUN
ajlm-846	112	56	separating	separate	VERB
ajlm-846	112	57	the	the	DET
ajlm-846	112	58	discharge	discharge	NOUN
ajlm-846	112	59	or	or	CCONJ
ajlm-846	112	60	end	end	NOUN
ajlm-846	112	61	of	of	ADP
ajlm-846	112	62	infectivity	infectivity	NOUN
ajlm-846	112	63	of	of	ADP
ajlm-846	112	64	the	the	DET
ajlm-846	112	65	initial	initial	ADJ
ajlm-846	112	66	case	case	NOUN
ajlm-846	112	67	and	and	CCONJ
ajlm-846	112	68	the	the	DET
ajlm-846	112	69	admission	admission	NOUN
ajlm-846	112	70	of	of	ADP
ajlm-846	112	71	patients	patient	NOUN
ajlm-846	112	72	who	who	PRON
ajlm-846	112	73	subsequently	subsequently	ADV
ajlm-846	112	74	developed	develop	VERB
ajlm-846	112	75	cdi	cdi	PROPN
ajlm-846	112	76	)	)	PUNCT
ajlm-846	112	77	and	and	CCONJ
ajlm-846	112	78	‘	'	PUNCT
ajlm-846	112	79	hospital	hospital	NOUN
ajlm-846	112	80	contacts	contact	NOUN
ajlm-846	112	81	’	'	PUNCT
ajlm-846	112	82	(	(	PUNCT
ajlm-846	112	83	patients	patient	NOUN
ajlm-846	112	84	in	in	ADP
ajlm-846	112	85	different	different	ADJ
ajlm-846	112	86	wards	ward	NOUN
ajlm-846	112	87	at	at	ADP
ajlm-846	112	88	the	the	DET
ajlm-846	112	89	same	same	ADJ
ajlm-846	112	90	hospital	hospital	NOUN
ajlm-846	112	91	over	over	ADP
ajlm-846	112	92	a	a	DET
ajlm-846	112	93	similar	similar	ADJ
ajlm-846	112	94	time	time	NOUN
ajlm-846	112	95	interval	interval	NOUN
ajlm-846	112	96	to	to	PART
ajlm-846	112	97	ward	ward	VERB
ajlm-846	112	98	contacts	contact	NOUN
ajlm-846	112	99	)	)	PUNCT
ajlm-846	112	100	.	.	PUNCT
ajlm-846	113	1	unfortunately	unfortunately	ADV
ajlm-846	113	2	,	,	PUNCT
ajlm-846	113	3	detailed	detailed	ADJ
ajlm-846	113	4	ward	ward	NOUN
ajlm-846	113	5	occupation	occupation	NOUN
ajlm-846	113	6	data	datum	NOUN
ajlm-846	113	7	and	and	CCONJ
ajlm-846	113	8	the	the	DET
ajlm-846	113	9	duration	duration	NOUN
ajlm-846	113	10	of	of	ADP
ajlm-846	113	11	disease	disease	NOUN
ajlm-846	113	12	symptoms	symptom	NOUN
ajlm-846	113	13	were	be	AUX
ajlm-846	113	14	not	not	PART
ajlm-846	113	15	available	available	ADJ
ajlm-846	113	16	for	for	ADP
ajlm-846	113	17	patients	patient	NOUN
ajlm-846	113	18	in	in	ADP
ajlm-846	113	19	this	this	DET
ajlm-846	113	20	study	study	NOUN
ajlm-846	113	21	and	and	CCONJ
ajlm-846	113	22	it	it	PRON
ajlm-846	113	23	is	be	AUX
ajlm-846	113	24	,	,	PUNCT
ajlm-846	113	25	therefore	therefore	ADV
ajlm-846	113	26	,	,	PUNCT
ajlm-846	113	27	not	not	PART
ajlm-846	113	28	possible	possible	ADJ
ajlm-846	113	29	to	to	PART
ajlm-846	113	30	differentiate	differentiate	VERB
ajlm-846	113	31	between	between	ADP
ajlm-846	113	32	the	the	DET
ajlm-846	113	33	three	three	NUM
ajlm-846	113	34	different	different	ADJ
ajlm-846	113	35	transmission	transmission	NOUN
ajlm-846	113	36	relationships	relationship	NOUN
ajlm-846	113	37	in	in	ADP
ajlm-846	113	38	the	the	DET
ajlm-846	113	39	current	current	ADJ
ajlm-846	113	40	analysis	analysis	NOUN
ajlm-846	113	41	.	.	PUNCT
ajlm-846	114	1	nevertheless	nevertheless	ADV
ajlm-846	114	2	,	,	PUNCT
ajlm-846	114	3	the	the	DET
ajlm-846	114	4	isolation	isolation	NOUN
ajlm-846	114	5	of	of	ADP
ajlm-846	114	6	several	several	ADJ
ajlm-846	114	7	clonally	clonally	ADV
ajlm-846	114	8	related	relate	VERB
ajlm-846	114	9	strains	strain	NOUN
ajlm-846	114	10	from	from	ADP
ajlm-846	114	11	samples	sample	NOUN
ajlm-846	114	12	submitted	submit	VERB
ajlm-846	114	13	by	by	ADP
ajlm-846	114	14	patients	patient	NOUN
ajlm-846	114	15	in	in	ADP
ajlm-846	114	16	the	the	DET
ajlm-846	114	17	same	same	ADJ
ajlm-846	114	18	ward	ward	NOUN
ajlm-846	114	19	within	within	ADP
ajlm-846	114	20	a	a	DET
ajlm-846	114	21	28	28	NUM
ajlm-846	114	22	-	-	PUNCT
ajlm-846	114	23	day	day	NOUN
ajlm-846	114	24	time	time	NOUN
ajlm-846	114	25	interval	interval	NOUN
ajlm-846	114	26	suggests	suggest	VERB
ajlm-846	114	27	that	that	SCONJ
ajlm-846	114	28	ward	ward	VERB
ajlm-846	114	29	contact	contact	NOUN
ajlm-846	114	30	or	or	CCONJ
ajlm-846	114	31	ward	ward	NOUN
ajlm-846	114	32	contamination	contamination	NOUN
ajlm-846	114	33	occurred	occur	VERB
ajlm-846	114	34	along	along	ADP
ajlm-846	114	35	with	with	ADP
ajlm-846	114	36	possible	possible	ADJ
ajlm-846	114	37	hospital	hospital	NOUN
ajlm-846	114	38	contact	contact	NOUN
ajlm-846	114	39	for	for	ADP
ajlm-846	114	40	samples	sample	NOUN
ajlm-846	114	41	from	from	ADP
ajlm-846	114	42	patients	patient	NOUN
ajlm-846	114	43	occupying	occupy	VERB
ajlm-846	114	44	different	different	ADJ
ajlm-846	114	45	wards	ward	NOUN
ajlm-846	114	46	.	.	PUNCT
ajlm-846	115	1	interestingly	interestingly	ADV
ajlm-846	115	2	,	,	PUNCT
ajlm-846	115	3	strains	strain	VERB
ajlm-846	115	4	with	with	ADP
ajlm-846	115	5	identical	identical	ADJ
ajlm-846	115	6	mlva	mlva	ADJ
ajlm-846	115	7	profiles	profile	NOUN
ajlm-846	115	8	were	be	AUX
ajlm-846	115	9	also	also	ADV
ajlm-846	115	10	isolated	isolate	VERB
ajlm-846	115	11	from	from	ADP
ajlm-846	115	12	different	different	ADJ
ajlm-846	115	13	patients	patient	NOUN
ajlm-846	115	14	at	at	ADP
ajlm-846	115	15	longer	long	ADJ
ajlm-846	115	16	time	time	NOUN
ajlm-846	115	17	intervals	interval	NOUN
ajlm-846	115	18	of	of	ADP
ajlm-846	115	19	three	three	NUM
ajlm-846	115	20	to	to	PART
ajlm-846	115	21	seven	seven	NUM
ajlm-846	115	22	months	month	NOUN
ajlm-846	115	23	.	.	PUNCT
ajlm-846	116	1	this	this	PRON
ajlm-846	116	2	has	have	AUX
ajlm-846	116	3	been	be	AUX
ajlm-846	116	4	observed	observe	VERB
ajlm-846	116	5	previously55	previously55	NOUN
ajlm-846	116	6	and	and	CCONJ
ajlm-846	116	7	may	may	AUX
ajlm-846	116	8	be	be	AUX
ajlm-846	116	9	due	due	ADJ
ajlm-846	116	10	to	to	ADP
ajlm-846	116	11	the	the	DET
ajlm-846	116	12	formation	formation	NOUN
ajlm-846	116	13	of	of	ADP
ajlm-846	116	14	spores	spore	NOUN
ajlm-846	116	15	that	that	PRON
ajlm-846	116	16	persist	persist	VERB
ajlm-846	116	17	in	in	ADP
ajlm-846	116	18	a	a	DET
ajlm-846	116	19	genetically	genetically	ADV
ajlm-846	116	20	quiescent	quiescent	ADJ
ajlm-846	116	21	state	state	NOUN
ajlm-846	116	22	on	on	ADP
ajlm-846	116	23	surfaces	surface	NOUN
ajlm-846	116	24	in	in	ADP
ajlm-846	116	25	the	the	DET
ajlm-846	116	26	hospital	hospital	NOUN
ajlm-846	116	27	environment	environment	NOUN
ajlm-846	116	28	.	.	PUNCT
ajlm-846	117	1	metronidazole	metronidazole	PROPN
ajlm-846	117	2	is	be	AUX
ajlm-846	117	3	the	the	DET
ajlm-846	117	4	recommended	recommend	VERB
ajlm-846	117	5	antibiotic	antibiotic	NOUN
ajlm-846	117	6	for	for	ADP
ajlm-846	117	7	initial	initial	ADJ
ajlm-846	117	8	episodes	episode	NOUN
ajlm-846	117	9	of	of	ADP
ajlm-846	117	10	cdi	cdi	PROPN
ajlm-846	117	11	,	,	PUNCT
ajlm-846	117	12	with	with	ADP
ajlm-846	117	13	vancomycin	vancomycin	PROPN
ajlm-846	117	14	reserved	reserve	VERB
ajlm-846	117	15	for	for	ADP
ajlm-846	117	16	cases	case	NOUN
ajlm-846	117	17	that	that	PRON
ajlm-846	117	18	do	do	AUX
ajlm-846	117	19	not	not	PART
ajlm-846	117	20	respond	respond	VERB
ajlm-846	117	21	to	to	ADP
ajlm-846	117	22	initial	initial	ADJ
ajlm-846	117	23	treatment	treatment	NOUN
ajlm-846	117	24	and	and	CCONJ
ajlm-846	117	25	for	for	ADP
ajlm-846	117	26	cases	case	NOUN
ajlm-846	117	27	of	of	ADP
ajlm-846	117	28	recurrent	recurrent	ADJ
ajlm-846	117	29	disease	disease	NOUN
ajlm-846	117	30	.	.	PUNCT
ajlm-846	118	1	no	no	DET
ajlm-846	118	2	resistance	resistance	NOUN
ajlm-846	118	3	to	to	ADP
ajlm-846	118	4	either	either	PRON
ajlm-846	118	5	of	of	ADP
ajlm-846	118	6	these	these	DET
ajlm-846	118	7	antibiotics	antibiotic	NOUN
ajlm-846	118	8	was	be	AUX
ajlm-846	118	9	observed	observe	VERB
ajlm-846	118	10	for	for	ADP
ajlm-846	118	11	local	local	ADJ
ajlm-846	118	12	isolates	isolate	NOUN
ajlm-846	118	13	.	.	PUNCT
ajlm-846	119	1	however	however	ADV
ajlm-846	119	2	,	,	PUNCT
ajlm-846	119	3	a	a	DET
ajlm-846	119	4	small	small	ADJ
ajlm-846	119	5	number	number	NOUN
ajlm-846	119	6	of	of	ADP
ajlm-846	119	7	strains	strain	NOUN
ajlm-846	119	8	exhibited	exhibit	VERB
ajlm-846	119	9	a	a	DET
ajlm-846	119	10	slightly	slightly	ADV
ajlm-846	119	11	elevated	elevated	ADJ
ajlm-846	119	12	metronidazole	metronidazole	NOUN
ajlm-846	119	13	mic	mic	NOUN
ajlm-846	119	14	of	of	ADP
ajlm-846	119	15	4	4	NUM
ajlm-846	119	16	mg	mg	PROPN
ajlm-846	119	17	/	/	SYM
ajlm-846	119	18	l.	l.	NOUN
ajlm-846	119	19	this	this	PRON
ajlm-846	119	20	may	may	AUX
ajlm-846	119	21	be	be	AUX
ajlm-846	119	22	clinically	clinically	ADV
ajlm-846	119	23	relevant	relevant	ADJ
ajlm-846	119	24	as	as	SCONJ
ajlm-846	119	25	the	the	DET
ajlm-846	119	26	maximum	maximum	ADJ
ajlm-846	119	27	level	level	NOUN
ajlm-846	119	28	of	of	ADP
ajlm-846	119	29	metronidazole	metronidazole	NOUN
ajlm-846	119	30	that	that	PRON
ajlm-846	119	31	can	can	AUX
ajlm-846	119	32	be	be	AUX
ajlm-846	119	33	maintained	maintain	VERB
ajlm-846	119	34	in	in	ADP
ajlm-846	119	35	the	the	DET
ajlm-846	119	36	gut	gut	NOUN
ajlm-846	119	37	during	during	ADP
ajlm-846	119	38	oral	oral	ADJ
ajlm-846	119	39	therapy	therapy	NOUN
ajlm-846	119	40	ranges	range	VERB
ajlm-846	119	41	between	between	ADP
ajlm-846	119	42	0.25	0.25	NUM
ajlm-846	119	43	mg	mg	PROPN
ajlm-846	119	44	/	/	SYM
ajlm-846	119	45	l	l	NOUN
ajlm-846	119	46	and	and	CCONJ
ajlm-846	119	47	9.5	9.5	NUM
ajlm-846	119	48	mg	mg	NUM
ajlm-846	119	49	/	/	SYM
ajlm-846	119	50	l.1	l.1	PUNCT
ajlm-846	119	51	fidaxomicin	fidaxomicin	PROPN
ajlm-846	119	52	,	,	PUNCT
ajlm-846	119	53	an	an	DET
ajlm-846	119	54	alternative	alternative	ADJ
ajlm-846	119	55	treatment	treatment	NOUN
ajlm-846	119	56	for	for	ADP
ajlm-846	119	57	cdi	cdi	PROPN
ajlm-846	119	58	with	with	ADP
ajlm-846	119	59	a	a	DET
ajlm-846	119	60	narrow	narrow	ADJ
ajlm-846	119	61	spectrum	spectrum	NOUN
ajlm-846	119	62	of	of	ADP
ajlm-846	119	63	activity	activity	NOUN
ajlm-846	119	64	,	,	PUNCT
ajlm-846	119	65	is	be	AUX
ajlm-846	119	66	not	not	PART
ajlm-846	119	67	yet	yet	ADV
ajlm-846	119	68	widely	widely	ADV
ajlm-846	119	69	available	available	ADJ
ajlm-846	119	70	for	for	ADP
ajlm-846	119	71	use	use	NOUN
ajlm-846	119	72	in	in	ADP
ajlm-846	119	73	south	south	PROPN
ajlm-846	119	74	africa	africa	PROPN
ajlm-846	119	75	.	.	PUNCT
ajlm-846	120	1	apart	apart	ADV
ajlm-846	120	2	from	from	ADP
ajlm-846	120	3	one	one	NUM
ajlm-846	120	4	non	non	ADJ
ajlm-846	120	5	-	-	ADJ
ajlm-846	120	6	rt017	rt017	ADJ
ajlm-846	120	7	isolate	isolate	NOUN
ajlm-846	120	8	,	,	PUNCT
ajlm-846	120	9	all	all	DET
ajlm-846	120	10	c.	c.	NOUN
ajlm-846	120	11	difficile	difficile	VERB
ajlm-846	120	12	strains	strain	NOUN
ajlm-846	120	13	isolated	isolate	VERB
ajlm-846	120	14	from	from	ADP
ajlm-846	120	15	patients	patient	NOUN
ajlm-846	120	16	attending	attend	VERB
ajlm-846	120	17	specialist	specialist	ADJ
ajlm-846	120	18	tuberculosis	tuberculosis	NOUN
ajlm-846	120	19	hospitals	hospital	NOUN
ajlm-846	120	20	were	be	AUX
ajlm-846	120	21	resistant	resistant	ADJ
ajlm-846	120	22	to	to	ADP
ajlm-846	120	23	rifampicin	rifampicin	VERB
ajlm-846	120	24	.	.	PUNCT
ajlm-846	121	1	this	this	PRON
ajlm-846	121	2	included	include	VERB
ajlm-846	121	3	samples	sample	NOUN
ajlm-846	121	4	from	from	ADP
ajlm-846	121	5	both	both	PRON
ajlm-846	121	6	ds	ds	ADJ
ajlm-846	121	7	tuberculosis	tuberculosis	NOUN
ajlm-846	121	8	and	and	CCONJ
ajlm-846	121	9	mdr	mdr	NOUN
ajlm-846	121	10	tuberculosis	tuberculosis	NOUN
ajlm-846	121	11	patients	patient	NOUN
ajlm-846	121	12	and	and	CCONJ
ajlm-846	121	13	contrasts	contrast	VERB
ajlm-846	121	14	with	with	ADP
ajlm-846	121	15	a	a	DET
ajlm-846	121	16	concurrent	concurrent	ADJ
ajlm-846	121	17	set	set	NOUN
ajlm-846	121	18	of	of	ADP
ajlm-846	121	19	isolates	isolate	NOUN
ajlm-846	121	20	obtained	obtain	VERB
ajlm-846	121	21	from	from	ADP
ajlm-846	121	22	patients	patient	NOUN
ajlm-846	121	23	attending	attend	VERB
ajlm-846	121	24	other	other	ADJ
ajlm-846	121	25	hospitals	hospital	NOUN
ajlm-846	121	26	in	in	ADP
ajlm-846	121	27	the	the	DET
ajlm-846	121	28	cape	cape	NOUN
ajlm-846	121	29	town	town	NOUN
ajlm-846	121	30	area	area	NOUN
ajlm-846	121	31	(	(	PUNCT
ajlm-846	121	32	37	37	NUM
ajlm-846	121	33	%	%	NOUN
ajlm-846	121	34	of	of	ADP
ajlm-846	121	35	strains	strain	NOUN
ajlm-846	121	36	resistant	resistant	ADJ
ajlm-846	121	37	to	to	ADP
ajlm-846	121	38	rifampicin).30	rifampicin).30	VERB
ajlm-846	121	39	it	it	PRON
ajlm-846	121	40	is	be	AUX
ajlm-846	121	41	also	also	ADV
ajlm-846	121	42	higher	high	ADJ
ajlm-846	121	43	than	than	ADP
ajlm-846	121	44	that	that	PRON
ajlm-846	121	45	observed	observe	VERB
ajlm-846	121	46	for	for	ADP
ajlm-846	121	47	strains	strain	NOUN
ajlm-846	121	48	isolated	isolate	VERB
ajlm-846	121	49	from	from	ADP
ajlm-846	121	50	the	the	DET
ajlm-846	121	51	general	general	ADJ
ajlm-846	121	52	hospital	hospital	NOUN
ajlm-846	121	53	population	population	NOUN
ajlm-846	121	54	in	in	ADP
ajlm-846	121	55	europe	europe	PROPN
ajlm-846	121	56	(	(	PUNCT
ajlm-846	121	57	0	0	NUM
ajlm-846	121	58	%	%	NOUN
ajlm-846	121	59	–	–	PUNCT
ajlm-846	121	60	63.64%).42	63.64%).42	NUM
ajlm-846	121	61	rifampicin	rifampicin	VERB
ajlm-846	121	62	is	be	AUX
ajlm-846	121	63	included	include	VERB
ajlm-846	121	64	as	as	ADP
ajlm-846	121	65	part	part	NOUN
ajlm-846	121	66	of	of	ADP
ajlm-846	121	67	the	the	DET
ajlm-846	121	68	standard	standard	ADJ
ajlm-846	121	69	ds	ds	ADJ
ajlm-846	121	70	tuberculosis	tuberculosis	NOUN
ajlm-846	121	71	treatment	treatment	NOUN
ajlm-846	121	72	regimen	regiman	NOUN
ajlm-846	121	73	and	and	CCONJ
ajlm-846	121	74	exposure	exposure	NOUN
ajlm-846	121	75	to	to	ADP
ajlm-846	121	76	antibiotics	antibiotic	NOUN
ajlm-846	121	77	belonging	belong	VERB
ajlm-846	121	78	to	to	ADP
ajlm-846	121	79	this	this	DET
ajlm-846	121	80	class	class	NOUN
ajlm-846	121	81	has	have	AUX
ajlm-846	121	82	been	be	AUX
ajlm-846	121	83	associated	associate	VERB
ajlm-846	121	84	with	with	ADP
ajlm-846	121	85	the	the	DET
ajlm-846	121	86	development	development	NOUN
ajlm-846	121	87	of	of	ADP
ajlm-846	121	88	resistance	resistance	NOUN
ajlm-846	121	89	in	in	ADP
ajlm-846	121	90	c.	c.	NOUN
ajlm-846	121	91	difficile.56	difficile.56	VERB
ajlm-846	121	92	similar	similar	ADJ
ajlm-846	121	93	results	result	NOUN
ajlm-846	121	94	have	have	AUX
ajlm-846	121	95	been	be	AUX
ajlm-846	121	96	observed	observe	VERB
ajlm-846	121	97	for	for	ADP
ajlm-846	121	98	rt046	rt046	NOUN
ajlm-846	121	99	strains	strain	NOUN
ajlm-846	121	100	isolated	isolate	VERB
ajlm-846	121	101	from	from	ADP
ajlm-846	121	102	a	a	DET
ajlm-846	121	103	tuberculosis	tuberculosis	NOUN
ajlm-846	121	104	hospital	hospital	NOUN
ajlm-846	121	105	population	population	NOUN
ajlm-846	121	106	in	in	ADP
ajlm-846	121	107	poland.16	poland.16	PROPN
ajlm-846	121	108	resistance	resistance	NOUN
ajlm-846	121	109	to	to	ADP
ajlm-846	121	110	rifamycin	rifamycin	NOUN
ajlm-846	121	111	in	in	ADP
ajlm-846	121	112	c.	c.	PROPN
ajlm-846	121	113	difficile	difficile	PROPN
ajlm-846	121	114	is	be	AUX
ajlm-846	121	115	usually	usually	ADV
ajlm-846	121	116	associated	associate	VERB
ajlm-846	121	117	with	with	ADP
ajlm-846	121	118	mutations	mutation	NOUN
ajlm-846	121	119	in	in	ADP
ajlm-846	121	120	the	the	DET
ajlm-846	121	121	rpob	rpob	PROPN
ajlm-846	121	122	gene	gene	NOUN
ajlm-846	121	123	,	,	PUNCT
ajlm-846	121	124	which	which	PRON
ajlm-846	121	125	typically	typically	ADV
ajlm-846	121	126	confer	confer	VERB
ajlm-846	121	127	cross	cross	NOUN
ajlm-846	121	128	-	-	NOUN
ajlm-846	121	129	resistance	resistance	NOUN
ajlm-846	121	130	to	to	ADP
ajlm-846	121	131	multiple	multiple	ADJ
ajlm-846	121	132	members	member	NOUN
ajlm-846	121	133	of	of	ADP
ajlm-846	121	134	the	the	DET
ajlm-846	121	135	antibiotic	antibiotic	ADJ
ajlm-846	121	136	class	class	NOUN
ajlm-846	121	137	and	and	CCONJ
ajlm-846	121	138	,	,	PUNCT
ajlm-846	121	139	importantly	importantly	ADV
ajlm-846	121	140	,	,	PUNCT
ajlm-846	121	141	are	be	AUX
ajlm-846	121	142	associated	associate	VERB
ajlm-846	121	143	with	with	ADP
ajlm-846	121	144	a	a	DET
ajlm-846	121	145	low	low	ADJ
ajlm-846	121	146	fitness	fitness	NOUN
ajlm-846	121	147	burden	burden	NOUN
ajlm-846	121	148	,	,	PUNCT
ajlm-846	121	149	allowing	allow	VERB
ajlm-846	121	150	the	the	DET
ajlm-846	121	151	phenotype	phenotype	NOUN
ajlm-846	121	152	to	to	PART
ajlm-846	121	153	be	be	AUX
ajlm-846	121	154	stably	stably	ADV
ajlm-846	121	155	maintained	maintain	VERB
ajlm-846	121	156	in	in	ADP
ajlm-846	121	157	the	the	DET
ajlm-846	121	158	bacterial	bacterial	ADJ
ajlm-846	121	159	population.57	population.57	ADJ
ajlm-846	121	160	fluoroquinolone	fluoroquinolone	NOUN
ajlm-846	121	161	resistance	resistance	NOUN
ajlm-846	121	162	was	be	AUX
ajlm-846	121	163	also	also	ADV
ajlm-846	121	164	common	common	ADJ
ajlm-846	121	165	among	among	ADP
ajlm-846	121	166	c.	c.	NOUN
ajlm-846	121	167	difficile	difficile	PROPN
ajlm-846	121	168	strains	strain	NOUN
ajlm-846	121	169	isolated	isolate	VERB
ajlm-846	121	170	from	from	ADP
ajlm-846	121	171	tuberculosis	tuberculosis	NOUN
ajlm-846	121	172	patients	patient	NOUN
ajlm-846	121	173	.	.	PUNCT
ajlm-846	122	1	previous	previous	ADJ
ajlm-846	122	2	exposure	exposure	NOUN
ajlm-846	122	3	to	to	ADP
ajlm-846	122	4	fluoroquinolones	fluoroquinolone	NOUN
ajlm-846	122	5	is	be	AUX
ajlm-846	122	6	a	a	DET
ajlm-846	122	7	recognised	recognise	VERB
ajlm-846	122	8	risk	risk	NOUN
ajlm-846	122	9	factor	factor	NOUN
ajlm-846	122	10	for	for	ADP
ajlm-846	122	11	the	the	DET
ajlm-846	122	12	development	development	NOUN
ajlm-846	122	13	of	of	ADP
ajlm-846	122	14	cdi	cdi	PROPN
ajlm-846	122	15	,	,	PUNCT
ajlm-846	122	16	and	and	CCONJ
ajlm-846	122	17	it	it	PRON
ajlm-846	122	18	is	be	AUX
ajlm-846	122	19	thought	think	VERB
ajlm-846	122	20	that	that	SCONJ
ajlm-846	122	21	acquisition	acquisition	NOUN
ajlm-846	122	22	of	of	ADP
ajlm-846	122	23	resistance	resistance	NOUN
ajlm-846	122	24	to	to	ADP
ajlm-846	122	25	third	third	ADJ
ajlm-846	122	26	and	and	CCONJ
ajlm-846	122	27	fourth	fourth	ADJ
ajlm-846	122	28	generation	generation	NOUN
ajlm-846	122	29	fluoroquinolones	fluoroquinolone	NOUN
ajlm-846	122	30	by	by	ADP
ajlm-846	122	31	rt027	rt027	PROPN
ajlm-846	122	32	strains	strain	NOUN
ajlm-846	122	33	was	be	AUX
ajlm-846	122	34	a	a	DET
ajlm-846	122	35	contributing	contribute	VERB
ajlm-846	122	36	factor	factor	NOUN
ajlm-846	122	37	to	to	ADP
ajlm-846	122	38	several	several	ADJ
ajlm-846	122	39	hospital	hospital	NOUN
ajlm-846	122	40	outbreaks	outbreak	NOUN
ajlm-846	122	41	in	in	ADP
ajlm-846	122	42	north	north	PROPN
ajlm-846	122	43	america	america	PROPN
ajlm-846	122	44	during	during	ADP
ajlm-846	122	45	the	the	DET
ajlm-846	122	46	early	early	ADJ
ajlm-846	122	47	2000s.4,58	2000s.4,58	NUM
ajlm-846	122	48	in	in	ADP
ajlm-846	122	49	south	south	PROPN
ajlm-846	122	50	africa	africa	PROPN
ajlm-846	122	51	,	,	PUNCT
ajlm-846	122	52	moxifloxacin	moxifloxacin	PROPN
ajlm-846	122	53	is	be	AUX
ajlm-846	122	54	included	include	VERB
ajlm-846	122	55	as	as	ADP
ajlm-846	122	56	part	part	NOUN
ajlm-846	122	57	of	of	ADP
ajlm-846	122	58	the	the	DET
ajlm-846	122	59	mdr	mdr	PROPN
ajlm-846	123	1	tuberculosis	tuberculosis	NOUN
ajlm-846	123	2	treatment	treatment	NOUN
ajlm-846	123	3	regimen	regiman	NOUN
ajlm-846	123	4	,	,	PUNCT
ajlm-846	123	5	and	and	CCONJ
ajlm-846	123	6	all	all	DET
ajlm-846	123	7	c.	c.	NOUN
ajlm-846	123	8	difficile	difficile	VERB
ajlm-846	123	9	strains	strain	NOUN
ajlm-846	123	10	isolated	isolate	VERB
ajlm-846	123	11	from	from	ADP
ajlm-846	123	12	mdr	mdr	PROPN
ajlm-846	124	1	tuberculosis	tuberculosis	NOUN
ajlm-846	124	2	patients	patient	NOUN
ajlm-846	124	3	were	be	AUX
ajlm-846	124	4	resistant	resistant	ADJ
ajlm-846	124	5	to	to	ADP
ajlm-846	124	6	the	the	DET
ajlm-846	124	7	antibiotic	antibiotic	NOUN
ajlm-846	124	8	.	.	PUNCT
ajlm-846	125	1	resistance	resistance	NOUN
ajlm-846	125	2	to	to	ADP
ajlm-846	125	3	fluoroquinolones	fluoroquinolone	NOUN
ajlm-846	125	4	in	in	ADP
ajlm-846	125	5	c.	c.	PROPN
ajlm-846	125	6	difficile	difficile	PROPN
ajlm-846	125	7	is	be	AUX
ajlm-846	125	8	chromosomally	chromosomally	ADV
ajlm-846	125	9	encoded,59	encoded,59	VERB
ajlm-846	125	10	readily	readily	ADV
ajlm-846	125	11	develops	develop	VERB
ajlm-846	125	12	following	follow	VERB
ajlm-846	125	13	exposure	exposure	NOUN
ajlm-846	125	14	to	to	ADP
ajlm-846	125	15	this	this	DET
ajlm-846	125	16	class	class	NOUN
ajlm-846	125	17	of	of	ADP
ajlm-846	125	18	antibiotics60	antibiotics60	NOUN
ajlm-846	125	19	and	and	CCONJ
ajlm-846	125	20	is	be	AUX
ajlm-846	125	21	associated	associate	VERB
ajlm-846	125	22	with	with	ADP
ajlm-846	125	23	a	a	DET
ajlm-846	125	24	low	low	ADJ
ajlm-846	125	25	fitness	fitness	NOUN
ajlm-846	125	26	cost	cost	NOUN
ajlm-846	125	27	to	to	ADP
ajlm-846	125	28	the	the	DET
ajlm-846	125	29	bacterium.61	bacterium.61	NOUN
ajlm-846	125	30	therefore	therefore	ADV
ajlm-846	125	31	,	,	PUNCT
ajlm-846	125	32	the	the	DET
ajlm-846	125	33	development	development	NOUN
ajlm-846	125	34	of	of	ADP
ajlm-846	125	35	resistance	resistance	NOUN
ajlm-846	125	36	to	to	ADP
ajlm-846	125	37	fluoroquinolones	fluoroquinolone	NOUN
ajlm-846	125	38	,	,	PUNCT
ajlm-846	125	39	as	as	ADV
ajlm-846	125	40	well	well	ADV
ajlm-846	125	41	as	as	ADP
ajlm-846	125	42	rifampicin	rifampicin	VERB
ajlm-846	125	43	,	,	PUNCT
ajlm-846	125	44	is	be	AUX
ajlm-846	125	45	likely	likely	ADJ
ajlm-846	125	46	to	to	PART
ajlm-846	125	47	be	be	AUX
ajlm-846	125	48	stably	stably	ADV
ajlm-846	125	49	maintained	maintain	VERB
ajlm-846	125	50	in	in	ADP
ajlm-846	125	51	the	the	DET
ajlm-846	125	52	c.	c.	NOUN
ajlm-846	125	53	difficile	difficile	PROPN
ajlm-846	125	54	population	population	NOUN
ajlm-846	125	55	circulating	circulate	VERB
ajlm-846	125	56	among	among	ADP
ajlm-846	125	57	tuberculosis	tuberculosis	NOUN
ajlm-846	125	58	patients	patient	NOUN
ajlm-846	125	59	.	.	PUNCT
ajlm-846	126	1	one	one	NUM
ajlm-846	126	2	reason	reason	NOUN
ajlm-846	126	3	proposed	propose	VERB
ajlm-846	126	4	for	for	ADP
ajlm-846	126	5	the	the	DET
ajlm-846	126	6	relatively	relatively	ADV
ajlm-846	126	7	low	low	ADJ
ajlm-846	126	8	rates	rate	NOUN
ajlm-846	126	9	of	of	ADP
ajlm-846	126	10	cdi	cdi	PROPN
ajlm-846	126	11	in	in	ADP
ajlm-846	126	12	patients	patient	NOUN
ajlm-846	126	13	undergoing	undergo	VERB
ajlm-846	126	14	anti	anti	ADJ
ajlm-846	126	15	-	-	ADJ
ajlm-846	126	16	tuberculosis	tuberculosis	ADJ
ajlm-846	126	17	therapy	therapy	NOUN
ajlm-846	126	18	in	in	ADP
ajlm-846	126	19	previous	previous	ADJ
ajlm-846	126	20	studies	study	NOUN
ajlm-846	126	21	is	be	AUX
ajlm-846	126	22	that	that	SCONJ
ajlm-846	126	23	rifampicin	rifampicin	VERB
ajlm-846	126	24	is	be	AUX
ajlm-846	126	25	often	often	ADV
ajlm-846	126	26	effective	effective	ADJ
ajlm-846	126	27	against	against	ADP
ajlm-846	126	28	c.	c.	NOUN
ajlm-846	126	29	difficile	difficile	NOUN
ajlm-846	126	30	and	and	CCONJ
ajlm-846	126	31	may	may	AUX
ajlm-846	126	32	help	help	VERB
ajlm-846	126	33	to	to	PART
ajlm-846	126	34	protect	protect	VERB
ajlm-846	126	35	against	against	ADP
ajlm-846	126	36	cdi	cdi	PROPN
ajlm-846	126	37	in	in	ADP
ajlm-846	126	38	these	these	DET
ajlm-846	126	39	patients.20	patients.20	NOUN
ajlm-846	126	40	since	since	SCONJ
ajlm-846	126	41	this	this	DET
ajlm-846	126	42	protection	protection	NOUN
ajlm-846	126	43	would	would	AUX
ajlm-846	126	44	be	be	AUX
ajlm-846	126	45	lacking	lack	VERB
ajlm-846	126	46	in	in	ADP
ajlm-846	126	47	a	a	DET
ajlm-846	126	48	background	background	NOUN
ajlm-846	126	49	of	of	ADP
ajlm-846	126	50	circulating	circulate	VERB
ajlm-846	126	51	rifampicin	rifampicin	NOUN
ajlm-846	126	52	-	-	PUNCT
ajlm-846	126	53	resistant	resistant	ADJ
ajlm-846	126	54	strains	strain	NOUN
ajlm-846	126	55	,	,	PUNCT
ajlm-846	126	56	the	the	DET
ajlm-846	126	57	presence	presence	NOUN
ajlm-846	126	58	of	of	ADP
ajlm-846	126	59	rifampicin	rifampicin	VERB
ajlm-846	126	60	resistance	resistance	NOUN
ajlm-846	126	61	among	among	ADP
ajlm-846	126	62	the	the	DET
ajlm-846	126	63	rt017	rt017	PROPN
ajlm-846	126	64	isolates	isolate	NOUN
ajlm-846	126	65	in	in	ADP
ajlm-846	126	66	the	the	DET
ajlm-846	126	67	current	current	ADJ
ajlm-846	126	68	study	study	NOUN
ajlm-846	126	69	is	be	AUX
ajlm-846	126	70	significant	significant	ADJ
ajlm-846	126	71	.	.	PUNCT
ajlm-846	127	1	moreover	moreover	ADV
ajlm-846	127	2	,	,	PUNCT
ajlm-846	127	3	co	co	NOUN
ajlm-846	127	4	-	-	NOUN
ajlm-846	127	5	resistance	resistance	NOUN
ajlm-846	127	6	to	to	ADP
ajlm-846	127	7	fourth	fourth	ADJ
ajlm-846	127	8	generation	generation	NOUN
ajlm-846	127	9	fluoroquinolones	fluoroquinolone	NOUN
ajlm-846	127	10	would	would	AUX
ajlm-846	127	11	allow	allow	VERB
ajlm-846	127	12	the	the	DET
ajlm-846	127	13	same	same	ADJ
ajlm-846	127	14	strains	strain	NOUN
ajlm-846	127	15	to	to	PART
ajlm-846	127	16	persist	persist	VERB
ajlm-846	127	17	in	in	ADP
ajlm-846	127	18	patients	patient	NOUN
ajlm-846	127	19	undergoing	undergo	VERB
ajlm-846	127	20	mdr	mdr	PROPN
ajlm-846	127	21	tuberculosis	tuberculosis	NOUN
ajlm-846	127	22	treatment	treatment	NOUN
ajlm-846	127	23	regimens	regimen	NOUN
ajlm-846	127	24	.	.	PUNCT
ajlm-846	128	1	together	together	ADV
ajlm-846	128	2	,	,	PUNCT
ajlm-846	128	3	these	these	DET
ajlm-846	128	4	results	result	NOUN
ajlm-846	128	5	may	may	AUX
ajlm-846	128	6	help	help	VERB
ajlm-846	128	7	to	to	PART
ajlm-846	128	8	explain	explain	VERB
ajlm-846	128	9	the	the	DET
ajlm-846	128	10	increased	increase	VERB
ajlm-846	128	11	risk	risk	NOUN
ajlm-846	128	12	of	of	ADP
ajlm-846	128	13	cdi	cdi	PROPN
ajlm-846	128	14	in	in	ADP
ajlm-846	128	15	tuberculosis	tuberculosis	NUM
ajlm-846	128	16	patients	patient	NOUN
ajlm-846	128	17	in	in	ADP
ajlm-846	128	18	cape	cape	NOUN
ajlm-846	128	19	town22	town22	NOUN
ajlm-846	128	20	compared	compare	VERB
ajlm-846	128	21	to	to	ADP
ajlm-846	128	22	previous	previous	ADJ
ajlm-846	128	23	studies	study	NOUN
ajlm-846	128	24	in	in	ADP
ajlm-846	128	25	hong	hong	PROPN
ajlm-846	128	26	kong20	kong20	NOUN
ajlm-846	128	27	and	and	CCONJ
ajlm-846	128	28	korea21	korea21	VERB
ajlm-846	128	29	and	and	CCONJ
ajlm-846	128	30	confirm	confirm	VERB
ajlm-846	128	31	the	the	DET
ajlm-846	128	32	need	need	NOUN
ajlm-846	128	33	to	to	PART
ajlm-846	128	34	monitor	monitor	VERB
ajlm-846	128	35	this	this	DET
ajlm-846	128	36	patient	patient	ADJ
ajlm-846	128	37	population	population	NOUN
ajlm-846	128	38	more	more	ADV
ajlm-846	128	39	carefully	carefully	ADV
ajlm-846	128	40	.	.	PUNCT
ajlm-846	129	1	limitations	limitation	NOUN
ajlm-846	129	2	there	there	PRON
ajlm-846	129	3	are	be	VERB
ajlm-846	129	4	several	several	ADJ
ajlm-846	129	5	limitations	limitation	NOUN
ajlm-846	129	6	to	to	ADP
ajlm-846	129	7	the	the	DET
ajlm-846	129	8	current	current	ADJ
ajlm-846	129	9	study	study	NOUN
ajlm-846	129	10	.	.	PUNCT
ajlm-846	130	1	as	as	SCONJ
ajlm-846	130	2	mentioned	mention	VERB
ajlm-846	130	3	,	,	PUNCT
ajlm-846	130	4	detailed	detailed	ADJ
ajlm-846	130	5	ward	ward	NOUN
ajlm-846	130	6	occupation	occupation	NOUN
ajlm-846	130	7	data	datum	NOUN
ajlm-846	130	8	were	be	AUX
ajlm-846	130	9	not	not	PART
ajlm-846	130	10	available	available	ADJ
ajlm-846	130	11	,	,	PUNCT
ajlm-846	130	12	and	and	CCONJ
ajlm-846	130	13	this	this	PRON
ajlm-846	130	14	will	will	AUX
ajlm-846	130	15	need	need	VERB
ajlm-846	130	16	to	to	PART
ajlm-846	130	17	be	be	AUX
ajlm-846	130	18	collected	collect	VERB
ajlm-846	130	19	in	in	ADP
ajlm-846	130	20	future	future	ADJ
ajlm-846	130	21	analyses	analysis	NOUN
ajlm-846	130	22	to	to	PART
ajlm-846	130	23	identify	identify	VERB
ajlm-846	130	24	various	various	ADJ
ajlm-846	130	25	potential	potential	ADJ
ajlm-846	130	26	strain	strain	NOUN
ajlm-846	130	27	transmission	transmission	NOUN
ajlm-846	130	28	routes	route	NOUN
ajlm-846	130	29	.	.	PUNCT
ajlm-846	131	1	additionally	additionally	ADV
ajlm-846	131	2	,	,	PUNCT
ajlm-846	131	3	while	while	SCONJ
ajlm-846	131	4	mlva	mlva	PROPN
ajlm-846	131	5	has	have	AUX
ajlm-846	131	6	previously	previously	ADV
ajlm-846	131	7	been	be	AUX
ajlm-846	131	8	shown	show	VERB
ajlm-846	131	9	to	to	PART
ajlm-846	131	10	be	be	AUX
ajlm-846	131	11	as	as	ADV
ajlm-846	131	12	sensitive	sensitive	ADJ
ajlm-846	131	13	as	as	ADP
ajlm-846	131	14	whole	whole	ADJ
ajlm-846	131	15	genome	genome	NOUN
ajlm-846	131	16	sequencing	sequencing	NOUN
ajlm-846	131	17	in	in	ADP
ajlm-846	131	18	tracking	track	VERB
ajlm-846	131	19	c.	c.	NOUN
ajlm-846	131	20	difficile	difficile	VERB
ajlm-846	131	21	transmission,38	transmission,38	NUM
ajlm-846	131	22	it	it	PRON
ajlm-846	131	23	has	have	AUX
ajlm-846	131	24	been	be	AUX
ajlm-846	131	25	noted	note	VERB
ajlm-846	131	26	that	that	SCONJ
ajlm-846	131	27	rt017	rt017	PROPN
ajlm-846	131	28	strains	strain	NOUN
ajlm-846	131	29	show	show	VERB
ajlm-846	131	30	very	very	ADV
ajlm-846	131	31	little	little	ADJ
ajlm-846	131	32	variation	variation	NOUN
ajlm-846	131	33	for	for	ADP
ajlm-846	131	34	several	several	ADJ
ajlm-846	131	35	of	of	ADP
ajlm-846	131	36	the	the	DET
ajlm-846	131	37	loci	loci	NOUN
ajlm-846	131	38	included	include	VERB
ajlm-846	131	39	in	in	ADP
ajlm-846	131	40	the	the	DET
ajlm-846	131	41	scheme,30,35	scheme,30,35	NOUN
ajlm-846	131	42	suggesting	suggest	VERB
ajlm-846	131	43	that	that	SCONJ
ajlm-846	131	44	the	the	DET
ajlm-846	131	45	method	method	NOUN
ajlm-846	131	46	may	may	AUX
ajlm-846	131	47	not	not	PART
ajlm-846	131	48	be	be	AUX
ajlm-846	131	49	suitable	suitable	ADJ
ajlm-846	131	50	for	for	ADP
ajlm-846	131	51	examining	examine	VERB
ajlm-846	131	52	rt017	rt017	PROPN
ajlm-846	131	53	transmission	transmission	NOUN
ajlm-846	131	54	dynamics	dynamic	NOUN
ajlm-846	131	55	.	.	PUNCT
ajlm-846	132	1	therefore	therefore	ADV
ajlm-846	132	2	,	,	PUNCT
ajlm-846	132	3	we	we	PRON
ajlm-846	132	4	are	be	AUX
ajlm-846	132	5	currently	currently	ADV
ajlm-846	132	6	performing	perform	VERB
ajlm-846	132	7	whole	whole	ADJ
ajlm-846	132	8	genome	genome	NOUN
ajlm-846	132	9	sequencing	sequencing	NOUN
ajlm-846	132	10	on	on	ADP
ajlm-846	132	11	selected	select	VERB
ajlm-846	132	12	isolates	isolate	NOUN
ajlm-846	132	13	to	to	PART
ajlm-846	132	14	determine	determine	VERB
ajlm-846	132	15	the	the	DET
ajlm-846	132	16	fine	fine	ADJ
ajlm-846	132	17	-	-	PUNCT
ajlm-846	132	18	scale	scale	NOUN
ajlm-846	132	19	molecular	molecular	ADJ
ajlm-846	132	20	epidemiology	epidemiology	NOUN
ajlm-846	132	21	of	of	ADP
ajlm-846	132	22	local	local	ADJ
ajlm-846	132	23	rt017	rt017	PROPN
ajlm-846	132	24	strains	strain	VERB
ajlm-846	132	25	in	in	ADP
ajlm-846	132	26	order	order	NOUN
ajlm-846	132	27	to	to	PART
ajlm-846	132	28	complement	complement	VERB
ajlm-846	132	29	the	the	DET
ajlm-846	132	30	mlva	mlva	ADJ
ajlm-846	132	31	results	result	NOUN
ajlm-846	132	32	.	.	PUNCT
ajlm-846	133	1	conclusion	conclusion	VERB
ajlm-846	133	2	the	the	DET
ajlm-846	133	3	presence	presence	NOUN
ajlm-846	133	4	of	of	ADP
ajlm-846	133	5	a	a	DET
ajlm-846	133	6	relatively	relatively	ADV
ajlm-846	133	7	large	large	ADJ
ajlm-846	133	8	number	number	NOUN
ajlm-846	133	9	of	of	ADP
ajlm-846	133	10	mdr	mdr	PROPN
ajlm-846	133	11	rt017	rt017	PROPN
ajlm-846	133	12	c.	c.	PROPN
ajlm-846	133	13	difficile	difficile	VERB
ajlm-846	133	14	strains	strain	NOUN
ajlm-846	133	15	in	in	ADP
ajlm-846	133	16	patients	patient	NOUN
ajlm-846	133	17	attending	attend	VERB
ajlm-846	133	18	specialist	specialist	ADJ
ajlm-846	133	19	tuberculosis	tuberculosis	NOUN
ajlm-846	133	20	hospitals	hospital	NOUN
ajlm-846	133	21	in	in	ADP
ajlm-846	133	22	cape	cape	NOUN
ajlm-846	133	23	town	town	NOUN
ajlm-846	133	24	is	be	AUX
ajlm-846	133	25	noteworthy	noteworthy	ADJ
ajlm-846	133	26	,	,	PUNCT
ajlm-846	133	27	especially	especially	ADV
ajlm-846	133	28	given	give	VERB
ajlm-846	133	29	their	their	PRON
ajlm-846	133	30	potential	potential	NOUN
ajlm-846	133	31	to	to	PART
ajlm-846	133	32	cause	cause	VERB
ajlm-846	133	33	outbreaks	outbreak	NOUN
ajlm-846	133	34	.	.	PUNCT
ajlm-846	134	1	many	many	ADJ
ajlm-846	134	2	of	of	ADP
ajlm-846	134	3	the	the	DET
ajlm-846	134	4	isolates	isolate	NOUN
ajlm-846	134	5	were	be	AUX
ajlm-846	134	6	closely	closely	ADV
ajlm-846	134	7	related	relate	VERB
ajlm-846	134	8	by	by	ADP
ajlm-846	134	9	mlva	mlva	NOUN
ajlm-846	134	10	,	,	PUNCT
ajlm-846	134	11	and	and	CCONJ
ajlm-846	134	12	there	there	PRON
ajlm-846	134	13	is	be	VERB
ajlm-846	134	14	some	some	DET
ajlm-846	134	15	evidence	evidence	NOUN
ajlm-846	134	16	to	to	PART
ajlm-846	134	17	suggest	suggest	VERB
ajlm-846	134	18	that	that	SCONJ
ajlm-846	134	19	patient	patient	NOUN
ajlm-846	134	20	-	-	PUNCT
ajlm-846	134	21	to	to	ADP
ajlm-846	134	22	-	-	PUNCT
ajlm-846	134	23	patient	patient	NOUN
ajlm-846	134	24	transfer	transfer	NOUN
ajlm-846	134	25	of	of	ADP
ajlm-846	134	26	strains	strain	NOUN
ajlm-846	134	27	took	take	VERB
ajlm-846	134	28	place	place	NOUN
ajlm-846	134	29	during	during	ADP
ajlm-846	134	30	the	the	DET
ajlm-846	134	31	study	study	NOUN
ajlm-846	134	32	period	period	NOUN
ajlm-846	134	33	.	.	PUNCT
ajlm-846	135	1	tuberculosis	tuberculosis	NOUN
ajlm-846	135	2	patients	patient	NOUN
ajlm-846	135	3	,	,	PUNCT
ajlm-846	135	4	many	many	ADJ
ajlm-846	135	5	of	of	ADP
ajlm-846	135	6	whom	whom	PRON
ajlm-846	135	7	are	be	AUX
ajlm-846	135	8	co	co	VERB
ajlm-846	135	9	-	-	VERB
ajlm-846	135	10	infected	infected	ADJ
ajlm-846	135	11	with	with	ADP
ajlm-846	135	12	hiv	hiv	PROPN
ajlm-846	135	13	,	,	PUNCT
ajlm-846	135	14	may	may	AUX
ajlm-846	135	15	represent	represent	VERB
ajlm-846	135	16	a	a	DET
ajlm-846	135	17	population	population	NOUN
ajlm-846	135	18	that	that	PRON
ajlm-846	135	19	is	be	AUX
ajlm-846	135	20	vulnerable	vulnerable	ADJ
ajlm-846	135	21	to	to	ADP
ajlm-846	135	22	cdi	cdi	PROPN
ajlm-846	135	23	and	and	CCONJ
ajlm-846	135	24	further	further	ADJ
ajlm-846	135	25	studies	study	NOUN
ajlm-846	135	26	should	should	AUX
ajlm-846	135	27	be	be	AUX
ajlm-846	135	28	undertaken	undertake	VERB
ajlm-846	135	29	to	to	PART
ajlm-846	135	30	evaluate	evaluate	VERB
ajlm-846	135	31	the	the	DET
ajlm-846	135	32	risk	risk	NOUN
ajlm-846	135	33	in	in	ADP
ajlm-846	135	34	this	this	DET
ajlm-846	135	35	patient	patient	NOUN
ajlm-846	135	36	group	group	NOUN
ajlm-846	135	37	.	.	PUNCT
ajlm-846	136	1	additionally	additionally	ADV
ajlm-846	136	2	,	,	PUNCT
ajlm-846	136	3	the	the	DET
ajlm-846	136	4	propensity	propensity	NOUN
ajlm-846	136	5	of	of	ADP
ajlm-846	136	6	c.	c.	PROPN
ajlm-846	136	7	difficile	difficile	VERB
ajlm-846	136	8	to	to	PART
ajlm-846	136	9	form	form	VERB
ajlm-846	136	10	highly	highly	ADV
ajlm-846	136	11	resistant	resistant	ADJ
ajlm-846	136	12	spores	spore	NOUN
ajlm-846	136	13	that	that	PRON
ajlm-846	136	14	are	be	AUX
ajlm-846	136	15	continually	continually	ADV
ajlm-846	136	16	shed	shed	VERB
ajlm-846	136	17	by	by	ADP
ajlm-846	136	18	individuals	individual	NOUN
ajlm-846	136	19	with	with	ADP
ajlm-846	136	20	cdi	cdi	PROPN
ajlm-846	136	21	warrants	warrant	NOUN
ajlm-846	136	22	additional	additional	ADJ
ajlm-846	136	23	studies	study	NOUN
ajlm-846	136	24	to	to	PART
ajlm-846	136	25	investigate	investigate	VERB
ajlm-846	136	26	potential	potential	ADJ
ajlm-846	136	27	contamination	contamination	NOUN
ajlm-846	136	28	of	of	ADP
ajlm-846	136	29	surfaces	surface	NOUN
ajlm-846	136	30	present	present	ADJ
ajlm-846	136	31	in	in	ADP
ajlm-846	136	32	the	the	DET
ajlm-846	136	33	hospital	hospital	NOUN
ajlm-846	136	34	environment	environment	NOUN
ajlm-846	136	35	.	.	PUNCT
ajlm-846	137	1	tuberculosis	tuberculosis	NOUN
ajlm-846	137	2	patients	patient	NOUN
ajlm-846	137	3	who	who	PRON
ajlm-846	137	4	do	do	AUX
ajlm-846	137	5	not	not	PART
ajlm-846	137	6	go	go	VERB
ajlm-846	137	7	on	on	ADP
ajlm-846	137	8	to	to	PART
ajlm-846	137	9	develop	develop	VERB
ajlm-846	137	10	active	active	ADJ
ajlm-846	137	11	cdi	cdi	PROPN
ajlm-846	137	12	may	may	AUX
ajlm-846	137	13	still	still	ADV
ajlm-846	137	14	be	be	AUX
ajlm-846	137	15	colonised	colonise	VERB
ajlm-846	137	16	and	and	CCONJ
ajlm-846	137	17	subsequently	subsequently	ADV
ajlm-846	137	18	become	become	VERB
ajlm-846	137	19	carriers	carrier	NOUN
ajlm-846	137	20	of	of	ADP
ajlm-846	137	21	the	the	DET
ajlm-846	137	22	organism	organism	NOUN
ajlm-846	137	23	to	to	ADP
ajlm-846	137	24	the	the	DET
ajlm-846	137	25	community	community	NOUN
ajlm-846	137	26	or	or	CCONJ
ajlm-846	137	27	other	other	ADJ
ajlm-846	137	28	healthcare	healthcare	NOUN
ajlm-846	137	29	facilities	facility	NOUN
ajlm-846	137	30	.	.	PUNCT
ajlm-846	138	1	finally	finally	ADV
ajlm-846	138	2	,	,	PUNCT
ajlm-846	138	3	information	information	NOUN
ajlm-846	138	4	regarding	regard	VERB
ajlm-846	138	5	c.	c.	NOUN
ajlm-846	138	6	difficile	difficile	NOUN
ajlm-846	138	7	in	in	ADP
ajlm-846	138	8	other	other	ADJ
ajlm-846	138	9	sub	sub	ADJ
ajlm-846	138	10	-	-	ADJ
ajlm-846	138	11	saharan	saharan	ADJ
ajlm-846	138	12	countries	country	NOUN
ajlm-846	138	13	is	be	AUX
ajlm-846	138	14	currently	currently	ADV
ajlm-846	138	15	lacking	lack	VERB
ajlm-846	138	16	and	and	CCONJ
ajlm-846	138	17	further	further	ADJ
ajlm-846	138	18	research	research	NOUN
ajlm-846	138	19	is	be	AUX
ajlm-846	138	20	needed	need	VERB
ajlm-846	138	21	to	to	PART
ajlm-846	138	22	understand	understand	VERB
ajlm-846	138	23	the	the	DET
ajlm-846	138	24	epidemiology	epidemiology	NOUN
ajlm-846	138	25	of	of	ADP
ajlm-846	138	26	the	the	DET
ajlm-846	138	27	organism	organism	NOUN
ajlm-846	138	28	in	in	ADP
ajlm-846	138	29	the	the	DET
ajlm-846	138	30	region	region	NOUN
ajlm-846	138	31	more	more	ADV
ajlm-846	138	32	thoroughly	thoroughly	ADV
ajlm-846	138	33	.	.	PUNCT
ajlm-846	139	1	acknowledgements	acknowledgement	NOUN
ajlm-846	139	2	media	medium	NOUN
ajlm-846	139	3	preparation	preparation	NOUN
ajlm-846	139	4	:	:	PUNCT
ajlm-846	139	5	elzane	elzane	PROPN
ajlm-846	139	6	cronje	cronje	PROPN
ajlm-846	139	7	and	and	CCONJ
ajlm-846	139	8	the	the	DET
ajlm-846	139	9	staff	staff	NOUN
ajlm-846	139	10	at	at	ADP
ajlm-846	139	11	the	the	DET
ajlm-846	139	12	national	national	PROPN
ajlm-846	139	13	health	health	PROPN
ajlm-846	139	14	laboratory	laboratory	PROPN
ajlm-846	139	15	service	service	NOUN
ajlm-846	139	16	media	medium	NOUN
ajlm-846	139	17	laboratory	laboratory	NOUN
ajlm-846	139	18	.	.	PUNCT
ajlm-846	140	1	sample	sample	NOUN
ajlm-846	140	2	collection	collection	NOUN
ajlm-846	140	3	and	and	CCONJ
ajlm-846	140	4	plating	plating	NOUN
ajlm-846	140	5	:	:	PUNCT
ajlm-846	140	6	dr	dr	PROPN
ajlm-846	140	7	justyna	justyna	PROPN
ajlm-846	140	8	wojno	wojno	PROPN
ajlm-846	140	9	,	,	PUNCT
ajlm-846	140	10	dr	dr	PROPN
ajlm-846	140	11	lourens	louren	NOUN
ajlm-846	140	12	robberts	robbert	NOUN
ajlm-846	140	13	,	,	PUNCT
ajlm-846	140	14	dr	dr	PROPN
ajlm-846	140	15	diane	diane	PROPN
ajlm-846	140	16	rip	rip	PROPN
ajlm-846	140	17	,	,	PUNCT
ajlm-846	140	18	zubeida	zubeida	PROPN
ajlm-846	140	19	salaam	salaam	PROPN
ajlm-846	140	20	-	-	PUNCT
ajlm-846	140	21	dreyer	dreyer	PROPN
ajlm-846	140	22	and	and	CCONJ
ajlm-846	140	23	the	the	DET
ajlm-846	140	24	staff	staff	NOUN
ajlm-846	140	25	at	at	ADP
ajlm-846	140	26	national	national	PROPN
ajlm-846	140	27	health	health	PROPN
ajlm-846	140	28	laboratory	laboratory	PROPN
ajlm-846	140	29	service	service	NOUN
ajlm-846	140	30	microbiology	microbiology	NOUN
ajlm-846	140	31	groote	groote	PROPN
ajlm-846	140	32	schuur	schuur	PROPN
ajlm-846	140	33	hospital	hospital	PROPN
ajlm-846	140	34	capillary	capillary	ADJ
ajlm-846	140	35	gel	gel	NOUN
ajlm-846	140	36	electrophoresis	electrophoresis	NOUN
ajlm-846	140	37	:	:	PUNCT
ajlm-846	140	38	alvera	alvera	NOUN
ajlm-846	140	39	vorster	vorster	NOUN
ajlm-846	140	40	.	.	PUNCT
ajlm-846	141	1	competing	compete	VERB
ajlm-846	141	2	interests	interest	NOUN
ajlm-846	141	3	the	the	DET
ajlm-846	141	4	authors	author	NOUN
ajlm-846	141	5	declare	declare	VERB
ajlm-846	141	6	that	that	SCONJ
ajlm-846	141	7	they	they	PRON
ajlm-846	141	8	have	have	VERB
ajlm-846	141	9	no	no	DET
ajlm-846	141	10	financial	financial	ADJ
ajlm-846	141	11	or	or	CCONJ
ajlm-846	141	12	personal	personal	ADJ
ajlm-846	141	13	relationships	relationship	NOUN
ajlm-846	141	14	which	which	PRON
ajlm-846	141	15	may	may	AUX
ajlm-846	141	16	have	have	AUX
ajlm-846	141	17	inappropriately	inappropriately	ADV
ajlm-846	141	18	influenced	influence	VERB
ajlm-846	141	19	them	they	PRON
ajlm-846	141	20	in	in	ADP
ajlm-846	141	21	writing	write	VERB
ajlm-846	141	22	this	this	DET
ajlm-846	141	23	article	article	NOUN
ajlm-846	141	24	.	.	PUNCT
ajlm-846	142	1	sources	source	NOUN
ajlm-846	142	2	of	of	ADP
ajlm-846	142	3	support	support	NOUN
ajlm-846	142	4	this	this	DET
ajlm-846	142	5	study	study	NOUN
ajlm-846	142	6	was	be	AUX
ajlm-846	142	7	funded	fund	VERB
ajlm-846	142	8	by	by	ADP
ajlm-846	142	9	the	the	DET
ajlm-846	142	10	national	national	PROPN
ajlm-846	142	11	research	research	PROPN
ajlm-846	142	12	foundation	foundation	PROPN
ajlm-846	142	13	of	of	ADP
ajlm-846	142	14	south	south	PROPN
ajlm-846	142	15	africa	africa	PROPN
ajlm-846	142	16	and	and	CCONJ
ajlm-846	142	17	the	the	DET
ajlm-846	142	18	south	south	ADJ
ajlm-846	142	19	african	african	PROPN
ajlm-846	142	20	medical	medical	PROPN
ajlm-846	142	21	research	research	PROPN
ajlm-846	142	22	council	council	PROPN
ajlm-846	142	23	.	.	PUNCT
ajlm-846	143	1	b.r.k	b.r.k	PROPN
ajlm-846	143	2	.	.	PUNCT
ajlm-846	143	3	acknowledges	acknowledge	VERB
ajlm-846	143	4	the	the	DET
ajlm-846	143	5	claude	claude	PROPN
ajlm-846	143	6	leon	leon	PROPN
ajlm-846	143	7	foundation	foundation	PROPN
ajlm-846	143	8	and	and	CCONJ
ajlm-846	143	9	the	the	DET
ajlm-846	143	10	carnegie	carnegie	NOUN
ajlm-846	143	11	corporation	corporation	NOUN
ajlm-846	143	12	of	of	ADP
ajlm-846	143	13	new	new	PROPN
ajlm-846	143	14	york	york	PROPN
ajlm-846	143	15	for	for	ADP
ajlm-846	143	16	postdoctoral	postdoctoral	ADJ
ajlm-846	143	17	fellowships	fellowship	NOUN
ajlm-846	143	18	.	.	PUNCT
ajlm-846	144	1	authors	author	NOUN
ajlm-846	144	2	’	'	PUNCT
ajlm-846	144	3	contributions	contribution	NOUN
ajlm-846	144	4	s.r	s.r	PROPN
ajlm-846	144	5	.	.	PROPN
ajlm-846	144	6	and	and	CCONJ
ajlm-846	144	7	v.a	v.a	PROPN
ajlm-846	144	8	.	.	PROPN
ajlm-846	144	9	were	be	AUX
ajlm-846	144	10	the	the	DET
ajlm-846	144	11	project	project	NOUN
ajlm-846	144	12	leaders	leader	NOUN
ajlm-846	144	13	.	.	PUNCT
ajlm-846	145	1	b.r.k	b.r.k	NOUN
ajlm-846	145	2	.	.	PROPN
ajlm-846	146	1	performed	perform	VERB
ajlm-846	146	2	the	the	DET
ajlm-846	146	3	experiments	experiment	NOUN
ajlm-846	146	4	.	.	PUNCT
ajlm-846	147	1	b.r.k	b.r.k	NOUN
ajlm-846	147	2	.	.	PROPN
ajlm-846	147	3	,	,	PUNCT
ajlm-846	147	4	s.r	s.r	PROPN
ajlm-846	147	5	.	.	PROPN
ajlm-846	147	6	and	and	CCONJ
ajlm-846	147	7	v.a	v.a	PROPN
ajlm-846	147	8	.	.	PROPN
ajlm-846	147	9	were	be	AUX
ajlm-846	147	10	responsible	responsible	ADJ
ajlm-846	147	11	for	for	ADP
ajlm-846	147	12	the	the	DET
ajlm-846	147	13	design	design	NOUN
ajlm-846	147	14	and	and	CCONJ
ajlm-846	147	15	implementation	implementation	NOUN
ajlm-846	147	16	of	of	ADP
ajlm-846	147	17	the	the	DET
ajlm-846	147	18	research	research	NOUN
ajlm-846	147	19	and	and	CCONJ
ajlm-846	147	20	for	for	ADP
ajlm-846	147	21	the	the	DET
ajlm-846	147	22	analysis	analysis	NOUN
ajlm-846	147	23	of	of	ADP
ajlm-846	147	24	the	the	DET
ajlm-846	147	25	results	result	NOUN
ajlm-846	147	26	.	.	PUNCT
ajlm-846	148	1	b.r.k	b.r.k	NOUN
ajlm-846	148	2	.	.	PROPN
ajlm-846	148	3	,	,	PUNCT
ajlm-846	148	4	s.r	s.r	PROPN
ajlm-846	148	5	.	.	PROPN
ajlm-846	148	6	and	and	CCONJ
ajlm-846	148	7	v.a	v.a	PROPN
ajlm-846	148	8	.	.	PROPN
ajlm-846	148	9	wrote	write	VERB
ajlm-846	148	10	the	the	DET
ajlm-846	148	11	manuscript	manuscript	NOUN
ajlm-846	148	12	.	.	PUNCT
ajlm-846	149	1	references	reference	NOUN
ajlm-846	149	2	freeman	freeman	PROPN
ajlm-846	149	3	j	j	PROPN
ajlm-846	149	4	,	,	PUNCT
ajlm-846	149	5	bauer	bauer	PROPN
ajlm-846	149	6	mp	mp	PROPN
ajlm-846	149	7	,	,	PUNCT
ajlm-846	149	8	baines	baine	VERB
ajlm-846	149	9	sd	sd	PROPN
ajlm-846	149	10	,	,	PUNCT
ajlm-846	149	11	et	et	PROPN
ajlm-846	149	12	al	al	PROPN
ajlm-846	149	13	.	.	PUNCT
ajlm-846	150	1	the	the	DET
ajlm-846	150	2	changing	change	VERB
ajlm-846	150	3	epidemiology	epidemiology	NOUN
ajlm-846	150	4	of	of	ADP
ajlm-846	150	5	clostridium	clostridium	NOUN
ajlm-846	150	6	difficile	difficile	ADJ
ajlm-846	150	7	infections	infection	NOUN
ajlm-846	150	8	.	.	PUNCT
ajlm-846	151	1	clin	clin	PROPN
ajlm-846	151	2	microbiol	microbiol	PROPN
ajlm-846	151	3	rev	rev	PROPN
ajlm-846	151	4	.	.	PROPN
ajlm-846	151	5	2010;23:529–549	2010;23:529–549	PROPN
ajlm-846	151	6	.	.	PUNCT
ajlm-846	152	1	https://doi.org/10.1128/cmr.00082-09	https://doi.org/10.1128/cmr.00082-09	PROPN
ajlm-846	152	2	ghantoji	ghantoji	PROPN
ajlm-846	152	3	ss	ss	PROPN
ajlm-846	152	4	,	,	PUNCT
ajlm-846	152	5	sail	sail	PROPN
ajlm-846	152	6	k	k	PROPN
ajlm-846	152	7	,	,	PUNCT
ajlm-846	152	8	lairson	lairson	PROPN
ajlm-846	152	9	dr	dr	PROPN
ajlm-846	152	10	,	,	PUNCT
ajlm-846	152	11	et	et	PROPN
ajlm-846	152	12	al	al	PROPN
ajlm-846	152	13	.	.	PUNCT
ajlm-846	153	1	economic	economic	ADJ
ajlm-846	153	2	healthcare	healthcare	PROPN
ajlm-846	153	3	costs	cost	NOUN
ajlm-846	153	4	of	of	ADP
ajlm-846	153	5	clostridium	clostridium	NOUN
ajlm-846	153	6	difficile	difficile	ADJ
ajlm-846	153	7	infection	infection	NOUN
ajlm-846	153	8	:	:	PUNCT
ajlm-846	153	9	a	a	DET
ajlm-846	153	10	systematic	systematic	ADJ
ajlm-846	153	11	review	review	NOUN
ajlm-846	153	12	.	.	PUNCT
ajlm-846	154	1	j	j	PROPN
ajlm-846	154	2	hosp	hosp	PROPN
ajlm-846	154	3	infect	infect	PROPN
ajlm-846	154	4	.	.	PUNCT
ajlm-846	155	1	2010;74:309–318	2010;74:309–318	NOUN
ajlm-846	155	2	.	.	PUNCT
ajlm-846	156	1	https://doi.org/10.1016/j.jhin.2009.10.016	https://doi.org/10.1016/j.jhin.2009.10.016	PROPN
ajlm-846	156	2	vardakas	vardakas	PROPN
ajlm-846	156	3	kz	kz	PROPN
ajlm-846	156	4	,	,	PUNCT
ajlm-846	156	5	polyzos	polyzos	PROPN
ajlm-846	156	6	ka	ka	PROPN
ajlm-846	156	7	,	,	PUNCT
ajlm-846	156	8	patouni	patouni	PROPN
ajlm-846	156	9	k	k	PROPN
ajlm-846	156	10	,	,	PUNCT
ajlm-846	156	11	et	et	PROPN
ajlm-846	156	12	al	al	PROPN
ajlm-846	156	13	.	.	PUNCT
ajlm-846	156	14	treatment	treatment	NOUN
ajlm-846	156	15	failure	failure	NOUN
ajlm-846	156	16	and	and	CCONJ
ajlm-846	156	17	recurrence	recurrence	NOUN
ajlm-846	156	18	of	of	ADP
ajlm-846	156	19	clostridium	clostridium	NOUN
ajlm-846	156	20	difficile	difficile	ADJ
ajlm-846	156	21	infection	infection	NOUN
ajlm-846	156	22	following	follow	VERB
ajlm-846	156	23	treatment	treatment	NOUN
ajlm-846	156	24	with	with	ADP
ajlm-846	156	25	vancomycin	vancomycin	PROPN
ajlm-846	156	26	or	or	CCONJ
ajlm-846	156	27	metronidazole	metronidazole	NOUN
ajlm-846	156	28	:	:	PUNCT
ajlm-846	156	29	a	a	DET
ajlm-846	156	30	systematic	systematic	ADJ
ajlm-846	156	31	review	review	NOUN
ajlm-846	156	32	of	of	ADP
ajlm-846	156	33	the	the	DET
ajlm-846	156	34	evidence	evidence	NOUN
ajlm-846	156	35	.	.	PUNCT
ajlm-846	157	1	int	int	NOUN
ajlm-846	157	2	j	j	PROPN
ajlm-846	157	3	antimicrob	antimicrob	PROPN
ajlm-846	157	4	agents	agent	NOUN
ajlm-846	157	5	.	.	PUNCT
ajlm-846	158	1	2012;40:1–8	2012;40:1–8	NUM
ajlm-846	158	2	.	.	PUNCT
ajlm-846	159	1	https://doi.org/10.1016/j.ijantimicag.2012.01.004	https://doi.org/10.1016/j.ijantimicag.2012.01.004	PROPN
ajlm-846	159	2	muto	muto	PROPN
ajlm-846	159	3	ca	can	AUX
ajlm-846	159	4	,	,	PUNCT
ajlm-846	159	5	pokrywka	pokrywka	PROPN
ajlm-846	159	6	m	m	PROPN
ajlm-846	159	7	,	,	PUNCT
ajlm-846	159	8	shutt	shutt	PROPN
ajlm-846	159	9	k	k	PROPN
ajlm-846	159	10	,	,	PUNCT
ajlm-846	159	11	et	et	PROPN
ajlm-846	159	12	al	al	PROPN
ajlm-846	159	13	.	.	PUNCT
ajlm-846	160	1	a	a	DET
ajlm-846	160	2	large	large	ADJ
ajlm-846	160	3	outbreak	outbreak	NOUN
ajlm-846	160	4	of	of	ADP
ajlm-846	160	5	clostridium	clostridium	NOUN
ajlm-846	160	6	difficile	difficile	ADJ
ajlm-846	160	7	-	-	PUNCT
ajlm-846	160	8	associated	associate	VERB
ajlm-846	160	9	disease	disease	NOUN
ajlm-846	160	10	with	with	ADP
ajlm-846	160	11	an	an	DET
ajlm-846	160	12	unexpected	unexpected	ADJ
ajlm-846	160	13	proportion	proportion	NOUN
ajlm-846	160	14	of	of	ADP
ajlm-846	160	15	deaths	death	NOUN
ajlm-846	160	16	and	and	CCONJ
ajlm-846	160	17	colectomies	colectomie	NOUN
ajlm-846	160	18	at	at	ADP
ajlm-846	160	19	a	a	DET
ajlm-846	160	20	teaching	teaching	NOUN
ajlm-846	160	21	hospital	hospital	NOUN
ajlm-846	160	22	following	follow	VERB
ajlm-846	160	23	increased	increase	VERB
ajlm-846	160	24	fluoroquinolone	fluoroquinolone	NOUN
ajlm-846	160	25	use	use	NOUN
ajlm-846	160	26	.	.	PUNCT
ajlm-846	161	1	infect	infect	VERB
ajlm-846	161	2	control	control	PROPN
ajlm-846	161	3	hosp	hosp	PROPN
ajlm-846	161	4	epidemiol	epidemiol	PROPN
ajlm-846	161	5	.	.	PUNCT
ajlm-846	162	1	2005;26:273–280	2005;26:273–280	NOUN
ajlm-846	162	2	.	.	PUNCT
ajlm-846	163	1	https://doi.org/10.1086/502539	https://doi.org/10.1086/502539	NOUN
ajlm-846	163	2	goorhuis	goorhuis	VERB
ajlm-846	163	3	a	a	DET
ajlm-846	163	4	,	,	PUNCT
ajlm-846	163	5	debast	debast	PROPN
ajlm-846	163	6	sb	sb	PROPN
ajlm-846	163	7	,	,	PUNCT
ajlm-846	163	8	dutilh	dutilh	PROPN
ajlm-846	163	9	jc	jc	PROPN
ajlm-846	163	10	,	,	PUNCT
ajlm-846	163	11	et	et	PROPN
ajlm-846	163	12	al	al	PROPN
ajlm-846	163	13	.	.	PROPN
ajlm-846	163	14	type	type	NOUN
ajlm-846	163	15	-	-	PUNCT
ajlm-846	163	16	specific	specific	ADJ
ajlm-846	163	17	risk	risk	NOUN
ajlm-846	163	18	factors	factor	NOUN
ajlm-846	163	19	and	and	CCONJ
ajlm-846	163	20	outcome	outcome	VERB
ajlm-846	163	21	in	in	ADP
ajlm-846	163	22	an	an	DET
ajlm-846	163	23	outbreak	outbreak	NOUN
ajlm-846	163	24	with	with	ADP
ajlm-846	163	25	2	2	NUM
ajlm-846	163	26	different	different	ADJ
ajlm-846	163	27	clostridium	clostridium	NOUN
ajlm-846	163	28	difficile	difficile	ADJ
ajlm-846	163	29	types	type	NOUN
ajlm-846	163	30	simultaneously	simultaneously	ADV
ajlm-846	163	31	in	in	ADP
ajlm-846	163	32	1	1	NUM
ajlm-846	163	33	hospital	hospital	NOUN
ajlm-846	163	34	.	.	PUNCT
ajlm-846	164	1	clin	clin	PROPN
ajlm-846	164	2	infect	infect	PROPN
ajlm-846	164	3	dis	dis	PROPN
ajlm-846	164	4	.	.	PUNCT
ajlm-846	165	1	2011;53:860–869	2011;53:860–869	NOUN
ajlm-846	165	2	.	.	PUNCT
ajlm-846	166	1	https://doi.org/10.1093/cid/cir549	https://doi.org/10.1093/cid/cir549	PROPN
ajlm-846	166	2	cairns	cairns	PROPN
ajlm-846	166	3	md	md	PROPN
ajlm-846	166	4	,	,	PUNCT
ajlm-846	166	5	preston	preston	PROPN
ajlm-846	166	6	md	md	PROPN
ajlm-846	166	7	,	,	PUNCT
ajlm-846	166	8	lawley	lawley	PROPN
ajlm-846	166	9	td	td	PROPN
ajlm-846	166	10	,	,	PUNCT
ajlm-846	166	11	et	et	PROPN
ajlm-846	166	12	al	al	PROPN
ajlm-846	166	13	.	.	PUNCT
ajlm-846	167	1	genomic	genomic	ADJ
ajlm-846	167	2	epidemiology	epidemiology	NOUN
ajlm-846	167	3	of	of	ADP
ajlm-846	167	4	a	a	DET
ajlm-846	167	5	protracted	protract	VERB
ajlm-846	167	6	hospital	hospital	NOUN
ajlm-846	167	7	outbreak	outbreak	NOUN
ajlm-846	167	8	caused	cause	VERB
ajlm-846	167	9	by	by	ADP
ajlm-846	167	10	a	a	DET
ajlm-846	167	11	toxin	toxin	NOUN
ajlm-846	167	12	a	a	PRON
ajlm-846	167	13	-	-	PUNCT
ajlm-846	167	14	negative	negative	ADJ
ajlm-846	167	15	clostridium	clostridium	NOUN
ajlm-846	167	16	difficile	difficile	ADJ
ajlm-846	167	17	sublineage	sublineage	NOUN
ajlm-846	167	18	pcr	pcr	NOUN
ajlm-846	167	19	ribotype	ribotype	NOUN
ajlm-846	167	20	017	017	NUM
ajlm-846	167	21	strain	strain	NOUN
ajlm-846	167	22	in	in	ADP
ajlm-846	167	23	london	london	PROPN
ajlm-846	167	24	,	,	PUNCT
ajlm-846	167	25	england	england	PROPN
ajlm-846	167	26	.	.	PUNCT
ajlm-846	168	1	j	j	PROPN
ajlm-846	168	2	clin	clin	PROPN
ajlm-846	168	3	microbiol	microbiol	PROPN
ajlm-846	168	4	.	.	PUNCT
ajlm-846	169	1	2015;53:3141–3147	2015;53:3141–3147	NOUN
ajlm-846	169	2	.	.	PUNCT
ajlm-846	170	1	https://doi.org/10.1128/jcm.00648-15	https://doi.org/10.1128/jcm.00648-15	PROPN
ajlm-846	170	2	kuehne	kuehne	PROPN
ajlm-846	170	3	sa	sa	PROPN
ajlm-846	170	4	,	,	PUNCT
ajlm-846	170	5	cartman	cartman	PROPN
ajlm-846	170	6	st	st	PROPN
ajlm-846	170	7	,	,	PUNCT
ajlm-846	170	8	minton	minton	PROPN
ajlm-846	170	9	np	np	PROPN
ajlm-846	170	10	.	.	PUNCT
ajlm-846	171	1	both	both	PRON
ajlm-846	171	2	,	,	PUNCT
ajlm-846	171	3	toxin	toxin	NOUN
ajlm-846	171	4	a	a	NOUN
ajlm-846	171	5	and	and	CCONJ
ajlm-846	171	6	toxin	toxin	NOUN
ajlm-846	171	7	b	b	NOUN
ajlm-846	171	8	,	,	PUNCT
ajlm-846	171	9	are	be	AUX
ajlm-846	171	10	important	important	ADJ
ajlm-846	171	11	in	in	ADP
ajlm-846	171	12	clostridium	clostridium	NOUN
ajlm-846	171	13	difficile	difficile	ADJ
ajlm-846	171	14	infection	infection	NOUN
ajlm-846	171	15	.	.	PUNCT
ajlm-846	172	1	gut	gut	NOUN
ajlm-846	172	2	microbes	microbe	NOUN
ajlm-846	172	3	.	.	PUNCT
ajlm-846	173	1	2011;2:252–255	2011;2:252–255	NUM
ajlm-846	173	2	.	.	PUNCT
ajlm-846	174	1	https://doi.org/10.4161/gmic.2.4.16109	https://doi.org/10.4161/gmic.2.4.16109	PROPN
ajlm-846	174	2	stewart	stewart	PROPN
ajlm-846	174	3	db	db	PROPN
ajlm-846	174	4	,	,	PUNCT
ajlm-846	174	5	berg	berg	PROPN
ajlm-846	174	6	a	a	PROPN
ajlm-846	174	7	,	,	PUNCT
ajlm-846	174	8	hegarty	hegarty	PROPN
ajlm-846	174	9	j.	j.	PROPN
ajlm-846	174	10	predicting	predicting	PROPN
ajlm-846	174	11	recurrence	recurrence	NOUN
ajlm-846	174	12	of	of	ADP
ajlm-846	174	13	c.	c.	NOUN
ajlm-846	174	14	difficile	difficile	VERB
ajlm-846	174	15	colitis	colitis	NOUN
ajlm-846	174	16	using	use	VERB
ajlm-846	174	17	bacterial	bacterial	ADJ
ajlm-846	174	18	virulence	virulence	NOUN
ajlm-846	174	19	factors	factor	NOUN
ajlm-846	174	20	:	:	PUNCT
ajlm-846	174	21	binary	binary	ADJ
ajlm-846	174	22	toxin	toxin	NOUN
ajlm-846	174	23	is	be	AUX
ajlm-846	174	24	the	the	DET
ajlm-846	174	25	key	key	NOUN
ajlm-846	174	26	.	.	PUNCT
ajlm-846	175	1	j	j	PROPN
ajlm-846	175	2	gastrointest	gastrointest	PROPN
ajlm-846	175	3	surg	surg	PROPN
ajlm-846	175	4	off	off	ADP
ajlm-846	175	5	j	j	PROPN
ajlm-846	175	6	soc	soc	PROPN
ajlm-846	175	7	surg	surg	PROPN
ajlm-846	175	8	aliment	aliment	NOUN
ajlm-846	175	9	tract	tract	NOUN
ajlm-846	175	10	.	.	PUNCT
ajlm-846	176	1	2013;17:118–124	2013;17:118–124	NUM
ajlm-846	176	2	;	;	PUNCT
ajlm-846	177	1	discussion	discussion	NOUN
ajlm-846	177	2	p.	p.	NOUN
ajlm-846	177	3	124–125	124–125	NUM
ajlm-846	177	4	.	.	PUNCT
ajlm-846	178	1	collins	collins	PROPN
ajlm-846	178	2	da	da	PROPN
ajlm-846	178	3	,	,	PUNCT
ajlm-846	178	4	hawkey	hawkey	ADJ
ajlm-846	178	5	pm	pm	NOUN
ajlm-846	178	6	,	,	PUNCT
ajlm-846	178	7	riley	riley	NOUN
ajlm-846	178	8	tv	tv	PROPN
ajlm-846	178	9	.	.	PUNCT
ajlm-846	179	1	epidemiology	epidemiology	NOUN
ajlm-846	179	2	of	of	ADP
ajlm-846	179	3	clostridium	clostridium	NOUN
ajlm-846	179	4	difficile	difficile	ADJ
ajlm-846	179	5	infection	infection	NOUN
ajlm-846	179	6	in	in	ADP
ajlm-846	179	7	asia	asia	PROPN
ajlm-846	179	8	.	.	PUNCT
ajlm-846	180	1	antimicrob	antimicrob	PROPN
ajlm-846	180	2	resist	resist	VERB
ajlm-846	180	3	infect	infect	ADJ
ajlm-846	180	4	control	control	NOUN
ajlm-846	180	5	.	.	PUNCT
ajlm-846	181	1	2013;2:21	2013;2:21	NOUN
ajlm-846	181	2	.	.	PUNCT
ajlm-846	182	1	https://doi.org/10.1186/2047-2994-2-21	https://doi.org/10.1186/2047-2994-2-21	NOUN
ajlm-846	182	2	slimings	sliming	NOUN
ajlm-846	182	3	c	c	PROPN
ajlm-846	182	4	,	,	PUNCT
ajlm-846	182	5	riley	riley	PROPN
ajlm-846	182	6	tv	tv	NOUN
ajlm-846	182	7	.	.	PUNCT
ajlm-846	183	1	antibiotics	antibiotic	NOUN
ajlm-846	183	2	and	and	CCONJ
ajlm-846	183	3	hospital	hospital	NOUN
ajlm-846	183	4	-	-	PUNCT
ajlm-846	183	5	acquired	acquire	VERB
ajlm-846	183	6	clostridium	clostridium	NOUN
ajlm-846	183	7	difficile	difficile	ADJ
ajlm-846	183	8	infection	infection	NOUN
ajlm-846	183	9	:	:	PUNCT
ajlm-846	183	10	update	update	NOUN
ajlm-846	183	11	of	of	ADP
ajlm-846	183	12	systematic	systematic	ADJ
ajlm-846	183	13	review	review	NOUN
ajlm-846	183	14	and	and	CCONJ
ajlm-846	183	15	meta	meta	ADJ
ajlm-846	183	16	-	-	PUNCT
ajlm-846	183	17	analysis	analysis	NOUN
ajlm-846	183	18	.	.	PUNCT
ajlm-846	184	1	j	j	PROPN
ajlm-846	184	2	antimicrob	antimicrob	PROPN
ajlm-846	184	3	chemother	chemother	PROPN
ajlm-846	184	4	.	.	PUNCT
ajlm-846	185	1	2014;69:881–891	2014;69:881–891	NUM
ajlm-846	185	2	.	.	PUNCT
ajlm-846	186	1	https://doi.org/10.1093/jac/dkt477	https://doi.org/10.1093/jac/dkt477	PROPN
ajlm-846	186	2	vardakas	vardakas	NOUN
ajlm-846	186	3	kz	kz	PROPN
ajlm-846	186	4	,	,	PUNCT
ajlm-846	186	5	konstantelias	konstantelia	VERB
ajlm-846	186	6	aa	aa	PROPN
ajlm-846	186	7	,	,	PUNCT
ajlm-846	186	8	loizidis	loizidis	PROPN
ajlm-846	186	9	g	g	PROPN
ajlm-846	186	10	,	,	PUNCT
ajlm-846	186	11	et	et	PROPN
ajlm-846	186	12	al	al	PROPN
ajlm-846	186	13	.	.	PUNCT
ajlm-846	187	1	risk	risk	NOUN
ajlm-846	187	2	factors	factor	NOUN
ajlm-846	187	3	for	for	ADP
ajlm-846	187	4	development	development	NOUN
ajlm-846	187	5	of	of	ADP
ajlm-846	187	6	clostridium	clostridium	NOUN
ajlm-846	187	7	difficile	difficile	ADJ
ajlm-846	187	8	infection	infection	NOUN
ajlm-846	187	9	due	due	ADP
ajlm-846	187	10	to	to	ADP
ajlm-846	187	11	bi	bi	PROPN
ajlm-846	187	12	/	/	SYM
ajlm-846	187	13	nap1/027	nap1/027	PRON
ajlm-846	187	14	strain	strain	NOUN
ajlm-846	187	15	:	:	PUNCT
ajlm-846	187	16	a	a	DET
ajlm-846	187	17	meta	meta	ADJ
ajlm-846	187	18	-	-	PUNCT
ajlm-846	187	19	analysis	analysis	NOUN
ajlm-846	187	20	.	.	PUNCT
ajlm-846	188	1	int	int	PROPN
ajlm-846	188	2	j	j	PROPN
ajlm-846	188	3	infect	infect	VERB
ajlm-846	188	4	dis	dis	PROPN
ajlm-846	188	5	.	.	PUNCT
ajlm-846	189	1	2012;16	2012;16	NUM
ajlm-846	189	2	:	:	PUNCT
ajlm-846	189	3	e768–773	e768–773	PROPN
ajlm-846	189	4	.	.	PUNCT
ajlm-846	190	1	oshima	oshima	PROPN
ajlm-846	190	2	t	t	PROPN
ajlm-846	190	3	,	,	PUNCT
ajlm-846	190	4	wu	wu	PROPN
ajlm-846	190	5	l	l	PROPN
ajlm-846	190	6	,	,	PUNCT
ajlm-846	190	7	li	li	PROPN
ajlm-846	190	8	m	m	PROPN
ajlm-846	190	9	,	,	PUNCT
ajlm-846	190	10	et	et	PROPN
ajlm-846	190	11	al	al	PROPN
ajlm-846	190	12	.	.	PROPN
ajlm-846	190	13	magnitude	magnitude	NOUN
ajlm-846	190	14	and	and	CCONJ
ajlm-846	190	15	direction	direction	NOUN
ajlm-846	190	16	of	of	ADP
ajlm-846	190	17	the	the	DET
ajlm-846	190	18	association	association	NOUN
ajlm-846	190	19	between	between	ADP
ajlm-846	190	20	clostridium	clostridium	NOUN
ajlm-846	190	21	difficile	difficile	ADJ
ajlm-846	190	22	infection	infection	NOUN
ajlm-846	190	23	and	and	CCONJ
ajlm-846	190	24	proton	proton	NOUN
ajlm-846	190	25	pump	pump	NOUN
ajlm-846	190	26	inhibitors	inhibitor	NOUN
ajlm-846	190	27	in	in	ADP
ajlm-846	190	28	adults	adult	NOUN
ajlm-846	190	29	and	and	CCONJ
ajlm-846	190	30	pediatric	pediatric	ADJ
ajlm-846	190	31	patients	patient	NOUN
ajlm-846	190	32	:	:	PUNCT
ajlm-846	190	33	a	a	DET
ajlm-846	190	34	systematic	systematic	ADJ
ajlm-846	190	35	review	review	NOUN
ajlm-846	190	36	and	and	CCONJ
ajlm-846	190	37	meta	meta	ADJ
ajlm-846	190	38	-	-	PUNCT
ajlm-846	190	39	analysis	analysis	NOUN
ajlm-846	190	40	.	.	PUNCT
ajlm-846	191	1	j	j	PROPN
ajlm-846	191	2	gastroenterol	gastroenterol	NOUN
ajlm-846	191	3	.	.	PUNCT
ajlm-846	192	1	2018;53:84–94	2018;53:84–94	NUM
ajlm-846	192	2	.	.	PUNCT
ajlm-846	193	1	https://doi.org/10.1007/s00535-017-1369-3	https://doi.org/10.1007/s00535-017-1369-3	NUM
ajlm-846	193	2	novack	novack	PROPN
ajlm-846	193	3	l	l	PROPN
ajlm-846	193	4	,	,	PUNCT
ajlm-846	193	5	kogan	kogan	PROPN
ajlm-846	193	6	s	s	PROPN
ajlm-846	193	7	,	,	PUNCT
ajlm-846	193	8	gimpelevich	gimpelevich	ADJ
ajlm-846	193	9	l	l	NOUN
ajlm-846	193	10	,	,	PUNCT
ajlm-846	193	11	et	et	PROPN
ajlm-846	193	12	al	al	PROPN
ajlm-846	193	13	.	.	PUNCT
ajlm-846	193	14	acid	acid	PROPN
ajlm-846	193	15	suppression	suppression	NOUN
ajlm-846	193	16	therapy	therapy	NOUN
ajlm-846	193	17	does	do	AUX
ajlm-846	193	18	not	not	PART
ajlm-846	193	19	predispose	predispose	VERB
ajlm-846	193	20	to	to	PART
ajlm-846	193	21	clostridium	clostridium	VERB
ajlm-846	193	22	difficile	difficile	ADJ
ajlm-846	193	23	infection	infection	NOUN
ajlm-846	193	24	:	:	PUNCT
ajlm-846	193	25	the	the	DET
ajlm-846	193	26	case	case	NOUN
ajlm-846	193	27	of	of	ADP
ajlm-846	193	28	the	the	DET
ajlm-846	193	29	potential	potential	ADJ
ajlm-846	193	30	bias	bias	NOUN
ajlm-846	193	31	.	.	PUNCT
ajlm-846	194	1	plos	plos	PROPN
ajlm-846	194	2	one	one	NUM
ajlm-846	194	3	.	.	PUNCT
ajlm-846	195	1	2014;9	2014;9	NUM
ajlm-846	195	2	:	:	PUNCT
ajlm-846	195	3	e110790	e110790	NOUN
ajlm-846	195	4	.	.	PUNCT
ajlm-846	196	1	https://doi.org/10.1371/journal.pone.0110790	https://doi.org/10.1371/journal.pone.0110790	VERB
ajlm-846	196	2	haines	haine	NOUN
ajlm-846	196	3	cf	cf	NOUN
ajlm-846	196	4	,	,	PUNCT
ajlm-846	196	5	moore	moore	PROPN
ajlm-846	196	6	rd	rd	PROPN
ajlm-846	196	7	,	,	PUNCT
ajlm-846	196	8	bartlett	bartlett	PROPN
ajlm-846	196	9	jg	jg	PROPN
ajlm-846	196	10	,	,	PUNCT
ajlm-846	196	11	et	et	PROPN
ajlm-846	196	12	al	al	PROPN
ajlm-846	196	13	.	.	PUNCT
ajlm-846	196	14	clostridium	clostridium	PROPN
ajlm-846	196	15	difficile	difficile	VERB
ajlm-846	196	16	in	in	ADP
ajlm-846	196	17	a	a	DET
ajlm-846	196	18	hiv	hiv	NOUN
ajlm-846	196	19	-	-	PUNCT
ajlm-846	196	20	infected	infect	VERB
ajlm-846	196	21	cohort	cohort	NOUN
ajlm-846	196	22	:	:	PUNCT
ajlm-846	196	23	incidence	incidence	NOUN
ajlm-846	196	24	,	,	PUNCT
ajlm-846	196	25	risk	risk	NOUN
ajlm-846	196	26	factors	factor	NOUN
ajlm-846	196	27	,	,	PUNCT
ajlm-846	196	28	and	and	CCONJ
ajlm-846	196	29	clinical	clinical	ADJ
ajlm-846	196	30	outcomes	outcome	NOUN
ajlm-846	196	31	.	.	PUNCT
ajlm-846	197	1	aids	aids	PROPN
ajlm-846	197	2	.	.	PUNCT
ajlm-846	198	1	2013;27:2799–2807	2013;27:2799–2807	ADJ
ajlm-846	198	2	.	.	PUNCT
ajlm-846	198	3	https://doi.org/10.1097/01.aids.0000432450.37863.e9	https://doi.org/10.1097/01.aids.0000432450.37863.e9	PROPN
ajlm-846	198	4	ziakas	ziakas	PROPN
ajlm-846	198	5	pd	pd	PROPN
ajlm-846	198	6	,	,	PUNCT
ajlm-846	198	7	zacharioudakis	zacharioudakis	PROPN
ajlm-846	198	8	i	i	PRON
ajlm-846	198	9	m	m	PROPN
ajlm-846	198	10	,	,	PUNCT
ajlm-846	198	11	zervou	zervou	PROPN
ajlm-846	198	12	fn	fn	PROPN
ajlm-846	198	13	,	,	PUNCT
ajlm-846	198	14	et	et	PROPN
ajlm-846	198	15	al	al	PROPN
ajlm-846	198	16	.	.	PUNCT
ajlm-846	199	1	asymptomatic	asymptomatic	ADJ
ajlm-846	199	2	carriers	carrier	NOUN
ajlm-846	199	3	of	of	ADP
ajlm-846	199	4	toxigenic	toxigenic	ADJ
ajlm-846	199	5	c.	c.	NOUN
ajlm-846	199	6	difficile	difficile	NOUN
ajlm-846	199	7	in	in	ADP
ajlm-846	199	8	long	long	ADJ
ajlm-846	199	9	-	-	PUNCT
ajlm-846	199	10	term	term	NOUN
ajlm-846	199	11	care	care	NOUN
ajlm-846	199	12	facilities	facility	NOUN
ajlm-846	199	13	:	:	PUNCT
ajlm-846	199	14	a	a	DET
ajlm-846	199	15	meta	meta	ADJ
ajlm-846	199	16	-	-	PUNCT
ajlm-846	199	17	analysis	analysis	NOUN
ajlm-846	199	18	of	of	ADP
ajlm-846	199	19	prevalence	prevalence	NOUN
ajlm-846	199	20	and	and	CCONJ
ajlm-846	199	21	risk	risk	NOUN
ajlm-846	199	22	factors	factor	NOUN
ajlm-846	199	23	.	.	PUNCT
ajlm-846	200	1	plos	plos	PROPN
ajlm-846	200	2	one	one	NUM
ajlm-846	200	3	.	.	PUNCT
ajlm-846	201	1	2015;10	2015;10	NUM
ajlm-846	201	2	:	:	PUNCT
ajlm-846	202	1	e0117195	e0117195	ADJ
ajlm-846	202	2	.	.	PUNCT
ajlm-846	203	1	https://doi.org/10.1371/journal.pone.0117195	https://doi.org/10.1371/journal.pone.0117195	ADJ
ajlm-846	203	2	obuch	obuch	NOUN
ajlm-846	203	3	-	-	PUNCT
ajlm-846	203	4	woszczatyński	woszczatyński	NOUN
ajlm-846	203	5	p	p	X
ajlm-846	203	6	,	,	PUNCT
ajlm-846	203	7	dubiel	dubiel	NOUN
ajlm-846	203	8	g	g	NOUN
ajlm-846	203	9	,	,	PUNCT
ajlm-846	203	10	harmanus	harmanus	NOUN
ajlm-846	203	11	c	c	NOUN
ajlm-846	203	12	,	,	PUNCT
ajlm-846	203	13	et	et	PROPN
ajlm-846	203	14	al	al	PROPN
ajlm-846	203	15	.	.	PROPN
ajlm-846	203	16	emergence	emergence	NOUN
ajlm-846	203	17	of	of	ADP
ajlm-846	203	18	clostridium	clostridium	NOUN
ajlm-846	203	19	difficile	difficile	ADJ
ajlm-846	203	20	infection	infection	NOUN
ajlm-846	203	21	in	in	ADP
ajlm-846	203	22	tuberculosis	tuberculosis	NOUN
ajlm-846	203	23	patients	patient	NOUN
ajlm-846	203	24	due	due	ADP
ajlm-846	203	25	to	to	ADP
ajlm-846	203	26	a	a	DET
ajlm-846	203	27	highly	highly	ADV
ajlm-846	203	28	rifampicin	rifampicin	VERB
ajlm-846	203	29	-	-	PUNCT
ajlm-846	203	30	resistant	resistant	ADJ
ajlm-846	203	31	pcr	pcr	NOUN
ajlm-846	203	32	ribotype	ribotype	NOUN
ajlm-846	203	33	046	046	NUM
ajlm-846	203	34	clone	clone	NOUN
ajlm-846	203	35	in	in	ADP
ajlm-846	203	36	poland	poland	PROPN
ajlm-846	203	37	.	.	PUNCT
ajlm-846	204	1	eur	eur	PROPN
ajlm-846	204	2	j	j	PROPN
ajlm-846	204	3	clin	clin	PROPN
ajlm-846	204	4	microbiol	microbiol	PROPN
ajlm-846	204	5	infect	infect	VERB
ajlm-846	204	6	dis	dis	PROPN
ajlm-846	204	7	.	.	PUNCT
ajlm-846	205	1	2013;32:1027–1030	2013;32:1027–1030	NOUN
ajlm-846	205	2	.	.	PUNCT
ajlm-846	206	1	https://doi.org/10.1007/s10096-013-1845-5	https://doi.org/10.1007/s10096-013-1845-5	PROPN
ajlm-846	206	2	sun	sun	PROPN
ajlm-846	206	3	y	y	PROPN
ajlm-846	206	4	-	-	PROPN
ajlm-846	206	5	x	x	PROPN
ajlm-846	206	6	,	,	PUNCT
ajlm-846	206	7	zhao	zhao	PROPN
ajlm-846	206	8	y	y	PROPN
ajlm-846	206	9	-	-	PUNCT
ajlm-846	206	10	t	t	PROPN
ajlm-846	206	11	,	,	PUNCT
ajlm-846	206	12	teng	teng	PROPN
ajlm-846	206	13	l	l	PROPN
ajlm-846	206	14	-	-	PROPN
ajlm-846	206	15	l	l	NOUN
ajlm-846	206	16	,	,	PUNCT
ajlm-846	206	17	et	et	PROPN
ajlm-846	206	18	al	al	PROPN
ajlm-846	206	19	.	.	PUNCT
ajlm-846	206	20	clostridium	clostridium	PROPN
ajlm-846	206	21	difficile	difficile	ADJ
ajlm-846	206	22	infection	infection	NOUN
ajlm-846	206	23	associated	associate	VERB
ajlm-846	206	24	with	with	ADP
ajlm-846	206	25	antituberculous	antituberculous	ADJ
ajlm-846	206	26	agents	agent	NOUN
ajlm-846	206	27	in	in	ADP
ajlm-846	206	28	a	a	DET
ajlm-846	206	29	patient	patient	NOUN
ajlm-846	206	30	with	with	ADP
ajlm-846	206	31	tuberculous	tuberculous	ADJ
ajlm-846	206	32	pericarditis	pericarditis	NOUN
ajlm-846	206	33	.	.	PUNCT
ajlm-846	207	1	intern	intern	PROPN
ajlm-846	207	2	med	med	PROPN
ajlm-846	207	3	.	.	PUNCT
ajlm-846	208	1	2013;52:1495–1497	2013;52:1495–1497	NUM
ajlm-846	208	2	.	.	PUNCT
ajlm-846	209	1	https://doi.org/10.2169/internalmedicine.52.0162	https://doi.org/10.2169/internalmedicine.52.0162	PROPN
ajlm-846	209	2	jung	jung	PROPN
ajlm-846	209	3	s	s	PROPN
ajlm-846	209	4	-	-	PUNCT
ajlm-846	209	5	w	w	PROPN
ajlm-846	209	6	,	,	PUNCT
ajlm-846	209	7	jeon	jeon	PROPN
ajlm-846	209	8	s	s	PROPN
ajlm-846	209	9	-	-	PUNCT
ajlm-846	209	10	w	w	PROPN
ajlm-846	209	11	,	,	PUNCT
ajlm-846	209	12	do	do	AUX
ajlm-846	209	13	b	b	X
ajlm-846	209	14	-	-	PUNCT
ajlm-846	209	15	h	h	NOUN
ajlm-846	209	16	,	,	PUNCT
ajlm-846	209	17	et	et	PROPN
ajlm-846	209	18	al	al	PROPN
ajlm-846	209	19	.	.	PUNCT
ajlm-846	209	20	clinical	clinical	ADJ
ajlm-846	209	21	aspects	aspect	NOUN
ajlm-846	209	22	of	of	ADP
ajlm-846	209	23	rifampicin	rifampicin	NOUN
ajlm-846	209	24	-	-	PUNCT
ajlm-846	209	25	associated	associate	VERB
ajlm-846	209	26	pseudomembranous	pseudomembranous	ADJ
ajlm-846	209	27	colitis	colitis	NOUN
ajlm-846	209	28	.	.	PUNCT
ajlm-846	210	1	j	j	PROPN
ajlm-846	210	2	clin	clin	PROPN
ajlm-846	210	3	gastroenterol	gastroenterol	PROPN
ajlm-846	210	4	.	.	PUNCT
ajlm-846	211	1	2007;41:38–40	2007;41:38–40	NUM
ajlm-846	211	2	.	.	PUNCT
ajlm-846	212	1	wang	wang	PROPN
ajlm-846	212	2	p	p	PROPN
ajlm-846	212	3	,	,	PUNCT
ajlm-846	212	4	zhou	zhou	PROPN
ajlm-846	212	5	y	y	PROPN
ajlm-846	212	6	,	,	PUNCT
ajlm-846	212	7	wang	wang	PROPN
ajlm-846	212	8	z	z	PROPN
ajlm-846	212	9	,	,	PUNCT
ajlm-846	212	10	et	et	PROPN
ajlm-846	212	11	al	al	PROPN
ajlm-846	212	12	.	.	PUNCT
ajlm-846	212	13	identification	identification	NOUN
ajlm-846	212	14	of	of	ADP
ajlm-846	212	15	clostridium	clostridium	NOUN
ajlm-846	212	16	difficile	difficile	NOUN
ajlm-846	212	17	ribotype	ribotype	NOUN
ajlm-846	212	18	027	027	NUM
ajlm-846	212	19	for	for	ADP
ajlm-846	212	20	the	the	DET
ajlm-846	212	21	first	first	ADJ
ajlm-846	212	22	time	time	NOUN
ajlm-846	212	23	in	in	ADP
ajlm-846	212	24	mainland	mainland	NOUN
ajlm-846	212	25	china	china	PROPN
ajlm-846	212	26	.	.	PUNCT
ajlm-846	213	1	infect	infect	VERB
ajlm-846	213	2	control	control	PROPN
ajlm-846	213	3	hosp	hosp	PROPN
ajlm-846	213	4	epidemiol	epidemiol	PROPN
ajlm-846	213	5	.	.	PUNCT
ajlm-846	214	1	2014;35:95–98	2014;35:95–98	NUM
ajlm-846	214	2	.	.	PUNCT
ajlm-846	215	1	https://doi.org/10.1086/674405	https://doi.org/10.1086/674405	X
ajlm-846	215	2	chang	chang	PROPN
ajlm-846	215	3	kc	kc	PROPN
ajlm-846	215	4	,	,	PUNCT
ajlm-846	215	5	leung	leung	PROPN
ajlm-846	215	6	cc	cc	PROPN
ajlm-846	215	7	,	,	PUNCT
ajlm-846	215	8	yew	yew	PROPN
ajlm-846	215	9	ww	ww	PROPN
ajlm-846	215	10	,	,	PUNCT
ajlm-846	215	11	et	et	PROPN
ajlm-846	215	12	al	al	PROPN
ajlm-846	215	13	.	.	PUNCT
ajlm-846	216	1	analyses	analysis	NOUN
ajlm-846	216	2	of	of	ADP
ajlm-846	216	3	fluoroquinolones	fluoroquinolone	NOUN
ajlm-846	216	4	and	and	CCONJ
ajlm-846	216	5	clostridium	clostridium	NOUN
ajlm-846	216	6	difficile	difficile	ADJ
ajlm-846	216	7	-	-	PUNCT
ajlm-846	216	8	associated	associate	VERB
ajlm-846	216	9	diarrhoea	diarrhoea	NOUN
ajlm-846	216	10	in	in	ADP
ajlm-846	216	11	tuberculosis	tuberculosis	NOUN
ajlm-846	216	12	patients	patient	NOUN
ajlm-846	216	13	.	.	PUNCT
ajlm-846	217	1	int	int	NOUN
ajlm-846	217	2	j	j	PROPN
ajlm-846	217	3	tuberc	tuberc	PROPN
ajlm-846	217	4	lung	lung	PROPN
ajlm-846	217	5	dis	dis	PROPN
ajlm-846	217	6	.	.	PUNCT
ajlm-846	218	1	2009;13:341–346	2009;13:341–346	PROPN
ajlm-846	218	2	.	.	PUNCT
ajlm-846	219	1	lee	lee	PROPN
ajlm-846	219	2	ym	ym	PROPN
ajlm-846	219	3	,	,	PUNCT
ajlm-846	219	4	huh	huh	INTJ
ajlm-846	220	1	kc	kc	PROPN
ajlm-846	220	2	,	,	PUNCT
ajlm-846	220	3	yoon	yoon	PROPN
ajlm-846	220	4	sm	sm	PROPN
ajlm-846	220	5	,	,	PUNCT
ajlm-846	220	6	et	et	PROPN
ajlm-846	220	7	al	al	PROPN
ajlm-846	220	8	.	.	PROPN
ajlm-846	220	9	incidence	incidence	NOUN
ajlm-846	220	10	and	and	CCONJ
ajlm-846	220	11	clinical	clinical	ADJ
ajlm-846	220	12	outcomes	outcome	NOUN
ajlm-846	220	13	of	of	ADP
ajlm-846	220	14	clostridium	clostridium	NOUN
ajlm-846	220	15	difficile	difficile	ADJ
ajlm-846	220	16	infection	infection	NOUN
ajlm-846	220	17	after	after	ADP
ajlm-846	220	18	treatment	treatment	NOUN
ajlm-846	220	19	with	with	ADP
ajlm-846	220	20	tuberculosis	tuberculosis	NOUN
ajlm-846	220	21	medication	medication	NOUN
ajlm-846	220	22	.	.	PUNCT
ajlm-846	221	1	gut	gut	NOUN
ajlm-846	221	2	liver	liver	NOUN
ajlm-846	221	3	.	.	PUNCT
ajlm-846	222	1	2016;10(2):250–254	2016;10(2):250–254	X
ajlm-846	222	2	.	.	PUNCT
ajlm-846	222	3	https://doi.org/10.5009/gnl14435	https://doi.org/10.5009/gnl14435	PROPN
ajlm-846	222	4	legenza	legenza	PROPN
ajlm-846	222	5	l	l	PROPN
ajlm-846	222	6	,	,	PUNCT
ajlm-846	222	7	barnett	barnett	PROPN
ajlm-846	222	8	s	s	PROPN
ajlm-846	222	9	,	,	PUNCT
ajlm-846	222	10	rose	rise	VERB
ajlm-846	222	11	w	w	PROPN
ajlm-846	222	12	,	,	PUNCT
ajlm-846	222	13	et	et	PROPN
ajlm-846	222	14	al	al	PROPN
ajlm-846	222	15	.	.	PUNCT
ajlm-846	222	16	epidemiology	epidemiology	NOUN
ajlm-846	222	17	and	and	CCONJ
ajlm-846	222	18	outcomes	outcome	NOUN
ajlm-846	222	19	of	of	ADP
ajlm-846	222	20	clostridium	clostridium	NOUN
ajlm-846	222	21	difficile	difficile	ADJ
ajlm-846	222	22	infection	infection	NOUN
ajlm-846	222	23	among	among	ADP
ajlm-846	222	24	hospitalised	hospitalised	ADJ
ajlm-846	222	25	patients	patient	NOUN
ajlm-846	222	26	:	:	PUNCT
ajlm-846	222	27	results	result	NOUN
ajlm-846	222	28	of	of	ADP
ajlm-846	222	29	a	a	DET
ajlm-846	222	30	multicentre	multicentre	NOUN
ajlm-846	222	31	retrospective	retrospective	ADJ
ajlm-846	222	32	study	study	NOUN
ajlm-846	222	33	in	in	ADP
ajlm-846	222	34	south	south	PROPN
ajlm-846	222	35	africa	africa	PROPN
ajlm-846	222	36	.	.	PUNCT
ajlm-846	223	1	bmj	bmj	PROPN
ajlm-846	223	2	glob	glob	NOUN
ajlm-846	223	3	health	health	NOUN
ajlm-846	223	4	.	.	PUNCT
ajlm-846	224	1	2018;3	2018;3	NUM
ajlm-846	224	2	:	:	PUNCT
ajlm-846	224	3	e000889	e000889	VERB
ajlm-846	224	4	.	.	PUNCT
ajlm-846	225	1	https://doi.org/10.1136/bmjgh-2018-000889	https://doi.org/10.1136/bmjgh-2018-000889	PROPN
ajlm-846	225	2	national	national	PROPN
ajlm-846	225	3	institute	institute	PROPN
ajlm-846	225	4	of	of	ADP
ajlm-846	225	5	communicable	communicable	NOUN
ajlm-846	225	6	diseases	disease	NOUN
ajlm-846	225	7	.	.	PUNCT
ajlm-846	226	1	clostridium	clostridium	NOUN
ajlm-846	226	2	difficile	difficile	ADJ
ajlm-846	226	3	cases	case	NOUN
ajlm-846	226	4	at	at	ADP
ajlm-846	226	5	a	a	DET
ajlm-846	226	6	hospital	hospital	NOUN
ajlm-846	226	7	in	in	ADP
ajlm-846	226	8	the	the	DET
ajlm-846	226	9	eastern	eastern	ADJ
ajlm-846	226	10	cape	cape	NOUN
ajlm-846	226	11	province	province	NOUN
ajlm-846	226	12	.	.	PUNCT
ajlm-846	227	1	nicd	nicd	PROPN
ajlm-846	227	2	commun	commun	PROPN
ajlm-846	227	3	dis	dis	PROPN
ajlm-846	227	4	commun	commun	PROPN
ajlm-846	227	5	.	.	PUNCT
ajlm-846	228	1	2016;15:6–7	2016;15:6–7	NUM
ajlm-846	228	2	.	.	PUNCT
ajlm-846	229	1	keeley	keeley	PROPN
ajlm-846	229	2	aj	aj	PROPN
ajlm-846	229	3	,	,	PUNCT
ajlm-846	229	4	beeching	beeche	VERB
ajlm-846	229	5	nj	nj	PROPN
ajlm-846	229	6	,	,	PUNCT
ajlm-846	229	7	stott	stott	PROPN
ajlm-846	229	8	ke	ke	PROPN
ajlm-846	229	9	,	,	PUNCT
ajlm-846	229	10	et	et	PROPN
ajlm-846	229	11	al	al	PROPN
ajlm-846	229	12	.	.	PUNCT
ajlm-846	229	13	clostridium	clostridium	PROPN
ajlm-846	229	14	difficile	difficile	PROPN
ajlm-846	229	15	:	:	PUNCT
ajlm-846	229	16	a	a	DET
ajlm-846	229	17	healthcare	healthcare	NOUN
ajlm-846	229	18	-	-	PUNCT
ajlm-846	229	19	associated	associate	VERB
ajlm-846	229	20	infection	infection	NOUN
ajlm-846	229	21	of	of	ADP
ajlm-846	229	22	unknown	unknown	ADJ
ajlm-846	229	23	significance	significance	NOUN
ajlm-846	229	24	in	in	ADP
ajlm-846	229	25	adults	adult	NOUN
ajlm-846	229	26	in	in	ADP
ajlm-846	229	27	sub	sub	ADJ
ajlm-846	229	28	-	-	ADJ
ajlm-846	229	29	saharan	saharan	ADJ
ajlm-846	229	30	africa	africa	PROPN
ajlm-846	229	31	.	.	PUNCT
ajlm-846	230	1	malawi	malawi	PROPN
ajlm-846	230	2	med	med	PROPN
ajlm-846	230	3	j.	j.	PROPN
ajlm-846	230	4	2016;28:66–69	2016;28:66–69	PROPN
ajlm-846	230	5	.	.	PUNCT
ajlm-846	231	1	https://doi.org/10.4314/mmj.v28i2.8	https://doi.org/10.4314/mmj.v28i2.8	PROPN
ajlm-846	231	2	roldan	roldan	PROPN
ajlm-846	231	3	ga	ga	PROPN
ajlm-846	231	4	,	,	PUNCT
ajlm-846	231	5	cui	cui	NOUN
ajlm-846	231	6	ax	ax	NOUN
ajlm-846	231	7	,	,	PUNCT
ajlm-846	231	8	pollock	pollock	NOUN
ajlm-846	231	9	nr	nr	PROPN
ajlm-846	231	10	.	.	PUNCT
ajlm-846	232	1	assessing	assess	VERB
ajlm-846	232	2	the	the	DET
ajlm-846	232	3	burden	burden	NOUN
ajlm-846	232	4	of	of	ADP
ajlm-846	232	5	c.	c.	NOUN
ajlm-846	232	6	difficile	difficile	PROPN
ajlm-846	232	7	infection	infection	NOUN
ajlm-846	232	8	in	in	ADP
ajlm-846	232	9	lowand	lowand	ADJ
ajlm-846	232	10	middle	middle	ADJ
ajlm-846	232	11	-	-	PUNCT
ajlm-846	232	12	income	income	NOUN
ajlm-846	232	13	countries	country	NOUN
ajlm-846	232	14	.	.	PUNCT
ajlm-846	233	1	j	j	PROPN
ajlm-846	233	2	clin	clin	PROPN
ajlm-846	233	3	microbiol	microbiol	PROPN
ajlm-846	233	4	.	.	PUNCT
ajlm-846	234	1	2018;56(3):e01747–17	2018;56(3):e01747–17	NUM
ajlm-846	234	2	.	.	PUNCT
ajlm-846	235	1	https://doi.org/10.1128/jcm.01747-17	https://doi.org/10.1128/jcm.01747-17	PROPN
ajlm-846	235	2	kullin	kullin	PROPN
ajlm-846	235	3	b	b	PROPN
ajlm-846	235	4	,	,	PUNCT
ajlm-846	235	5	meggersee	meggersee	ADJ
ajlm-846	235	6	r	r	PROPN
ajlm-846	235	7	,	,	PUNCT
ajlm-846	235	8	d’alton	d’alton	PROPN
ajlm-846	235	9	j	j	PROPN
ajlm-846	235	10	,	,	PUNCT
ajlm-846	235	11	et	et	PROPN
ajlm-846	235	12	al	al	PROPN
ajlm-846	235	13	.	.	PUNCT
ajlm-846	236	1	prevalence	prevalence	NOUN
ajlm-846	236	2	of	of	ADP
ajlm-846	236	3	gastrointestinal	gastrointestinal	ADJ
ajlm-846	236	4	pathogenic	pathogenic	ADJ
ajlm-846	236	5	bacteria	bacteria	NOUN
ajlm-846	236	6	in	in	ADP
ajlm-846	236	7	patients	patient	NOUN
ajlm-846	236	8	with	with	ADP
ajlm-846	236	9	diarrhoea	diarrhoea	NOUN
ajlm-846	236	10	attending	attend	VERB
ajlm-846	236	11	groote	groote	ADJ
ajlm-846	236	12	schuur	schuur	PROPN
ajlm-846	236	13	hospital	hospital	PROPN
ajlm-846	236	14	,	,	PUNCT
ajlm-846	236	15	cape	cape	NOUN
ajlm-846	236	16	town	town	NOUN
ajlm-846	236	17	,	,	PUNCT
ajlm-846	236	18	south	south	PROPN
ajlm-846	236	19	africa	africa	PROPN
ajlm-846	236	20	.	.	PUNCT
ajlm-846	237	1	south	south	PROPN
ajlm-846	237	2	afr	afr	PROPN
ajlm-846	237	3	med	med	PROPN
ajlm-846	237	4	j.	j.	PROPN
ajlm-846	237	5	2015;105:121–125	2015;105:121–125	PROPN
ajlm-846	237	6	.	.	PUNCT
ajlm-846	238	1	rajabally	rajabally	ADV
ajlm-846	238	2	nm	nm	PROPN
ajlm-846	238	3	,	,	PUNCT
ajlm-846	238	4	pentecost	pentecost	PROPN
ajlm-846	238	5	m	m	PROPN
ajlm-846	238	6	,	,	PUNCT
ajlm-846	238	7	pretorius	pretorius	PROPN
ajlm-846	238	8	g	g	PROPN
ajlm-846	238	9	,	,	PUNCT
ajlm-846	238	10	et	et	PROPN
ajlm-846	238	11	al	al	PROPN
ajlm-846	238	12	.	.	PUNCT
ajlm-846	239	1	the	the	DET
ajlm-846	239	2	clostridium	clostridium	NOUN
ajlm-846	239	3	difficile	difficile	ADJ
ajlm-846	239	4	problem	problem	NOUN
ajlm-846	239	5	:	:	PUNCT
ajlm-846	239	6	a	a	DET
ajlm-846	239	7	south	south	ADJ
ajlm-846	239	8	african	african	ADJ
ajlm-846	239	9	tertiary	tertiary	ADJ
ajlm-846	239	10	institution	institution	NOUN
ajlm-846	239	11	’s	’s	PART
ajlm-846	239	12	prospective	prospective	ADJ
ajlm-846	239	13	perspective	perspective	NOUN
ajlm-846	239	14	.	.	PUNCT
ajlm-846	240	1	south	south	PROPN
ajlm-846	240	2	afr	afr	PROPN
ajlm-846	240	3	med	med	PROPN
ajlm-846	240	4	j.	j.	PROPN
ajlm-846	240	5	2013;103:168–172	2013;103:168–172	PROPN
ajlm-846	240	6	.	.	PUNCT
ajlm-846	241	1	samie	samie	PROPN
ajlm-846	241	2	a	a	PRON
ajlm-846	241	3	,	,	PUNCT
ajlm-846	241	4	obi	obi	PROPN
ajlm-846	241	5	cl	cl	NOUN
ajlm-846	241	6	,	,	PUNCT
ajlm-846	241	7	franasiak	franasiak	PROPN
ajlm-846	241	8	j	j	PROPN
ajlm-846	241	9	,	,	PUNCT
ajlm-846	241	10	et	et	PROPN
ajlm-846	241	11	al	al	PROPN
ajlm-846	241	12	.	.	PUNCT
ajlm-846	242	1	pcr	pcr	PROPN
ajlm-846	242	2	detection	detection	NOUN
ajlm-846	242	3	of	of	ADP
ajlm-846	242	4	clostridium	clostridium	NOUN
ajlm-846	242	5	difficile	difficile	NOUN
ajlm-846	242	6	triose	triose	NOUN
ajlm-846	242	7	phosphate	phosphate	NOUN
ajlm-846	242	8	isomerase	isomerase	NOUN
ajlm-846	242	9	(	(	PUNCT
ajlm-846	242	10	tpi	tpi	PROPN
ajlm-846	242	11	)	)	PUNCT
ajlm-846	242	12	,	,	PUNCT
ajlm-846	242	13	toxin	toxin	NOUN
ajlm-846	242	14	a	a	DET
ajlm-846	242	15	(	(	PUNCT
ajlm-846	242	16	tcda	tcda	NOUN
ajlm-846	242	17	)	)	PUNCT
ajlm-846	242	18	,	,	PUNCT
ajlm-846	242	19	toxin	toxin	NOUN
ajlm-846	242	20	b	b	PROPN
ajlm-846	242	21	(	(	PUNCT
ajlm-846	242	22	tcdb	tcdb	NOUN
ajlm-846	242	23	)	)	PUNCT
ajlm-846	242	24	,	,	PUNCT
ajlm-846	242	25	binary	binary	ADJ
ajlm-846	242	26	toxin	toxin	NOUN
ajlm-846	242	27	(	(	PUNCT
ajlm-846	242	28	cdta	cdta	PROPN
ajlm-846	242	29	,	,	PUNCT
ajlm-846	242	30	cdtb	cdtb	NOUN
ajlm-846	242	31	)	)	PUNCT
ajlm-846	242	32	,	,	PUNCT
ajlm-846	242	33	and	and	CCONJ
ajlm-846	242	34	tcdc	tcdc	NOUN
ajlm-846	242	35	genes	gene	NOUN
ajlm-846	242	36	in	in	ADP
ajlm-846	242	37	vhembe	vhembe	PROPN
ajlm-846	242	38	district	district	NOUN
ajlm-846	242	39	,	,	PUNCT
ajlm-846	242	40	south	south	PROPN
ajlm-846	242	41	africa	africa	PROPN
ajlm-846	242	42	.	.	PUNCT
ajlm-846	243	1	am	be	AUX
ajlm-846	243	2	j	j	PROPN
ajlm-846	243	3	trop	trop	X
ajlm-846	243	4	med	med	PROPN
ajlm-846	243	5	hyg	hyg	PROPN
ajlm-846	243	6	.	.	PUNCT
ajlm-846	244	1	2008;78:577–585	2008;78:577–585	PROPN
ajlm-846	244	2	.	.	PUNCT
ajlm-846	245	1	https://doi.org/10.4269/ajtmh.2008.78.577	https://doi.org/10.4269/ajtmh.2008.78.577	PROPN
ajlm-846	245	2	lekalakala	lekalakala	PROPN
ajlm-846	245	3	mr	mr	PROPN
ajlm-846	245	4	,	,	PUNCT
ajlm-846	245	5	lewis	lewis	PROPN
ajlm-846	245	6	e	e	PROPN
ajlm-846	245	7	,	,	PUNCT
ajlm-846	245	8	hoosen	hoosen	ADJ
ajlm-846	245	9	aa	aa	NOUN
ajlm-846	245	10	.	.	PUNCT
ajlm-846	246	1	clostridium	clostridium	NOUN
ajlm-846	246	2	difficile	difficile	NOUN
ajlm-846	246	3	infections	infection	NOUN
ajlm-846	246	4	in	in	ADP
ajlm-846	246	5	a	a	DET
ajlm-846	246	6	tertiary	tertiary	ADJ
ajlm-846	246	7	hospital	hospital	NOUN
ajlm-846	246	8	:	:	PUNCT
ajlm-846	246	9	value	value	NOUN
ajlm-846	246	10	of	of	ADP
ajlm-846	246	11	surveillance	surveillance	NOUN
ajlm-846	246	12	.	.	PUNCT
ajlm-846	247	1	j	j	PROPN
ajlm-846	247	2	hosp	hosp	PROPN
ajlm-846	247	3	infect	infect	PROPN
ajlm-846	247	4	.	.	PUNCT
ajlm-846	248	1	2010;75:328–329	2010;75:328–329	NOUN
ajlm-846	248	2	.	.	PUNCT
ajlm-846	249	1	https://doi.org/10.1016/j.jhin.2010.03.016	https://doi.org/10.1016/j.jhin.2010.03.016	PROPN
ajlm-846	249	2	kullin	kullin	PROPN
ajlm-846	249	3	b	b	PROPN
ajlm-846	249	4	,	,	PUNCT
ajlm-846	249	5	wojno	wojno	VERB
ajlm-846	249	6	j	j	PROPN
ajlm-846	249	7	,	,	PUNCT
ajlm-846	249	8	abratt	abratt	PROPN
ajlm-846	249	9	v	v	PROPN
ajlm-846	249	10	,	,	PUNCT
ajlm-846	249	11	et	et	PROPN
ajlm-846	250	1	al	al	PROPN
ajlm-846	250	2	.	.	PROPN
ajlm-846	250	3	toxin	toxin	PROPN
ajlm-846	251	1	a	a	DET
ajlm-846	251	2	-	-	PUNCT
ajlm-846	251	3	negative	negative	ADJ
ajlm-846	251	4	toxin	toxin	NOUN
ajlm-846	251	5	b	b	NOUN
ajlm-846	251	6	-	-	PUNCT
ajlm-846	251	7	positive	positive	ADJ
ajlm-846	251	8	ribotype	ribotype	NOUN
ajlm-846	251	9	017	017	NUM
ajlm-846	251	10	clostridium	clostridium	NOUN
ajlm-846	251	11	difficile	difficile	NOUN
ajlm-846	251	12	is	be	AUX
ajlm-846	251	13	the	the	DET
ajlm-846	251	14	dominant	dominant	ADJ
ajlm-846	251	15	strain	strain	NOUN
ajlm-846	251	16	type	type	NOUN
ajlm-846	251	17	in	in	ADP
ajlm-846	251	18	patients	patient	NOUN
ajlm-846	251	19	with	with	ADP
ajlm-846	251	20	diarrhoea	diarrhoea	NOUN
ajlm-846	251	21	attending	attend	VERB
ajlm-846	251	22	tuberculosis	tuberculosis	NOUN
ajlm-846	251	23	hospitals	hospital	NOUN
ajlm-846	251	24	in	in	ADP
ajlm-846	251	25	cape	cape	NOUN
ajlm-846	251	26	town	town	NOUN
ajlm-846	251	27	,	,	PUNCT
ajlm-846	251	28	south	south	PROPN
ajlm-846	251	29	africa	africa	PROPN
ajlm-846	251	30	.	.	PUNCT
ajlm-846	252	1	eur	eur	PROPN
ajlm-846	252	2	j	j	PROPN
ajlm-846	252	3	clin	clin	PROPN
ajlm-846	252	4	microbiol	microbiol	PROPN
ajlm-846	252	5	infect	infect	VERB
ajlm-846	252	6	dis	dis	PROPN
ajlm-846	252	7	.	.	PUNCT
ajlm-846	253	1	2017;36:163–175	2017;36:163–175	PROPN
ajlm-846	253	2	.	.	PUNCT
ajlm-846	254	1	https://doi.org/10.1007/s10096-016-2790-x	https://doi.org/10.1007/s10096-016-2790-x	NOUN
ajlm-846	254	2	brazier	brazier	NOUN
ajlm-846	254	3	js	js	PROPN
ajlm-846	254	4	.	.	PUNCT
ajlm-846	255	1	role	role	NOUN
ajlm-846	255	2	of	of	ADP
ajlm-846	255	3	the	the	DET
ajlm-846	255	4	laboratory	laboratory	NOUN
ajlm-846	255	5	in	in	ADP
ajlm-846	255	6	investigations	investigation	NOUN
ajlm-846	255	7	of	of	ADP
ajlm-846	255	8	clostridium	clostridium	NOUN
ajlm-846	255	9	difficile	difficile	ADJ
ajlm-846	255	10	diarrhea	diarrhea	NOUN
ajlm-846	255	11	.	.	PUNCT
ajlm-846	256	1	clin	clin	PROPN
ajlm-846	256	2	infect	infect	PROPN
ajlm-846	256	3	dis	dis	PROPN
ajlm-846	256	4	.	.	PUNCT
ajlm-846	257	1	1993;16	1993;16	NUM
ajlm-846	257	2	suppl	suppl	ADJ
ajlm-846	257	3	4	4	NUM
ajlm-846	257	4	:	:	PUNCT
ajlm-846	257	5	s228	s228	NUM
ajlm-846	257	6	–	–	PUNCT
ajlm-846	257	7	s233	s233	NUM
ajlm-846	257	8	.	.	PUNCT
ajlm-846	258	1	https://doi.org/10.1093/clinids/16.supplement_4.s228	https://doi.org/10.1093/clinids/16.supplement_4.s228	PROPN
ajlm-846	258	2	stubbs	stubbs	PROPN
ajlm-846	258	3	s	s	PART
ajlm-846	258	4	,	,	PUNCT
ajlm-846	258	5	rupnik	rupnik	PROPN
ajlm-846	258	6	m	m	PROPN
ajlm-846	258	7	,	,	PUNCT
ajlm-846	258	8	gibert	gibert	PROPN
ajlm-846	258	9	m	m	PROPN
ajlm-846	258	10	,	,	PUNCT
ajlm-846	258	11	et	et	PROPN
ajlm-846	258	12	al	al	PROPN
ajlm-846	258	13	.	.	PUNCT
ajlm-846	259	1	production	production	NOUN
ajlm-846	259	2	of	of	ADP
ajlm-846	259	3	actin	actin	NOUN
ajlm-846	259	4	-	-	PUNCT
ajlm-846	259	5	specific	specific	ADJ
ajlm-846	259	6	adp	adp	PROPN
ajlm-846	259	7	-	-	PUNCT
ajlm-846	259	8	ribosyltransferase	ribosyltransferase	NOUN
ajlm-846	259	9	(	(	PUNCT
ajlm-846	259	10	binary	binary	ADJ
ajlm-846	259	11	toxin	toxin	NOUN
ajlm-846	259	12	)	)	PUNCT
ajlm-846	259	13	by	by	ADP
ajlm-846	259	14	strains	strain	NOUN
ajlm-846	259	15	of	of	ADP
ajlm-846	259	16	clostridium	clostridium	NOUN
ajlm-846	259	17	difficile	difficile	ADJ
ajlm-846	259	18	.	.	PUNCT
ajlm-846	260	1	fems	fems	PROPN
ajlm-846	260	2	microbiol	microbiol	PROPN
ajlm-846	260	3	lett	lett	PROPN
ajlm-846	260	4	.	.	PUNCT
ajlm-846	261	1	2000;186:307–312	2000;186:307–312	NUM
ajlm-846	261	2	.	.	PUNCT
ajlm-846	262	1	https://doi.org/10.1111/j.1574-6968.2000.tb09122.x	https://doi.org/10.1111/j.1574-6968.2000.tb09122.x	PROPN
ajlm-846	262	2	lemee	lemee	PROPN
ajlm-846	262	3	l	l	PROPN
ajlm-846	262	4	,	,	PUNCT
ajlm-846	262	5	dhalluin	dhalluin	NOUN
ajlm-846	262	6	a	a	NOUN
ajlm-846	262	7	,	,	PUNCT
ajlm-846	262	8	testelin	testelin	PROPN
ajlm-846	262	9	s	s	PART
ajlm-846	262	10	,	,	PUNCT
ajlm-846	262	11	et	et	PROPN
ajlm-846	262	12	al	al	PROPN
ajlm-846	262	13	.	.	PROPN
ajlm-846	263	1	multiplex	multiplex	PROPN
ajlm-846	263	2	pcr	pcr	PROPN
ajlm-846	263	3	targeting	target	VERB
ajlm-846	263	4	tpi	tpi	NOUN
ajlm-846	263	5	(	(	PUNCT
ajlm-846	263	6	triose	triose	NOUN
ajlm-846	263	7	phosphate	phosphate	NOUN
ajlm-846	263	8	isomerase	isomerase	NOUN
ajlm-846	263	9	)	)	PUNCT
ajlm-846	263	10	,	,	PUNCT
ajlm-846	263	11	tcda	tcda	NOUN
ajlm-846	263	12	(	(	PUNCT
ajlm-846	263	13	toxin	toxin	NOUN
ajlm-846	263	14	a	a	PRON
ajlm-846	263	15	)	)	PUNCT
ajlm-846	263	16	,	,	PUNCT
ajlm-846	263	17	and	and	CCONJ
ajlm-846	263	18	tcdb	tcdb	NOUN
ajlm-846	263	19	(	(	PUNCT
ajlm-846	263	20	toxin	toxin	NOUN
ajlm-846	263	21	b	b	NOUN
ajlm-846	263	22	)	)	PUNCT
ajlm-846	263	23	genes	gene	NOUN
ajlm-846	263	24	for	for	ADP
ajlm-846	263	25	toxigenic	toxigenic	ADJ
ajlm-846	263	26	culture	culture	NOUN
ajlm-846	263	27	of	of	ADP
ajlm-846	263	28	clostridium	clostridium	NOUN
ajlm-846	263	29	difficile	difficile	NOUN
ajlm-846	263	30	.	.	PUNCT
ajlm-846	264	1	j	j	PROPN
ajlm-846	264	2	clin	clin	PROPN
ajlm-846	264	3	microbiol	microbiol	PROPN
ajlm-846	264	4	.	.	PUNCT
ajlm-846	265	1	2004;42:5710–5714	2004;42:5710–5714	X
ajlm-846	265	2	.	.	PUNCT
ajlm-846	266	1	https://doi.org/10.1128/jcm.42.12.5710-5714.2004	https://doi.org/10.1128/jcm.42.12.5710-5714.2004	PROPN
ajlm-846	266	2	fawley	fawley	PROPN
ajlm-846	266	3	wn	wn	PROPN
ajlm-846	266	4	,	,	PUNCT
ajlm-846	266	5	knetsch	knetsch	PROPN
ajlm-846	266	6	cw	cw	PROPN
ajlm-846	266	7	,	,	PUNCT
ajlm-846	266	8	maccannell	maccannell	PROPN
ajlm-846	266	9	dr	dr	PROPN
ajlm-846	266	10	,	,	PUNCT
ajlm-846	266	11	et	et	PROPN
ajlm-846	266	12	al	al	PROPN
ajlm-846	266	13	.	.	PROPN
ajlm-846	266	14	development	development	PROPN
ajlm-846	266	15	and	and	CCONJ
ajlm-846	266	16	validation	validation	NOUN
ajlm-846	266	17	of	of	ADP
ajlm-846	266	18	an	an	DET
ajlm-846	266	19	internationally	internationally	ADV
ajlm-846	266	20	-	-	PUNCT
ajlm-846	266	21	standardized	standardized	ADJ
ajlm-846	266	22	,	,	PUNCT
ajlm-846	266	23	high	high	ADJ
ajlm-846	266	24	-	-	PUNCT
ajlm-846	266	25	resolution	resolution	NOUN
ajlm-846	266	26	capillary	capillary	ADJ
ajlm-846	266	27	gel	gel	NOUN
ajlm-846	266	28	-	-	PUNCT
ajlm-846	266	29	based	base	VERB
ajlm-846	266	30	electrophoresis	electrophoresis	NOUN
ajlm-846	266	31	pcr	pcr	NOUN
ajlm-846	266	32	-	-	PUNCT
ajlm-846	266	33	ribotyping	ribotype	VERB
ajlm-846	266	34	protocol	protocol	NOUN
ajlm-846	266	35	for	for	ADP
ajlm-846	266	36	clostridium	clostridium	NOUN
ajlm-846	266	37	difficile	difficile	NOUN
ajlm-846	266	38	.	.	PUNCT
ajlm-846	267	1	plos	plos	PROPN
ajlm-846	267	2	one	one	NUM
ajlm-846	267	3	.	.	PUNCT
ajlm-846	268	1	2015;10	2015;10	NUM
ajlm-846	268	2	:	:	PUNCT
ajlm-846	269	1	e0118150	e0118150	ADJ
ajlm-846	269	2	.	.	PUNCT
ajlm-846	270	1	https://doi.org/10.1371/journal.pone.0118150	https://doi.org/10.1371/journal.pone.0118150	PROPN
ajlm-846	270	2	van	van	PROPN
ajlm-846	270	3	den	den	PROPN
ajlm-846	270	4	berg	berg	PROPN
ajlm-846	270	5	rj	rj	PROPN
ajlm-846	270	6	,	,	PUNCT
ajlm-846	270	7	schaap	schaap	PROPN
ajlm-846	270	8	i	i	PROPN
ajlm-846	270	9	,	,	PUNCT
ajlm-846	270	10	templeton	templeton	PROPN
ajlm-846	270	11	ke	ke	PROPN
ajlm-846	270	12	,	,	PUNCT
ajlm-846	270	13	et	et	PROPN
ajlm-846	270	14	al	al	PROPN
ajlm-846	270	15	.	.	PUNCT
ajlm-846	271	1	typing	type	VERB
ajlm-846	271	2	and	and	CCONJ
ajlm-846	271	3	subtyping	subtyping	NOUN
ajlm-846	271	4	of	of	ADP
ajlm-846	271	5	clostridium	clostridium	NOUN
ajlm-846	271	6	difficile	difficile	ADJ
ajlm-846	271	7	isolates	isolate	NOUN
ajlm-846	271	8	by	by	ADP
ajlm-846	271	9	using	use	VERB
ajlm-846	271	10	multiple	multiple	ADJ
ajlm-846	271	11	-	-	PUNCT
ajlm-846	271	12	locus	locus	ADJ
ajlm-846	271	13	variable	variable	ADJ
ajlm-846	271	14	-	-	PUNCT
ajlm-846	271	15	number	number	NOUN
ajlm-846	271	16	tandem	tandem	NOUN
ajlm-846	271	17	-	-	PUNCT
ajlm-846	271	18	repeat	repeat	NOUN
ajlm-846	271	19	analysis	analysis	NOUN
ajlm-846	271	20	.	.	PUNCT
ajlm-846	272	1	j	j	PROPN
ajlm-846	272	2	clin	clin	PROPN
ajlm-846	272	3	microbiol	microbiol	PROPN
ajlm-846	272	4	.	.	PUNCT
ajlm-846	273	1	2007;45:1024–1028	2007;45:1024–1028	NOUN
ajlm-846	273	2	.	.	PUNCT
ajlm-846	274	1	https://doi.org/10.1128/jcm.02023-06	https://doi.org/10.1128/jcm.02023-06	NOUN
ajlm-846	274	2	salipante	salipante	NOUN
ajlm-846	274	3	sj	sj	PROPN
ajlm-846	274	4	,	,	PUNCT
ajlm-846	274	5	hall	hall	PROPN
ajlm-846	274	6	bg	bg	PROPN
ajlm-846	274	7	.	.	PROPN
ajlm-846	275	1	inadequacies	inadequacy	NOUN
ajlm-846	275	2	of	of	ADP
ajlm-846	275	3	minimum	minimum	ADJ
ajlm-846	275	4	spanning	span	VERB
ajlm-846	275	5	trees	tree	NOUN
ajlm-846	275	6	in	in	ADP
ajlm-846	275	7	molecular	molecular	ADJ
ajlm-846	275	8	epidemiology	epidemiology	NOUN
ajlm-846	275	9	.	.	PUNCT
ajlm-846	276	1	j	j	PROPN
ajlm-846	276	2	clin	clin	PROPN
ajlm-846	276	3	microbiol	microbiol	PROPN
ajlm-846	276	4	.	.	PUNCT
ajlm-846	277	1	2011;49:3568–3575	2011;49:3568–3575	NUM
ajlm-846	277	2	.	.	PUNCT
ajlm-846	278	1	https://doi.org/10.1128/jcm.00919-11	https://doi.org/10.1128/jcm.00919-11	PROPN
ajlm-846	278	2	bastian	bastian	PROPN
ajlm-846	278	3	m	m	PROPN
ajlm-846	278	4	,	,	PUNCT
ajlm-846	278	5	heymann	heymann	PROPN
ajlm-846	278	6	s	s	NOUN
ajlm-846	278	7	,	,	PUNCT
ajlm-846	278	8	jacomy	jacomy	NOUN
ajlm-846	278	9	m.	m.	NOUN
ajlm-846	278	10	gephi	gephi	ADJ
ajlm-846	278	11	:	:	PUNCT
ajlm-846	278	12	an	an	DET
ajlm-846	278	13	open	open	ADJ
ajlm-846	278	14	source	source	NOUN
ajlm-846	278	15	software	software	NOUN
ajlm-846	278	16	for	for	ADP
ajlm-846	278	17	exploring	explore	VERB
ajlm-846	278	18	and	and	CCONJ
ajlm-846	278	19	manipulating	manipulate	VERB
ajlm-846	278	20	networks	network	NOUN
ajlm-846	279	1	[	[	X
ajlm-846	279	2	homepage	homepage	NOUN
ajlm-846	279	3	on	on	ADP
ajlm-846	279	4	the	the	DET
ajlm-846	279	5	internet	internet	NOUN
ajlm-846	279	6	]	]	PUNCT
ajlm-846	279	7	.	.	PUNCT
ajlm-846	280	1	2009	2009	NUM
ajlm-846	281	1	[	[	X
ajlm-846	281	2	cited	cite	VERB
ajlm-846	281	3	2018	2018	NUM
ajlm-846	281	4	jun	jun	PROPN
ajlm-846	281	5	04	04	NUM
ajlm-846	281	6	]	]	PUNCT
ajlm-846	281	7	.	.	PUNCT
ajlm-846	282	1	available	available	ADJ
ajlm-846	282	2	from	from	ADP
ajlm-846	282	3	:	:	PUNCT
ajlm-846	282	4	http://www.aaai.org/ocs/index.php/icwsm/09/paper/view/154	http://www.aaai.org/ocs/index.php/icwsm/09/paper/view/154	PROPN
ajlm-846	282	5	eyre	eyre	PROPN
ajlm-846	282	6	dw	dw	PROPN
ajlm-846	282	7	,	,	PUNCT
ajlm-846	282	8	fawley	fawley	PROPN
ajlm-846	282	9	wn	wn	PROPN
ajlm-846	282	10	,	,	PUNCT
ajlm-846	282	11	best	good	ADJ
ajlm-846	282	12	el	el	PROPN
ajlm-846	282	13	,	,	PUNCT
ajlm-846	282	14	et	et	PROPN
ajlm-846	282	15	al	al	PROPN
ajlm-846	282	16	.	.	PROPN
ajlm-846	282	17	comparison	comparison	NOUN
ajlm-846	282	18	of	of	ADP
ajlm-846	282	19	multilocus	multilocus	NOUN
ajlm-846	282	20	variable	variable	ADJ
ajlm-846	282	21	-	-	PUNCT
ajlm-846	282	22	number	number	NOUN
ajlm-846	282	23	tandem	tandem	NOUN
ajlm-846	282	24	-	-	PUNCT
ajlm-846	282	25	repeat	repeat	NOUN
ajlm-846	282	26	analysis	analysis	NOUN
ajlm-846	282	27	and	and	CCONJ
ajlm-846	282	28	whole	whole	ADJ
ajlm-846	282	29	-	-	PUNCT
ajlm-846	282	30	genome	genome	NOUN
ajlm-846	282	31	sequencing	sequencing	NOUN
ajlm-846	282	32	for	for	ADP
ajlm-846	282	33	investigation	investigation	NOUN
ajlm-846	282	34	of	of	ADP
ajlm-846	282	35	clostridium	clostridium	NOUN
ajlm-846	282	36	difficile	difficile	ADJ
ajlm-846	282	37	transmission	transmission	NOUN
ajlm-846	282	38	.	.	PUNCT
ajlm-846	283	1	j	j	PROPN
ajlm-846	283	2	clin	clin	PROPN
ajlm-846	283	3	microbiol	microbiol	PROPN
ajlm-846	283	4	.	.	PUNCT
ajlm-846	284	1	2013;51:4141–4149	2013;51:4141–4149	NUM
ajlm-846	284	2	.	.	PUNCT
ajlm-846	285	1	https://doi.org/10.1128/jcm.01095-13	https://doi.org/10.1128/jcm.01095-13	PROPN
ajlm-846	285	2	marsh	marsh	PROPN
ajlm-846	285	3	jw	jw	PROPN
ajlm-846	285	4	,	,	PUNCT
ajlm-846	285	5	o’leary	o’leary	PROPN
ajlm-846	285	6	mm	mm	PROPN
ajlm-846	285	7	,	,	PUNCT
ajlm-846	285	8	shutt	shutt	PROPN
ajlm-846	285	9	ka	ka	PROPN
ajlm-846	285	10	,	,	PUNCT
ajlm-846	285	11	et	et	PROPN
ajlm-846	285	12	al	al	PROPN
ajlm-846	285	13	.	.	PROPN
ajlm-846	286	1	multilocus	multilocus	PROPN
ajlm-846	286	2	variable	variable	ADJ
ajlm-846	286	3	-	-	PUNCT
ajlm-846	286	4	number	number	NOUN
ajlm-846	286	5	tandem	tandem	NOUN
ajlm-846	286	6	-	-	PUNCT
ajlm-846	286	7	repeat	repeat	NOUN
ajlm-846	286	8	analysis	analysis	NOUN
ajlm-846	286	9	for	for	ADP
ajlm-846	286	10	investigation	investigation	NOUN
ajlm-846	286	11	of	of	ADP
ajlm-846	286	12	clostridium	clostridium	NOUN
ajlm-846	286	13	difficile	difficile	ADJ
ajlm-846	286	14	transmission	transmission	NOUN
ajlm-846	286	15	in	in	ADP
ajlm-846	286	16	hospitals	hospital	NOUN
ajlm-846	286	17	.	.	PUNCT
ajlm-846	287	1	j	j	PROPN
ajlm-846	287	2	clin	clin	PROPN
ajlm-846	287	3	microbiol	microbiol	PROPN
ajlm-846	287	4	.	.	PUNCT
ajlm-846	288	1	2006;44:2558–2566	2006;44:2558–2566	NUM
ajlm-846	288	2	.	.	PUNCT
ajlm-846	289	1	https://doi.org/10.1128/jcm.02364-05	https://doi.org/10.1128/jcm.02364-05	PROPN
ajlm-846	289	2	clinical	clinical	ADJ
ajlm-846	289	3	and	and	CCONJ
ajlm-846	289	4	laboratory	laboratory	NOUN
ajlm-846	289	5	standards	standard	NOUN
ajlm-846	289	6	institute	institute	PROPN
ajlm-846	289	7	(	(	PUNCT
ajlm-846	289	8	clsi	clsi	PROPN
ajlm-846	289	9	)	)	PUNCT
ajlm-846	289	10	.	.	PUNCT
ajlm-846	290	1	performance	performance	NOUN
ajlm-846	290	2	standards	standard	NOUN
ajlm-846	290	3	for	for	ADP
ajlm-846	290	4	antimicrobial	antimicrobial	ADJ
ajlm-846	290	5	susceptibility	susceptibility	NOUN
ajlm-846	290	6	testing	testing	NOUN
ajlm-846	290	7	.	.	PUNCT
ajlm-846	291	1	28th	28th	ADJ
ajlm-846	291	2	ed	ed	NOUN
ajlm-846	291	3	.	.	PUNCT
ajlm-846	291	4	clsi	clsi	PROPN
ajlm-846	291	5	supplement	supplement	NOUN
ajlm-846	291	6	m100	m100	PROPN
ajlm-846	291	7	.	.	PUNCT
ajlm-846	292	1	28th	28th	ADJ
ajlm-846	292	2	ed	ed	NOUN
ajlm-846	292	3	.	.	PUNCT
ajlm-846	293	1	wayne	wayne	PROPN
ajlm-846	293	2	,	,	PUNCT
ajlm-846	293	3	pa	pa	PROPN
ajlm-846	293	4	,	,	PUNCT
ajlm-846	293	5	usa	usa	PROPN
ajlm-846	293	6	:	:	PUNCT
ajlm-846	293	7	clinical	clinical	ADJ
ajlm-846	293	8	and	and	CCONJ
ajlm-846	293	9	laboratory	laboratory	NOUN
ajlm-846	293	10	standards	standard	NOUN
ajlm-846	293	11	institute	institute	NOUN
ajlm-846	293	12	;	;	PUNCT
ajlm-846	293	13	2018	2018	NUM
ajlm-846	293	14	.	.	PUNCT
ajlm-846	294	1	eucast	eucast	NOUN
ajlm-846	294	2	.	.	PUNCT
ajlm-846	295	1	the	the	DET
ajlm-846	295	2	european	european	PROPN
ajlm-846	295	3	committee	committee	PROPN
ajlm-846	295	4	on	on	ADP
ajlm-846	295	5	antimicrobial	antimicrobial	ADJ
ajlm-846	295	6	susceptibility	susceptibility	NOUN
ajlm-846	295	7	testing	testing	NOUN
ajlm-846	295	8	.	.	PUNCT
ajlm-846	296	1	breakpoint	breakpoint	NOUN
ajlm-846	296	2	tables	table	NOUN
ajlm-846	296	3	for	for	ADP
ajlm-846	296	4	interpretation	interpretation	NOUN
ajlm-846	296	5	of	of	ADP
ajlm-846	296	6	mics	mic	NOUN
ajlm-846	296	7	and	and	CCONJ
ajlm-846	296	8	zone	zone	NOUN
ajlm-846	296	9	diameters	diameter	NOUN
ajlm-846	297	1	[	[	X
ajlm-846	297	2	homepage	homepage	NOUN
ajlm-846	297	3	on	on	ADP
ajlm-846	297	4	the	the	DET
ajlm-846	297	5	internet	internet	NOUN
ajlm-846	297	6	]	]	PUNCT
ajlm-846	297	7	.	.	PUNCT
ajlm-846	298	1	version	version	NOUN
ajlm-846	298	2	8.1	8.1	NUM
ajlm-846	298	3	.	.	PUNCT
ajlm-846	299	1	2018	2018	NUM
ajlm-846	300	1	[	[	X
ajlm-846	300	2	cited	cite	VERB
ajlm-846	300	3	2018	2018	NUM
ajlm-846	300	4	jun	jun	PROPN
ajlm-846	300	5	04	04	NUM
ajlm-846	300	6	]	]	PUNCT
ajlm-846	300	7	.	.	PUNCT
ajlm-846	301	1	available	available	ADJ
ajlm-846	301	2	from	from	ADP
ajlm-846	301	3	:	:	PUNCT
ajlm-846	301	4	http://www.eucast.org	http://www.eucast.org	PROPN
ajlm-846	301	5	freeman	freeman	PROPN
ajlm-846	301	6	j	j	PROPN
ajlm-846	301	7	,	,	PUNCT
ajlm-846	301	8	vernon	vernon	PROPN
ajlm-846	301	9	j	j	PROPN
ajlm-846	301	10	,	,	PUNCT
ajlm-846	301	11	morris	morris	PROPN
ajlm-846	301	12	k	k	PROPN
ajlm-846	301	13	,	,	PUNCT
ajlm-846	301	14	et	et	PROPN
ajlm-846	301	15	al	al	PROPN
ajlm-846	301	16	.	.	PROPN
ajlm-846	302	1	pan	pan	ADJ
ajlm-846	302	2	-	-	ADJ
ajlm-846	302	3	european	european	ADJ
ajlm-846	302	4	longitudinal	longitudinal	ADJ
ajlm-846	302	5	surveillance	surveillance	NOUN
ajlm-846	302	6	of	of	ADP
ajlm-846	302	7	antibiotic	antibiotic	ADJ
ajlm-846	302	8	resistance	resistance	NOUN
ajlm-846	302	9	among	among	ADP
ajlm-846	302	10	prevalent	prevalent	ADJ
ajlm-846	302	11	clostridium	clostridium	NOUN
ajlm-846	302	12	difficile	difficile	ADJ
ajlm-846	302	13	ribotypes	ribotype	NOUN
ajlm-846	302	14	.	.	PUNCT
ajlm-846	303	1	clin	clin	PROPN
ajlm-846	303	2	microbiol	microbiol	PROPN
ajlm-846	303	3	infect	infect	VERB
ajlm-846	303	4	.	.	PUNCT
ajlm-846	304	1	2015;21:248.e9–248.e16	2015;21:248.e9–248.e16	X
ajlm-846	304	2	.	.	PUNCT
ajlm-846	305	1	baines	baine	NOUN
ajlm-846	305	2	sd	sd	NOUN
ajlm-846	305	3	,	,	PUNCT
ajlm-846	305	4	o’connor	o’connor	ADV
ajlm-846	305	5	r	r	NOUN
ajlm-846	305	6	,	,	PUNCT
ajlm-846	305	7	freeman	freeman	PROPN
ajlm-846	305	8	j	j	PROPN
ajlm-846	305	9	,	,	PUNCT
ajlm-846	305	10	et	et	PROPN
ajlm-846	305	11	al	al	PROPN
ajlm-846	305	12	.	.	PROPN
ajlm-846	305	13	emergence	emergence	NOUN
ajlm-846	305	14	of	of	ADP
ajlm-846	305	15	reduced	reduce	VERB
ajlm-846	305	16	susceptibility	susceptibility	NOUN
ajlm-846	305	17	to	to	PART
ajlm-846	305	18	metronidazole	metronidazole	VERB
ajlm-846	305	19	in	in	ADP
ajlm-846	305	20	clostridium	clostridium	NOUN
ajlm-846	305	21	difficile	difficile	NOUN
ajlm-846	305	22	.	.	PUNCT
ajlm-846	306	1	j	j	PROPN
ajlm-846	306	2	antimicrob	antimicrob	PROPN
ajlm-846	306	3	chemother	chemother	PROPN
ajlm-846	306	4	.	.	PUNCT
ajlm-846	307	1	2008;62:1046–1052	2008;62:1046–1052	PRON
ajlm-846	307	2	.	.	PUNCT
ajlm-846	308	1	https://doi.org/10.1093/jac/dkn313	https://doi.org/10.1093/jac/dkn313	PROPN
ajlm-846	308	2	wilcox	wilcox	PROPN
ajlm-846	308	3	mh	mh	PROPN
ajlm-846	308	4	,	,	PUNCT
ajlm-846	308	5	shetty	shetty	PROPN
ajlm-846	308	6	n	n	CCONJ
ajlm-846	308	7	,	,	PUNCT
ajlm-846	308	8	fawley	fawley	PROPN
ajlm-846	308	9	wn	wn	PROPN
ajlm-846	308	10	,	,	PUNCT
ajlm-846	308	11	et	et	PROPN
ajlm-846	308	12	al	al	PROPN
ajlm-846	308	13	.	.	PUNCT
ajlm-846	308	14	changing	change	VERB
ajlm-846	308	15	epidemiology	epidemiology	NOUN
ajlm-846	308	16	of	of	ADP
ajlm-846	308	17	clostridium	clostridium	NOUN
ajlm-846	308	18	difficile	difficile	ADJ
ajlm-846	308	19	infection	infection	NOUN
ajlm-846	308	20	following	follow	VERB
ajlm-846	308	21	the	the	DET
ajlm-846	308	22	introduction	introduction	NOUN
ajlm-846	308	23	of	of	ADP
ajlm-846	308	24	a	a	DET
ajlm-846	308	25	national	national	ADJ
ajlm-846	308	26	ribotyping	ribotyping	NOUN
ajlm-846	308	27	-	-	PUNCT
ajlm-846	308	28	based	base	VERB
ajlm-846	308	29	surveillance	surveillance	NOUN
ajlm-846	308	30	scheme	scheme	NOUN
ajlm-846	308	31	in	in	ADP
ajlm-846	308	32	england	england	PROPN
ajlm-846	308	33	.	.	PUNCT
ajlm-846	309	1	clin	clin	PROPN
ajlm-846	309	2	infect	infect	PROPN
ajlm-846	309	3	dis	dis	PROPN
ajlm-846	309	4	.	.	PUNCT
ajlm-846	310	1	2012;55:1056–1063	2012;55:1056–1063	NUM
ajlm-846	310	2	.	.	PUNCT
ajlm-846	311	1	https://doi.org/10.1093/cid/cis614	https://doi.org/10.1093/cid/cis614	PROPN
ajlm-846	311	2	al	al	PROPN
ajlm-846	311	3	-	-	PUNCT
ajlm-846	311	4	barrak	barrak	PROPN
ajlm-846	311	5	a	a	X
ajlm-846	311	6	,	,	PUNCT
ajlm-846	311	7	embil	embil	PROPN
ajlm-846	311	8	j	j	PROPN
ajlm-846	311	9	,	,	PUNCT
ajlm-846	311	10	dyck	dyck	PROPN
ajlm-846	311	11	b	b	PROPN
ajlm-846	311	12	,	,	PUNCT
ajlm-846	311	13	et	et	PROPN
ajlm-846	311	14	al	al	PROPN
ajlm-846	311	15	.	.	PUNCT
ajlm-846	312	1	an	an	DET
ajlm-846	312	2	outbreak	outbreak	NOUN
ajlm-846	312	3	of	of	ADP
ajlm-846	312	4	toxin	toxin	NOUN
ajlm-846	312	5	a	a	DET
ajlm-846	312	6	negative	negative	ADJ
ajlm-846	312	7	,	,	PUNCT
ajlm-846	312	8	toxin	toxin	NOUN
ajlm-846	312	9	b	b	NUM
ajlm-846	312	10	positive	positive	ADJ
ajlm-846	312	11	clostridium	clostridium	NOUN
ajlm-846	312	12	difficile	difficile	VERB
ajlm-846	312	13	-	-	PUNCT
ajlm-846	312	14	associated	associate	VERB
ajlm-846	312	15	diarrhea	diarrhea	NOUN
ajlm-846	312	16	in	in	ADP
ajlm-846	312	17	a	a	DET
ajlm-846	312	18	canadian	canadian	ADJ
ajlm-846	312	19	tertiary	tertiary	ADJ
ajlm-846	312	20	-	-	PUNCT
ajlm-846	312	21	care	care	NOUN
ajlm-846	312	22	hospital	hospital	NOUN
ajlm-846	312	23	.	.	PUNCT
ajlm-846	313	1	can	can	AUX
ajlm-846	313	2	commun	commun	VERB
ajlm-846	313	3	dis	dis	PROPN
ajlm-846	313	4	rep	rep	PROPN
ajlm-846	313	5	.	.	PROPN
ajlm-846	313	6	1999;25:65–69	1999;25:65–69	NUM
ajlm-846	313	7	.	.	PUNCT
ajlm-846	314	1	hawkey	hawkey	PROPN
ajlm-846	314	2	pm	pm	PROPN
ajlm-846	314	3	,	,	PUNCT
ajlm-846	314	4	marriott	marriott	PROPN
ajlm-846	314	5	c	c	PROPN
ajlm-846	314	6	,	,	PUNCT
ajlm-846	314	7	liu	liu	PROPN
ajlm-846	314	8	we	we	PRON
ajlm-846	314	9	,	,	PUNCT
ajlm-846	314	10	et	et	PROPN
ajlm-846	314	11	al	al	PROPN
ajlm-846	314	12	.	.	PROPN
ajlm-846	315	1	molecular	molecular	ADJ
ajlm-846	315	2	epidemiology	epidemiology	NOUN
ajlm-846	315	3	of	of	ADP
ajlm-846	315	4	clostridium	clostridium	NOUN
ajlm-846	315	5	difficile	difficile	ADJ
ajlm-846	315	6	infection	infection	NOUN
ajlm-846	315	7	in	in	ADP
ajlm-846	315	8	a	a	DET
ajlm-846	315	9	major	major	ADJ
ajlm-846	315	10	chinese	chinese	ADJ
ajlm-846	315	11	hospital	hospital	NOUN
ajlm-846	315	12	:	:	PUNCT
ajlm-846	315	13	an	an	DET
ajlm-846	315	14	underrecognized	underrecognized	ADJ
ajlm-846	315	15	problem	problem	NOUN
ajlm-846	315	16	in	in	ADP
ajlm-846	315	17	asia	asia	PROPN
ajlm-846	315	18	?	?	PUNCT
ajlm-846	316	1	j	j	PROPN
ajlm-846	316	2	clin	clin	PROPN
ajlm-846	316	3	microbiol	microbiol	PROPN
ajlm-846	316	4	.	.	PUNCT
ajlm-846	317	1	2013;51:3308–3313	2013;51:3308–3313	NUM
ajlm-846	317	2	.	.	PUNCT
ajlm-846	318	1	https://doi.org/10.1128/jcm.00587-13	https://doi.org/10.1128/jcm.00587-13	PROPN
ajlm-846	318	2	kim	kim	PROPN
ajlm-846	318	3	h	h	PROPN
ajlm-846	318	4	,	,	PUNCT
ajlm-846	318	5	riley	riley	PROPN
ajlm-846	318	6	tv	tv	PROPN
ajlm-846	318	7	,	,	PUNCT
ajlm-846	318	8	kim	kim	PROPN
ajlm-846	318	9	m	m	PROPN
ajlm-846	318	10	,	,	PUNCT
ajlm-846	318	11	et	et	PROPN
ajlm-846	318	12	al	al	PROPN
ajlm-846	318	13	.	.	PUNCT
ajlm-846	319	1	increasing	increase	VERB
ajlm-846	319	2	prevalence	prevalence	NOUN
ajlm-846	319	3	of	of	ADP
ajlm-846	319	4	toxin	toxin	NOUN
ajlm-846	319	5	a	a	PRON
ajlm-846	319	6	-	-	PUNCT
ajlm-846	319	7	negative	negative	ADJ
ajlm-846	319	8	,	,	PUNCT
ajlm-846	319	9	toxin	toxin	NOUN
ajlm-846	319	10	b	b	NOUN
ajlm-846	319	11	-	-	PUNCT
ajlm-846	319	12	positive	positive	ADJ
ajlm-846	319	13	isolates	isolate	NOUN
ajlm-846	319	14	of	of	ADP
ajlm-846	319	15	clostridium	clostridium	NOUN
ajlm-846	319	16	difficile	difficile	NOUN
ajlm-846	319	17	in	in	ADP
ajlm-846	319	18	korea	korea	PROPN
ajlm-846	319	19	:	:	PUNCT
ajlm-846	319	20	impact	impact	NOUN
ajlm-846	319	21	on	on	ADP
ajlm-846	319	22	laboratory	laboratory	NOUN
ajlm-846	319	23	diagnosis	diagnosis	NOUN
ajlm-846	319	24	.	.	PUNCT
ajlm-846	320	1	j	j	PROPN
ajlm-846	320	2	clin	clin	PROPN
ajlm-846	320	3	microbiol	microbiol	PROPN
ajlm-846	320	4	.	.	PUNCT
ajlm-846	321	1	2008;46:1116–1117	2008;46:1116–1117	NUM
ajlm-846	321	2	.	.	PUNCT
ajlm-846	322	1	https://doi.org/10.1128/jcm.01188-07	https://doi.org/10.1128/jcm.01188-07	NOUN
ajlm-846	322	2	goorhuis	goorhuis	NOUN
ajlm-846	322	3	a	a	PRON
ajlm-846	322	4	,	,	PUNCT
ajlm-846	322	5	legaria	legaria	PROPN
ajlm-846	322	6	mc	mc	PROPN
ajlm-846	322	7	,	,	PUNCT
ajlm-846	322	8	van	van	PROPN
ajlm-846	322	9	den	den	PROPN
ajlm-846	322	10	berg	berg	PROPN
ajlm-846	322	11	rj	rj	PROPN
ajlm-846	322	12	,	,	PUNCT
ajlm-846	322	13	et	et	PROPN
ajlm-846	322	14	al	al	PROPN
ajlm-846	322	15	.	.	PUNCT
ajlm-846	322	16	application	application	NOUN
ajlm-846	322	17	of	of	ADP
ajlm-846	322	18	multiple	multiple	ADJ
ajlm-846	322	19	-	-	PUNCT
ajlm-846	322	20	locus	locus	ADJ
ajlm-846	322	21	variable	variable	ADJ
ajlm-846	322	22	-	-	PUNCT
ajlm-846	322	23	number	number	NOUN
ajlm-846	322	24	tandem	tandem	NOUN
ajlm-846	322	25	-	-	PUNCT
ajlm-846	322	26	repeat	repeat	NOUN
ajlm-846	322	27	analysis	analysis	NOUN
ajlm-846	322	28	to	to	PART
ajlm-846	322	29	determine	determine	VERB
ajlm-846	322	30	clonal	clonal	ADJ
ajlm-846	322	31	spread	spread	NOUN
ajlm-846	322	32	of	of	ADP
ajlm-846	322	33	toxin	toxin	NOUN
ajlm-846	322	34	a	a	PRON
ajlm-846	322	35	-	-	PUNCT
ajlm-846	322	36	negative	negative	ADJ
ajlm-846	322	37	clostridium	clostridium	NOUN
ajlm-846	322	38	difficile	difficile	NOUN
ajlm-846	322	39	in	in	ADP
ajlm-846	322	40	a	a	DET
ajlm-846	322	41	general	general	ADJ
ajlm-846	322	42	hospital	hospital	NOUN
ajlm-846	322	43	in	in	ADP
ajlm-846	322	44	buenos	buenos	PROPN
ajlm-846	322	45	aires	aires	PROPN
ajlm-846	322	46	,	,	PUNCT
ajlm-846	322	47	argentina	argentina	PROPN
ajlm-846	322	48	.	.	PUNCT
ajlm-846	323	1	clin	clin	PROPN
ajlm-846	323	2	microbiol	microbiol	PROPN
ajlm-846	323	3	infect	infect	PROPN
ajlm-846	323	4	.	.	PUNCT
ajlm-846	324	1	2009;15:1080–1086	2009;15:1080–1086	NUM
ajlm-846	324	2	.	.	PUNCT
ajlm-846	325	1	samra	samra	PROPN
ajlm-846	325	2	z	z	PROPN
ajlm-846	325	3	,	,	PUNCT
ajlm-846	325	4	talmor	talmor	PROPN
ajlm-846	325	5	s	s	PROPN
ajlm-846	325	6	,	,	PUNCT
ajlm-846	325	7	bahar	bahar	PROPN
ajlm-846	325	8	j.	j.	PROPN
ajlm-846	325	9	high	high	PROPN
ajlm-846	325	10	prevalence	prevalence	NOUN
ajlm-846	325	11	of	of	ADP
ajlm-846	325	12	toxin	toxin	NOUN
ajlm-846	325	13	a	a	PRON
ajlm-846	325	14	-	-	PUNCT
ajlm-846	325	15	negative	negative	ADJ
ajlm-846	325	16	toxin	toxin	NOUN
ajlm-846	325	17	b	b	NOUN
ajlm-846	325	18	-	-	PUNCT
ajlm-846	325	19	positive	positive	ADJ
ajlm-846	325	20	clostridium	clostridium	NOUN
ajlm-846	325	21	difficile	difficile	NOUN
ajlm-846	325	22	in	in	ADP
ajlm-846	325	23	hospitalized	hospitalize	VERB
ajlm-846	325	24	patients	patient	NOUN
ajlm-846	325	25	with	with	ADP
ajlm-846	325	26	gastrointestinal	gastrointestinal	ADJ
ajlm-846	325	27	disease	disease	NOUN
ajlm-846	325	28	.	.	PUNCT
ajlm-846	326	1	diagn	diagn	PROPN
ajlm-846	326	2	microbiol	microbiol	PROPN
ajlm-846	326	3	infect	infect	VERB
ajlm-846	326	4	dis	dis	PROPN
ajlm-846	326	5	.	.	PUNCT
ajlm-846	327	1	2002;43:189–192	2002;43:189–192	X
ajlm-846	327	2	.	.	PUNCT
ajlm-846	327	3	https://doi.org/10.1016/s0732-8893(02)00400-5	https://doi.org/10.1016/s0732-8893(02)00400-5	PROPN
ajlm-846	327	4	komatsu	komatsu	PROPN
ajlm-846	327	5	m	m	PROPN
ajlm-846	327	6	,	,	PUNCT
ajlm-846	327	7	kato	kato	PROPN
ajlm-846	327	8	h	h	PROPN
ajlm-846	327	9	,	,	PUNCT
ajlm-846	327	10	aihara	aihara	PROPN
ajlm-846	327	11	m	m	PROPN
ajlm-846	327	12	,	,	PUNCT
ajlm-846	327	13	et	et	PROPN
ajlm-846	327	14	al	al	PROPN
ajlm-846	327	15	.	.	PROPN
ajlm-846	327	16	high	high	ADJ
ajlm-846	327	17	frequency	frequency	NOUN
ajlm-846	327	18	of	of	ADP
ajlm-846	327	19	antibiotic	antibiotic	NOUN
ajlm-846	327	20	-	-	PUNCT
ajlm-846	327	21	associated	associate	VERB
ajlm-846	327	22	diarrhea	diarrhea	NOUN
ajlm-846	327	23	due	due	ADJ
ajlm-846	327	24	to	to	ADP
ajlm-846	327	25	toxin	toxin	NOUN
ajlm-846	327	26	a	a	PRON
ajlm-846	327	27	-	-	PUNCT
ajlm-846	327	28	negative	negative	ADJ
ajlm-846	327	29	,	,	PUNCT
ajlm-846	327	30	toxin	toxin	NOUN
ajlm-846	327	31	b	b	X
ajlm-846	327	32	-	-	PUNCT
ajlm-846	327	33	positive	positive	ADJ
ajlm-846	327	34	clostridium	clostridium	NOUN
ajlm-846	327	35	difficile	difficile	NOUN
ajlm-846	327	36	in	in	ADP
ajlm-846	327	37	a	a	DET
ajlm-846	327	38	hospital	hospital	NOUN
ajlm-846	327	39	in	in	ADP
ajlm-846	327	40	japan	japan	PROPN
ajlm-846	327	41	and	and	CCONJ
ajlm-846	327	42	risk	risk	NOUN
ajlm-846	327	43	factors	factor	NOUN
ajlm-846	327	44	for	for	ADP
ajlm-846	327	45	infection	infection	NOUN
ajlm-846	327	46	.	.	PUNCT
ajlm-846	328	1	eur	eur	PROPN
ajlm-846	328	2	j	j	PROPN
ajlm-846	328	3	clin	clin	PROPN
ajlm-846	328	4	microbiol	microbiol	PROPN
ajlm-846	328	5	infect	infect	VERB
ajlm-846	328	6	dis	dis	PROPN
ajlm-846	328	7	.	.	PUNCT
ajlm-846	329	1	2003;22:525–529	2003;22:525–529	NOUN
ajlm-846	329	2	.	.	PUNCT
ajlm-846	330	1	https://doi.org/10.1007/s10096-003-0992-5	https://doi.org/10.1007/s10096-003-0992-5	NUM
ajlm-846	330	2	drudy	drudy	ADJ
ajlm-846	330	3	d	d	NOUN
ajlm-846	330	4	,	,	PUNCT
ajlm-846	330	5	harnedy	harnedy	NOUN
ajlm-846	330	6	n	n	CCONJ
ajlm-846	330	7	,	,	PUNCT
ajlm-846	330	8	fanning	fan	VERB
ajlm-846	330	9	s	s	PROPN
ajlm-846	330	10	,	,	PUNCT
ajlm-846	330	11	et	et	PROPN
ajlm-846	330	12	al	al	PROPN
ajlm-846	330	13	.	.	PUNCT
ajlm-846	330	14	isolation	isolation	NOUN
ajlm-846	330	15	and	and	CCONJ
ajlm-846	330	16	characterisation	characterisation	NOUN
ajlm-846	330	17	of	of	ADP
ajlm-846	330	18	toxin	toxin	NOUN
ajlm-846	330	19	a	a	PRON
ajlm-846	330	20	-	-	PUNCT
ajlm-846	330	21	negative	negative	ADJ
ajlm-846	330	22	,	,	PUNCT
ajlm-846	330	23	toxin	toxin	NOUN
ajlm-846	330	24	b	b	X
ajlm-846	330	25	-	-	PUNCT
ajlm-846	330	26	positive	positive	ADJ
ajlm-846	330	27	clostridium	clostridium	NOUN
ajlm-846	330	28	difficile	difficile	NOUN
ajlm-846	330	29	in	in	ADP
ajlm-846	330	30	dublin	dublin	PROPN
ajlm-846	330	31	,	,	PUNCT
ajlm-846	330	32	ireland	ireland	PROPN
ajlm-846	330	33	.	.	PUNCT
ajlm-846	331	1	clin	clin	PROPN
ajlm-846	331	2	microbiol	microbiol	PROPN
ajlm-846	331	3	infect	infect	PROPN
ajlm-846	331	4	.	.	PUNCT
ajlm-846	332	1	2007;13:298–304	2007;13:298–304	X
ajlm-846	332	2	.	.	PUNCT
ajlm-846	333	1	spigaglia	spigaglia	PROPN
ajlm-846	333	2	p	p	NOUN
ajlm-846	333	3	,	,	PUNCT
ajlm-846	333	4	barbanti	barbanti	PROPN
ajlm-846	333	5	f	f	PROPN
ajlm-846	333	6	,	,	PUNCT
ajlm-846	333	7	mastrantonio	mastrantonio	VERB
ajlm-846	333	8	p	p	X
ajlm-846	333	9	,	,	PUNCT
ajlm-846	333	10	et	et	PROPN
ajlm-846	333	11	al	al	PROPN
ajlm-846	333	12	.	.	PROPN
ajlm-846	334	1	multidrug	multidrug	VERB
ajlm-846	334	2	resistance	resistance	NOUN
ajlm-846	334	3	in	in	ADP
ajlm-846	334	4	european	european	ADJ
ajlm-846	334	5	clostridium	clostridium	NOUN
ajlm-846	334	6	difficile	difficile	VERB
ajlm-846	334	7	clinical	clinical	ADJ
ajlm-846	334	8	isolates	isolate	NOUN
ajlm-846	334	9	.	.	PUNCT
ajlm-846	335	1	j	j	PROPN
ajlm-846	335	2	antimicrob	antimicrob	PROPN
ajlm-846	335	3	chemother	chemother	PROPN
ajlm-846	335	4	.	.	PUNCT
ajlm-846	336	1	2011;66:2227–2234	2011;66:2227–2234	X
ajlm-846	336	2	.	.	PUNCT
ajlm-846	337	1	https://doi.org/10.1093/jac/dkr292	https://doi.org/10.1093/jac/dkr292	PROPN
ajlm-846	337	2	walker	walker	PROPN
ajlm-846	337	3	as	as	ADP
ajlm-846	337	4	,	,	PUNCT
ajlm-846	337	5	eyre	eyre	PROPN
ajlm-846	337	6	dw	dw	PROPN
ajlm-846	337	7	,	,	PUNCT
ajlm-846	337	8	wyllie	wyllie	PROPN
ajlm-846	337	9	dh	dh	PROPN
ajlm-846	337	10	,	,	PUNCT
ajlm-846	337	11	et	et	PROPN
ajlm-846	337	12	al	al	PROPN
ajlm-846	337	13	.	.	PROPN
ajlm-846	337	14	relationship	relationship	NOUN
ajlm-846	337	15	between	between	ADP
ajlm-846	337	16	bacterial	bacterial	ADJ
ajlm-846	337	17	strain	strain	NOUN
ajlm-846	337	18	type	type	NOUN
ajlm-846	337	19	,	,	PUNCT
ajlm-846	337	20	host	host	NOUN
ajlm-846	337	21	biomarkers	biomarker	NOUN
ajlm-846	337	22	,	,	PUNCT
ajlm-846	337	23	and	and	CCONJ
ajlm-846	337	24	mortality	mortality	NOUN
ajlm-846	337	25	in	in	ADP
ajlm-846	337	26	clostridium	clostridium	NOUN
ajlm-846	337	27	difficile	difficile	ADJ
ajlm-846	337	28	infection	infection	NOUN
ajlm-846	337	29	.	.	PUNCT
ajlm-846	338	1	clin	clin	PROPN
ajlm-846	338	2	infect	infect	PROPN
ajlm-846	338	3	dis	dis	PROPN
ajlm-846	338	4	.	.	PUNCT
ajlm-846	339	1	2013;56:1589–1600	2013;56:1589–1600	X
ajlm-846	339	2	.	.	PUNCT
ajlm-846	340	1	https://doi.org/10.1093/cid/cit127	https://doi.org/10.1093/cid/cit127	PROPN
ajlm-846	340	2	kullin	kullin	PROPN
ajlm-846	340	3	b	b	PROPN
ajlm-846	340	4	,	,	PUNCT
ajlm-846	340	5	brock	brock	PROPN
ajlm-846	340	6	t	t	PROPN
ajlm-846	340	7	,	,	PUNCT
ajlm-846	340	8	rajabally	rajabally	ADV
ajlm-846	340	9	n	n	CCONJ
ajlm-846	340	10	,	,	PUNCT
ajlm-846	340	11	et	et	PROPN
ajlm-846	340	12	al	al	PROPN
ajlm-846	340	13	.	.	PROPN
ajlm-846	340	14	characterisation	characterisation	NOUN
ajlm-846	340	15	of	of	ADP
ajlm-846	340	16	clostridium	clostridium	NOUN
ajlm-846	340	17	difficile	difficile	NOUN
ajlm-846	340	18	strains	strain	NOUN
ajlm-846	340	19	isolated	isolate	VERB
ajlm-846	340	20	from	from	ADP
ajlm-846	340	21	groote	groote	PROPN
ajlm-846	340	22	schuur	schuur	PROPN
ajlm-846	340	23	hospital	hospital	PROPN
ajlm-846	340	24	,	,	PUNCT
ajlm-846	340	25	cape	cape	NOUN
ajlm-846	340	26	town	town	NOUN
ajlm-846	340	27	,	,	PUNCT
ajlm-846	340	28	south	south	PROPN
ajlm-846	340	29	africa	africa	PROPN
ajlm-846	340	30	.	.	PUNCT
ajlm-846	341	1	eur	eur	PROPN
ajlm-846	341	2	j	j	PROPN
ajlm-846	341	3	clin	clin	PROPN
ajlm-846	341	4	microbiol	microbiol	PROPN
ajlm-846	341	5	infect	infect	VERB
ajlm-846	341	6	dis	dis	PROPN
ajlm-846	341	7	.	.	PUNCT
ajlm-846	342	1	2016;35:1709–1718	2016;35:1709–1718	X
ajlm-846	342	2	.	.	PUNCT
ajlm-846	343	1	https://doi.org/10.1007/s10096-016-2717-6	https://doi.org/10.1007/s10096-016-2717-6	PROPN
ajlm-846	343	2	eyre	eyre	PROPN
ajlm-846	343	3	dw	dw	PROPN
ajlm-846	343	4	,	,	PUNCT
ajlm-846	343	5	cule	cule	PROPN
ajlm-846	343	6	ml	ml	PROPN
ajlm-846	343	7	,	,	PUNCT
ajlm-846	343	8	wilson	wilson	PROPN
ajlm-846	343	9	dj	dj	PROPN
ajlm-846	343	10	,	,	PUNCT
ajlm-846	343	11	et	et	PROPN
ajlm-846	343	12	al	al	PROPN
ajlm-846	343	13	.	.	PUNCT
ajlm-846	344	1	diverse	diverse	ADJ
ajlm-846	344	2	sources	source	NOUN
ajlm-846	344	3	of	of	ADP
ajlm-846	344	4	c.	c.	PROPN
ajlm-846	344	5	difficile	difficile	PROPN
ajlm-846	344	6	infection	infection	NOUN
ajlm-846	344	7	identified	identify	VERB
ajlm-846	344	8	on	on	ADP
ajlm-846	344	9	whole	whole	ADJ
ajlm-846	344	10	-	-	PUNCT
ajlm-846	344	11	genome	genome	NOUN
ajlm-846	344	12	sequencing	sequencing	NOUN
ajlm-846	344	13	.	.	PUNCT
ajlm-846	345	1	n	n	CCONJ
ajlm-846	345	2	engl	engl	PROPN
ajlm-846	345	3	j	j	PROPN
ajlm-846	345	4	med	med	PROPN
ajlm-846	345	5	.	.	PUNCT
ajlm-846	346	1	2013;369:1195–1205	2013;369:1195–1205	NUM
ajlm-846	346	2	.	.	PUNCT
ajlm-846	347	1	https://doi.org/10.1056/nejmoa1216064	https://doi.org/10.1056/nejmoa1216064	NOUN
ajlm-846	347	2	curry	curry	PROPN
ajlm-846	347	3	sr	sr	PROPN
ajlm-846	347	4	,	,	PUNCT
ajlm-846	347	5	marsh	marsh	PROPN
ajlm-846	347	6	jw	jw	PROPN
ajlm-846	347	7	,	,	PUNCT
ajlm-846	347	8	shutt	shutt	PROPN
ajlm-846	347	9	ka	ka	PROPN
ajlm-846	347	10	,	,	PUNCT
ajlm-846	347	11	et	et	PROPN
ajlm-846	347	12	al	al	PROPN
ajlm-846	347	13	.	.	PROPN
ajlm-846	347	14	high	high	ADJ
ajlm-846	347	15	frequency	frequency	NOUN
ajlm-846	347	16	of	of	ADP
ajlm-846	347	17	rifampin	rifampin	NOUN
ajlm-846	347	18	resistance	resistance	NOUN
ajlm-846	347	19	identified	identify	VERB
ajlm-846	347	20	in	in	ADP
ajlm-846	347	21	an	an	DET
ajlm-846	347	22	epidemic	epidemic	NOUN
ajlm-846	347	23	clostridium	clostridium	NOUN
ajlm-846	347	24	difficile	difficile	NOUN
ajlm-846	347	25	clone	clone	NOUN
ajlm-846	347	26	from	from	ADP
ajlm-846	347	27	a	a	DET
ajlm-846	347	28	large	large	ADJ
ajlm-846	347	29	teaching	teaching	NOUN
ajlm-846	347	30	hospital	hospital	NOUN
ajlm-846	347	31	.	.	PUNCT
ajlm-846	348	1	clin	clin	PROPN
ajlm-846	348	2	infect	infect	PROPN
ajlm-846	348	3	dis	dis	PROPN
ajlm-846	348	4	.	.	PUNCT
ajlm-846	349	1	2009;48:425–429	2009;48:425–429	PROPN
ajlm-846	349	2	.	.	PUNCT
ajlm-846	350	1	https://doi.org/10.1086/596315	https://doi.org/10.1086/596315	PROPN
ajlm-846	350	2	dang	dang	INTJ
ajlm-846	350	3	ut	ut	PROPN
ajlm-846	350	4	,	,	PUNCT
ajlm-846	350	5	zamora	zamora	PROPN
ajlm-846	351	1	i	i	PRON
ajlm-846	351	2	,	,	PUNCT
ajlm-846	351	3	hevener	hevener	PROPN
ajlm-846	351	4	ke	ke	PROPN
ajlm-846	351	5	,	,	PUNCT
ajlm-846	351	6	et	et	PROPN
ajlm-846	351	7	al	al	PROPN
ajlm-846	351	8	.	.	PUNCT
ajlm-846	352	1	rifamycin	rifamycin	PROPN
ajlm-846	352	2	resistance	resistance	NOUN
ajlm-846	352	3	in	in	ADP
ajlm-846	352	4	clostridium	clostridium	NOUN
ajlm-846	352	5	difficile	difficile	NOUN
ajlm-846	352	6	is	be	AUX
ajlm-846	352	7	generally	generally	ADV
ajlm-846	352	8	associated	associate	VERB
ajlm-846	352	9	with	with	ADP
ajlm-846	352	10	a	a	DET
ajlm-846	352	11	low	low	ADJ
ajlm-846	352	12	fitness	fitness	NOUN
ajlm-846	352	13	burden	burden	NOUN
ajlm-846	352	14	.	.	PUNCT
ajlm-846	353	1	antimicrob	antimicrob	PROPN
ajlm-846	353	2	agents	agents	PROPN
ajlm-846	353	3	chemother	chemother	PROPN
ajlm-846	353	4	.	.	PUNCT
ajlm-846	354	1	2016;60:5604–5607	2016;60:5604–5607	VERB
ajlm-846	354	2	.	.	PUNCT
ajlm-846	355	1	https://doi.org/10.1128/aac.01137-16	https://doi.org/10.1128/aac.01137-16	PROPN
ajlm-846	355	2	stabler	stable	ADJ
ajlm-846	355	3	ra	ra	PROPN
ajlm-846	355	4	,	,	PUNCT
ajlm-846	355	5	he	he	PRON
ajlm-846	355	6	m	m	PROPN
ajlm-846	355	7	,	,	PUNCT
ajlm-846	355	8	dawson	dawson	PROPN
ajlm-846	355	9	l	l	PROPN
ajlm-846	355	10	,	,	PUNCT
ajlm-846	355	11	et	et	PROPN
ajlm-846	355	12	al	al	PROPN
ajlm-846	355	13	.	.	PROPN
ajlm-846	355	14	comparative	comparative	ADJ
ajlm-846	355	15	genome	genome	NOUN
ajlm-846	355	16	and	and	CCONJ
ajlm-846	355	17	phenotypic	phenotypic	ADJ
ajlm-846	355	18	analysis	analysis	NOUN
ajlm-846	355	19	of	of	ADP
ajlm-846	355	20	clostridium	clostridium	NOUN
ajlm-846	355	21	difficile	difficile	NOUN
ajlm-846	355	22	027	027	NUM
ajlm-846	355	23	strains	strain	NOUN
ajlm-846	355	24	provides	provide	VERB
ajlm-846	355	25	insight	insight	NOUN
ajlm-846	355	26	into	into	ADP
ajlm-846	355	27	the	the	DET
ajlm-846	355	28	evolution	evolution	NOUN
ajlm-846	355	29	of	of	ADP
ajlm-846	355	30	a	a	DET
ajlm-846	355	31	hypervirulent	hypervirulent	ADJ
ajlm-846	355	32	bacterium	bacterium	NOUN
ajlm-846	355	33	.	.	PUNCT
ajlm-846	356	1	genome	genome	NOUN
ajlm-846	356	2	biol	biol	NOUN
ajlm-846	356	3	.	.	PUNCT
ajlm-846	357	1	2009;10	2009;10	NUM
ajlm-846	357	2	:	:	PUNCT
ajlm-846	357	3	r102	r102	NUM
ajlm-846	357	4	.	.	PUNCT
ajlm-846	357	5	https://doi.org/10.1186/gb-2009-10-9-r102	https://doi.org/10.1186/gb-2009-10-9-r102	PROPN
ajlm-846	357	6	dridi	dridi	ADJ
ajlm-846	357	7	l	l	NOUN
ajlm-846	357	8	,	,	PUNCT
ajlm-846	357	9	tankovic	tankovic	PROPN
ajlm-846	357	10	j	j	PROPN
ajlm-846	357	11	,	,	PUNCT
ajlm-846	357	12	burghoffer	burghoffer	PROPN
ajlm-846	357	13	b	b	PROPN
ajlm-846	357	14	,	,	PUNCT
ajlm-846	357	15	et	et	PROPN
ajlm-846	357	16	al	al	PROPN
ajlm-846	357	17	.	.	PUNCT
ajlm-846	357	18	gyra	gyra	PROPN
ajlm-846	357	19	and	and	CCONJ
ajlm-846	357	20	gyrb	gyrb	NOUN
ajlm-846	357	21	mutations	mutation	NOUN
ajlm-846	357	22	are	be	AUX
ajlm-846	357	23	implicated	implicate	VERB
ajlm-846	357	24	in	in	ADP
ajlm-846	357	25	cross	cross	NOUN
ajlm-846	357	26	-	-	NOUN
ajlm-846	357	27	resistance	resistance	NOUN
ajlm-846	357	28	to	to	ADP
ajlm-846	357	29	ciprofloxacin	ciprofloxacin	PROPN
ajlm-846	357	30	and	and	CCONJ
ajlm-846	357	31	moxifloxacin	moxifloxacin	NOUN
ajlm-846	357	32	in	in	ADP
ajlm-846	357	33	clostridium	clostridium	NOUN
ajlm-846	357	34	difficile	difficile	ADJ
ajlm-846	357	35	.	.	PUNCT
ajlm-846	358	1	antimicrob	antimicrob	PROPN
ajlm-846	358	2	agents	agents	PROPN
ajlm-846	358	3	chemother	chemother	PROPN
ajlm-846	358	4	.	.	PUNCT
ajlm-846	359	1	2002;46:3418–3421	2002;46:3418–3421	NUM
ajlm-846	359	2	.	.	PUNCT
ajlm-846	360	1	https://doi.org/10.1128/aac.46.11.3418-3421.2002	https://doi.org/10.1128/aac.46.11.3418-3421.2002	PRON
ajlm-846	360	2	spigaglia	spigaglia	PROPN
ajlm-846	360	3	p	p	NOUN
ajlm-846	360	4	,	,	PUNCT
ajlm-846	360	5	barbanti	barbanti	PROPN
ajlm-846	360	6	f	f	PROPN
ajlm-846	360	7	,	,	PUNCT
ajlm-846	360	8	louie	louie	PROPN
ajlm-846	360	9	t	t	PROPN
ajlm-846	360	10	,	,	PUNCT
ajlm-846	360	11	et	et	PROPN
ajlm-846	360	12	al	al	PROPN
ajlm-846	360	13	.	.	PUNCT
ajlm-846	361	1	molecular	molecular	ADJ
ajlm-846	361	2	analysis	analysis	NOUN
ajlm-846	361	3	of	of	ADP
ajlm-846	361	4	the	the	DET
ajlm-846	361	5	gyra	gyra	NOUN
ajlm-846	361	6	and	and	CCONJ
ajlm-846	361	7	gyrb	gyrb	VERB
ajlm-846	361	8	quinolone	quinolone	NOUN
ajlm-846	361	9	resistance	resistance	NOUN
ajlm-846	361	10	-	-	PUNCT
ajlm-846	361	11	determining	determine	VERB
ajlm-846	361	12	regions	region	NOUN
ajlm-846	361	13	of	of	ADP
ajlm-846	361	14	fluoroquinolone	fluoroquinolone	NOUN
ajlm-846	361	15	-	-	PUNCT
ajlm-846	361	16	resistant	resistant	ADJ
ajlm-846	361	17	clostridium	clostridium	NOUN
ajlm-846	361	18	difficile	difficile	NOUN
ajlm-846	361	19	mutants	mutant	NOUN
ajlm-846	361	20	selected	select	VERB
ajlm-846	361	21	in	in	ADP
ajlm-846	361	22	vitro	vitro	X
ajlm-846	361	23	.	.	PUNCT
ajlm-846	362	1	antimicrob	antimicrob	PROPN
ajlm-846	362	2	agents	agents	PROPN
ajlm-846	362	3	chemother	chemother	PROPN
ajlm-846	362	4	.	.	PUNCT
ajlm-846	363	1	2009;53:2463–2468	2009;53:2463–2468	NUM
ajlm-846	363	2	.	.	PUNCT
ajlm-846	364	1	https://doi.org/10.1128/aac.01252-08	https://doi.org/10.1128/aac.01252-08	NOUN
ajlm-846	364	2	wasels	wasel	VERB
ajlm-846	364	3	f	f	PROPN
ajlm-846	364	4	,	,	PUNCT
ajlm-846	364	5	kuehne	kuehne	PROPN
ajlm-846	364	6	sa	sa	PROPN
ajlm-846	364	7	,	,	PUNCT
ajlm-846	364	8	cartman	cartman	PROPN
ajlm-846	364	9	st	st	PROPN
ajlm-846	364	10	,	,	PUNCT
ajlm-846	364	11	et	et	PROPN
ajlm-846	364	12	al	al	PROPN
ajlm-846	364	13	.	.	PROPN
ajlm-846	364	14	fluoroquinolone	fluoroquinolone	NOUN
ajlm-846	364	15	resistance	resistance	NOUN
ajlm-846	364	16	does	do	AUX
ajlm-846	364	17	not	not	PART
ajlm-846	364	18	impose	impose	VERB
ajlm-846	364	19	a	a	DET
ajlm-846	364	20	cost	cost	NOUN
ajlm-846	364	21	on	on	ADP
ajlm-846	364	22	the	the	DET
ajlm-846	364	23	fitness	fitness	NOUN
ajlm-846	364	24	of	of	ADP
ajlm-846	364	25	clostridium	clostridium	NOUN
ajlm-846	364	26	difficile	difficile	VERB
ajlm-846	364	27	in	in	ADP
ajlm-846	364	28	vitro	vitro	X
ajlm-846	364	29	.	.	PUNCT
ajlm-846	365	1	antimicrob	antimicrob	PROPN
ajlm-846	365	2	agents	agents	PROPN
ajlm-846	365	3	chemother	chemother	PROPN
ajlm-846	365	4	.	.	PUNCT
ajlm-846	366	1	2015;59:1794–1796	2015;59:1794–1796	NUM
ajlm-846	366	2	.	.	PUNCT
ajlm-846	367	1	https://doi.org/10.1128/aac.04503-14	https://doi.org/10.1128/aac.04503-14	PROPN